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Studies on Mouse Oocyte Meiotic Arrest and Maturation 
Katie Mae Lowther
University of Connecticut, 2013 
Mammalian oocytes enter meiosis during embryonic development and arrest at 
prophase I until a preovulatory surge of lutenizing hormone (LH) from the pituitary 
stimulates meiotic resumption.  Meiotic arrest is maintained by high levels of cAMP 
generated in the oocyte by the constitutively active receptor, GPR3.  It is unknown how 
GPR3 activity in the oocyte is regulated and whether the receptor is desensitized and 
endocytosed by GPCR kinase (GRK)-?????????????????????????????-arrestin 
recruitment.  In the mouse oocyte, endocytic inhibition increased cAMP levels and 
inhibited spontaneous maturation.  We hypothesize that GPR3 signals from the cell 
surface and inhibiting endocytosis causes GPR3 to accumulate at the cell surface and 
increase cAMP levels.  In order to directly compare the localization and signaling of 
GPR3, we extended our studies in HEK293 cells.  Endocytic inhibition increased cell 
surface-?????????????????????????????????????????????????????????????????-arrestin-2 
decreased cell surface-localized GPR3 and cAMP levels.  Mutation of potential 
phosphorylation sites in the third intracellular loop dramatically increased cAMP 
production compared to WT; however, these sites are not targeted by GRK2 for 
desensitization.  Mutation of serines in the C-terminus did not change cAMP levels but 
did decrease the membrane localization of GPR3.  We conclude that GPR3 signals at the 
cell membrane and does not continue to signal following internalization, although 
placement at the plasma membrane may not be required for cAMP production and GPR3 
may be able to signal prior to membrane insertion. Further studies are required to 
determine if GPR3 is phosphorylated and targeted for regulation by other kinases or G 
protein-coupled interacting proteins.
Katie Mae Lowther – University of Connecticut, 2013
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 CHAPTER ONE
UIntroduction
I. U Meiotic Transition in Mammalian Oocytes
Prior to fertilization, diploid germ cells reduce their number of chromosomes in 
half, a process defined as meiosis.  In the female, oocytes enter meiosis during embryonic 
development but arrest at the diplotene stage of prophase I.  Oocytes remain arrested until 
reproductive maturity, which may last months to years depending on the mammalian 
species (Eppig et al., 2004a).  During the estrus or menstrual cycle, the oocyte completes 
growth and achieves meiotic competence. In response a preovulatory surge of luteinizing 
hormone (LH), released from the pituitary gland, the oocyte is stimulated to resume 
meiosis.  The oocyte arrests again at metaphase II until fertilization causes the completion 
of meiosis (Mehlmann, 2005b).
During development, the oocyte is surrounded by one or more layers of granulosa 
cells, a structure referred to as an ovarian follicle (Gougeon, 1996).  At the earliest stage, 
the primordial follicle contains an oocyte surrounded by one layer of squamous pre-
granulosa cells. The primordial follicle transitions to a primary follicle, a process in 
which the granulosa cells change from squamous to cuboidal. During follicular growth, 
the granulosa cells divide, forming several layers around the oocyte to become a
secondary, preantral follicle.  Oocytes within primary and preantral follicles are 
meiotically incompetent.  In response to the pituitary gonadotropin, follicle-stimulating 
hormone (FSH), the granulosa cells continue to proliferate, the oocyte enlarges, and a 
fluid-filled antrum begins to form between the granulosa cells producing a tertiary, antral 
follicle (Gougeon, 1996).  The antrum separates the granulosa cells into two separate 
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 compartments: the outer mural granulosa cells that line the basement membrane of the 
follicle and the inner cumulus cells that surround the oocyte.  During this time, the 
follicle also develops LH receptors on the outer mural granulosa cells.  The oocyte 
achieves meiotic competence around the time of antrum formation when the oocyte has 
reached its full size (~75 μm diameter in mouse) and when a sufficient amount of cell 
cycle proteins are synthesized (Mehlmann, 2005b).
Meiotic Arrest is Mediated by High Levels of cAMP in the Oocyte
Prophase I arrest in a fully grown, competent oocyte is achieved by high levels of 
cyclic adenosine 3’ 5’-monophosphate (cAMP) (Conti et al., 2002).  cAMP is produced 
by the constitutively active G-protein coupled receptor, GPR3 (mouse) or GPR12 (rat) 
(Mehlmann et al. 2002; Mehlmann et al, 2004; Hinckley et al. 2005; Ledent et al. 2005; 
Vaccari et al. 2008).  GPR3 is also expressed in Xenopus, human, and porcine oocytes, 
suggesting a conserved function across species (Deng et al., 2008; DiLuigi et al., 2008; 
Rios-Cardona et al., 2008; Yang et al., 2012).  GPR3/12 activates the G?RsR G protein, 
which in turn activates adenylate cyclase type 3 to synthesize cAMP (Horner et al. 2003; 
Freudzon et al. 2005; Hinckley et al. 2005; Mehlmann 2005b).  Removal or inactivation 
of any of the components of this signaling pathway causes the oocyte to resume meiosis 
in the absence of the LH signal (Mehlmann et al. 2002; Horner et al. 2003; Mehlmann et 
al. 2004; Ledent et al. 2005; Mehlmann 2005b; DiLuigi et al. 2008; Vaccari et al. 2008).
Elevated cAMP levels prevent meiotic maturation by inhibiting the activity of 
downstream cell cycle regulatory proteins referred to as meiosis promoting factor (MPF).  
MPF is a serine/threonine kinase protein heterodimer composed of a catalytic subunit, 
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 cyclin-dependent kinase 1 (CDK1), and a regulatory subunit, cyclin B.  cAMP activates 
protein kinase A (PKA), which indirectly regulates MPF activity by controlling the 
activities of the phosphatase CDC25B (Lincoln et al., 2002; Pirino et al., 2009) and the 
kinases WEE1 and MYT1 (Han and Conti, 2006; Stanford and Ruderman, 2005).  PKA 
activates the WEE1 and MYT1 kinases that phosphorylate CDK1 on Thr14 and Tyr15 
residues to render it inactive (Duckworth et al., 2002).  PKA also phosphorylates
CDC25B, causing the phosphatase to be sequestered in the cytoplasm, and keeping
CDK1 in the nucleus inactive (Oh et al., 2010).  When cAMP in the oocyte decreases, 
CDC25B is no longer phosphorylated by PKA, it becomes active and translocates to the 
nucleus, where it dephosphorylates CDK1(Morgan, 1995; Oh et al., 2010).
Dephosphorylation of CDK1, association with cyclin B, and a change in cyclin B levels 
result in MPF activation and meiotic resumption (Clarke and Karsenti, 1991; Ledan et al., 
2001).
cGMP from the Somatic Cells of the Follicle Maintains Meiotic Arrest
Although the oocyte contains all the components necessary to produce cAMP, 
meiotic arrest is under the control of the surrounding follicle cells.  Evidence of this came 
from early experiments in which removal of the oocyte or cumulus-enclosed oocyte 
complexes from the follicle caused the oocyte to resume meiosis spontaneously 
(Edwards, 1965; Pincus and Enzmann, 1935). Spontaneous maturation occurs due to a 
decrease in cAMP in the oocyte (Vivarelli et al., 1983) and can be prevented by 
membrane permeable cAMP analogs (Cho et al., 1974) or phosphodiesterase (PDE)
inhibitors (Magnusson and Hillensjo, 1977). Recent studies support the hypothesis that 
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 the level of cAMP in the oocyte is regulated by PDE3A, the main PDE isoform expressed 
in the mouse oocyte (Masciarelli et al., 2004; Shitsukawa et al., 2001; Tsafriri et al., 
1996) that in turn is regulated by a signal from the somatic cells. Consistent with this 
hypothesis, it has been demonstrated that the follicle supplies the oocyte with cyclic 
guanosine 3’, 5’-monophosphate (cGMP), a competitive inhibitor of PDE3A (Jaffe and 
Norris, 2010).  cGMP levels in the follicle are controlled by a paracrine loop in which 
granulosa cells express natriuretic peptide precursor type C (NPPC). NPPC activates the 
NPPC receptor (NPR2), a membrane-bound guanylate cyclase, on the cumulus and 
granulosa cells that stimulates the generation of cGMP (Zhang et al., 2010).  cGMP 
diffuses into the oocyte via gap junctions and inhibits PDE3A, thus maintaining cAMP at 
a high level necessary for meiotic arrest (Jaffe and Norris, 2010; Norris et al., 2009).
LH Initiates Meiotic Resumption by Stimulating PDE3A Activity in the Oocyte
The follicle is not only important for maintaining arrest, but is also important for 
meiotic resumption stimulated by LH. The oocyte does not express LH receptors,
instead, LH binds to receptors located on the theca and outer granulosa cells (Eppig et al., 
1997; Peng et al., 1991). It is now well accepted that LH causes cGMP levels to 
significantly decrease in the somatic cells and in the oocyte, thereby allowing PDE3A
activation (Norris et al., 2009; Vaccari et al., 2009) and subsequent cAMP degradation in 
the oocyte. Following 1-1.4 hours after LH treatment, cAMP decreases from ~700 nM 
to ~140 nM in in vitro antral follicle-enclosed oocytes and this is in within the range to 
decrease PKA activity (Norris et al., 2009). cGMP in the oocyte decreases due to the 
decrease in cGMP in the somatic cells and also due to gap junction closure between 
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 granulosa cells that prevents cGMP from diffusing into the oocyte (Jaffe and Norris, 
2010; Norris et al., 2008; Norris et al., 2009; Zhang et al., 2010).  The level of cGMP 
decreases in the somatic cells following LH due to the decrease in NPR2 activity 
(Robinson et al., 2012) and the decrease in expression of NPPC transcripts (Kawamura et 
al., 2011). In summary, LH treatment or removal of the oocyte from the follicle leads to 
a decrease in cGMP in the oocyte and relieves the inhibition of PDE3A.  As a result, 
cAMP levels in the oocyte decrease and meiotic resumption occurs.
Cytoplasmic Changes Occur during Meiotic Resumption that are Important for 
Fertilization and Early Development
Following meiotic resumption, the oocyte progresses to metaphase II where it 
undergoes a second meiotic arrest.  This transition involves coordinated nuclear and 
cytoplasmic changes such that when the egg is ovulated it is at the appropriate stage to be 
fertilized and begin early embryonic development (Eppig et al., 2004a).  In the appendix 
of this dissertation, nuclear and cytoplasmic changes are examined in oocytes that have 
been vitrified and matured in vitro.  Because cryopreservation and in vitro maturation 
(IVM) are becoming promising technologies for assisted reproduction, it is important to 
understand if nuclear and cytoplasmic changes are preserved during these processes as 
indicators of developmental competence.
Morphologically, meiotic resumption is characterized by the disappearance of the 
nuclear envelope, or germinal vesicle (GV); this is called germinal vesicle breakdown 
(GVBD).  Changes in chromatin configuration, formation of microtubule organization 
centers, and restructuring of microfilaments occur during this time (Schuh and Ellenberg, 
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 2007). The first meiotic division progresses unequally with most of the cytoplasm 
retained in the egg and the extrusion of the first polar body. Several cytoplasmic changes 
also occur during meiotic maturation that are important for the ability of an egg to 
respond to inositol 1,4,5-trisphosphate (IPR3R) and release CaP2+P at fertilization (Carroll et
al., 1994; Goud et al., 1999; Jones et al., 1995; Mehlmann and Kline, 1994).  We will 
focus on one major cytoplasmic change that is the dramatic reorganization of the 
endoplasmic reticulum (ER), the major site of CaP2+P storage.  ER structure can be easily 
visualized by dicarbocyanine dyes (DiI) and confocal microscopy (Kline, 2000);
therefore, this profound reorganization has been well documented.
IPR3R sensitivity and CaP2+P release are indicators of developmental competence 
because they are important for events that lead to early embryo development, including 
resumption and completion of meiosis, the prevention of polyspermy, and recruitment of 
mRNAs required for activation of the embryo genome (Ducibella et al., 2006).  The 
development of a metaphase II-like CaP2+P release does not seem to depend on meiotic 
progression because oocytes arrested spontaneously at MI produce continuous CaP2+P
oscillations similar to a fertilized MII egg (Jones et al., 1995).  This underscores the 
importance of cytoplasmic changes that occur during oocyte maturation for fertilization 
and early embryonic development.
II. UStudies on the Constitutively Active G protein-Coupled Receptor 3 
Identification of GPR3 as an Activator of GRsR for Meiotic Arrest
As discussed previously, GPR3 is essential for maintaining prophase I arrest in 
mouse and porcine oocytes (Hinckley et al., 2005; Ledent et al., 2005; Mehlmann et al., 
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 2004; Yang et al., 2012) and may play a role in meiotic arrest in human and Xenopus
oocytes (Deng et al., 2008; DiLuigi et al., 2008; Rios-Cardona et al., 2008).  Prior to the 
identification of GPR3, it was well acknowledged that prophase I arrest is dependent
upon high levels of cAMP in the oocyte, ?????????????????????????????????????????????RsR,
but how this signaling pathway is activated was unknown.  As GRsR does not exhibit 
constitutive activity, it was thought that a GPCR in the oocyte was present to keep it 
active. GPR3 was identified as a candidate for this receptor by searching for GPCRs in 
an EST database from a cDNA library of fully grown prophase-arrested mouse oocytes.  
Fifteen putative GPCRs were identified, many of which were orphan receptors with no 
known function (Mehlmann et al., 2004).  Of these, GPR3 was of interest because it
elevates cAMP when transfected into cultured cells (Eggerickx et al., 1995; Hinckley et 
al., 2005).
To confirm that GPR3 is the GRsR-linked receptor that maintains meiotic arrest in 
mouse oocytes, histological sections of ovaries from Gpr3 knockout mice were 
examined.  Although the ovaries from these mice appeared to be normal and displayed 
normal ovulation and luteinization, the oocytes within antral follicles had resumed 
meiosis and contained metaphase chromosomes (Mehlmann et al., 2004). Oocytes in 
preantral follicles remained arrested until antral spaces formed and the oocytes achieved 
meiotic competence, at which point the oocytes spontaneously resumed meiosis.
Premature maturation is due to the absence GPR3 in the oocyte because it can be rescued 
by injection of Gpr3 mRNA into preantral or early antral follicle-enclosed oocytes 
(Mehlmann et al., 2004). Furthermore, oocyte-specific knockdown of Gpr3 using RNA 
interference (RNAi), or reduction of GPR3 using morpholinos, stimulated premature 
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 maturation (Mehlmann, 2005; Hinckley et al., 2005).   Thus, in the absence of oocyte-
specific GPR3, the oocyte can no longer produce cAMP required to maintain arrest and
premature meiotic resumption occurs.  
Following the identification of GPR3 in the oocyte, it was subsequently shown 
??????????????????????RsR in the oocyte and that GPR3 activity does not depend on the 
presence of the follicle cells (Freudzon et al., 2005). GPR3 is also not a target for LH-
induced meiotic resumption. It was thought that LH could provide an inverse agonist that 
would turn off GPR3 and reduce cAMP levels in the oocyte.  However, treatment of 
follicle-?????????????????????????????????????????????????????Rs Ractivity (Norris et al, 
2007).  Thus, the follicle does not appear to produce an agonist or antagonist that affects 
GPR3 activity, nor does LH stimulate meiotic resumption by terminating GPR3-GRsR
signaling. In addition, it seems as though GPR3 remains constitutively active at least 
until metaphase II.  Gpr3 mRNA is present in oocytes, eggs, and early embryos at the one 
and two cell stage.  A trace amount of Gpr3 mRNA is detected in morulae and it is absent 
in blastocysts (Ledent, 2005).    
In addition to premature maturation, Gpr3-deficient mice are subfertile and 
display a progressive reduction in litter size with advancing maternal age. Aging Gpr3-
deficient females exhibit an increase in the number of fragmented oocytes, reduced 
developmental capacity of embryos, and increased signs of reproductive aging.  This 
phenotype presumably occurs because the coordination of meiotic progression and 
fertilization is disrupted.  Consequently, Gpr3-deficient mice may constitute a relevant 
model of premature ovarian failure (Ledent et al., 2005). Several studies have examined 
whether mutations in GPR3 are present in women with premature ovarian failure.
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 However, no perturbations were found in the coding region of GPR3 in the populations
included in these studies (Kovanci et al., 2008; Zhou et al., 2009).  Whether GPR3 
expression or activity in the ovary is abnormally regulated in these women remains to be 
explored.
GPR3 also has Functions in the Central Nervous System
GPR3 is not only important for female fertility, but also has several functions in 
the brain.  Two studies by the same group demonstrated that GPR3 regulates neurite 
outgrowth and postnatal cerebellar development, two processes that require elevated 
cAMP levels (Tanaka et al., 2007; Tanaka et al., 2009). Within the past several years 
there have been additional studies linking GPR3 to several other neurological processes 
in the brain.  For example, GPR3 appears to be a novel actor in emotional-like responses, 
involved in the development of neuropathic pain, and modulates early phases of cocaine 
reinforcement (Ruiz-Medina et al., 2011; Tourino et al., 2012; Valverde et al., 2009).
GPR3 was also found to modulate Amyloid-Beta peptide generation in neurons, a 
pathological hallmark of Alzheimer’s disease.  GPR3 is highly expressed in regions of 
the human brain associated with Alzheimer’s disease and its expression is increased in 
the sporadic Alzheimer’s disease brain (Thathiah et al., 2009). In summary, GPR3
appears to have other functions in the brain and has been implicated in both physiological 
and pathological processes.  
GPR3 is an Orphan Receptor that Mediates cAMP Production in the Absence of an 
Agonist
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 Human GPR3 and mouse Gpr3 were originally identified from genomic libraries
by low-stringency PCR using degenerate oligonucleotide primers against conserved 
regions corresponding to the second, third, sixth, and seventh transmembrane regions of 
GPCRs  (Eggerickx et al., 1995; Saeki et al., 1993; Song et al., 1994). Gpr3 mRNA is 
highly expressed in the whole brain with lower expression in the ovary, testis, and eye 
(Eggerickx et al., 1995; Saeki et al., 1993). The open reading frame of GPR3 is 990
nucleotides and encodes a protein that is 330 amino acids with seven 20-25-amino-acid 
hydrophobic segments typical of GPCRs.  It has a predicted molecular mass of 35.5 kD,
but the actual molecular mass of the mature protein may be higher because GPR3 
contains a potential glycosylation site in the amino-terminus.  GPR3 also contains two 
potential sites for phosphorylation by protein kinase C (PKC) as well as several 
serine/threonine residues that could be targets for G protein-receptor kinases (GRKs) in 
the desensitization pathway (Eggerickx et al., 1995; Saeki et al., 1993). Human and 
mouse GPR3 have 91-93% amino acid identity scores (Eggerickx et al., 1995; Song et al., 
1995).
GPR3 is closely related to GPR6 and GPR12 and share ~60% amino acid identity.  
These receptors are classified as rhodopsin-like GPCRs (Class A) belonging to a 
subgroup of GPCRs that includes the orphan receptors EDG1, rCNL3, AGR16, R334, 
and the melanocortin, adrenocorticotropic, and central and peripheral cannabinoid 
receptors (Eggerickx et al., 1995; Song et al., 1995).  GPR3/6/12 also show sequence 
similarities to ACTH receptors, adenosine receptors, and H2 histamine receptors (Saeki 
et al., 1993).  GPR3 and its subgroup share specific structural features and lack distinct 
motifs when compared to other receptor classes.  For example, these receptors lack a
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 conserved cysteine residue in the second extracellular loop that is believed to form a 
disulfide bridge in most GPCRs, a Glu-Asn motif is present rather than Gly-Asn in the 
first transmembrane segment, and no proline residue exists in the fifth transmembrane 
segment (Eggerickx et al., 1995).
Following the molecular cloning of GPR3, extensive studies were performed to 
examine its activity when transfected into cultured cells as well as to identify a potential 
ligand.  Through these studies, it was demonstrated that GPR3 behaves similarly to a 
constitutive activator of adenylate cyclase.  When GPR3 is transfected into a variety of 
cell lines originating from different species, it induces a significant increase in cAMP 
production compared to empty vector cells or cells transfected with GRsR-coupled GPCRs 
without agonist stimulation (Eggerickx et al., 1995).  For example, in CHO cells, basal 
cAMP is 0.2 pmol/mL and increases to 40-55 pmol/mL in response to GPR3 expression.  
This dramatic stimulation of adenylate cyclase is similar to that obtained by GPCRs fully 
stimulated by their corresponding ligands.  cAMP levels can be increased even further to 
80-120 pmol/mL upon stimulation with forskolin, suggesting that the signaling pathway 
could be further modified upwards or downwards by ligands (Eggerickx et al., 1995).
????????????????????????????????????????????????????????????RiR ??????RsR in HEK293 
cells (Uhlenbrock et al., 2002).
The finding that GPR3 stimulates cAMP accumulation in the absence of a ligand 
presents two possibilities: (1) GPR3 has constitutive activity; or (2) an agonist is 
produced by the cells, in the assay medium, or in a component of the assay. It is unlikely 
that the ligand was present in the assay medium because culturing cells in 1% Fetal 
Bovine Serum (FBS), 10% (FBS), serum-free, or defined media did not have significant 
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 effects on cAMP levels.  The ligand was also unlikely to be secreted by the cells because
extensive washing and co-culture experiments did not affect cAMP production
(Eggerickx et al., 1995). These experiments, however, cannot rule out a membrane-
bound ligand.  Due to the sequence similarity of GPR3 to the cannabinoid receptor and its 
ligand anandamide, it is possible that the ligand for GPR3 could be a membrane-derived 
or membrane-bound lipid that is ubiquitously expressed across cell types.  It is also 
possible that an internal ligand present in the cytoplasm activates GPR3.
A number of potential ligands for GPR3 have been tested inconclusively
(Eggerickx et al., 1995; Saeki et al., 1993; Yin et al., 2009).  A small effect of 
sphingosine 1-phosphate (S1P) has been reported on GPR3 activity with <20% increase 
in cAMP over basal levels (Hinckley et al., 2005; Uhlenbrock et al., 2002), although it 
has not been definitively established that the stimulatory effect of S1P on cAMP 
production is due to GPR3 or a S1P receptor expressed endogenously. There are also 
conflicting results in the literature on the effect of serum-containing lipids on GPR3 
activity (Eggerickx et al., 1995; Hinckley et al., 2005; Uhlenbrock et al., 2002). Because 
constitutive signaling is still dramatic in serum-free medium, it suggests that a lipid is not 
the only ligand or that GPR3 is a true constitutively active receptor.  The effect of S1P on 
GPR3 activity may be cell-specific, because S1P does not enhance GPR3 activity in CHO 
cells (Valverde et al., 2009), whereas it does in HEK293 cells (Uhlenbrock et al., 2002; 
Yang et al., 2012). Furthermore, S1P has been reported to induce GPR3 internalization 
in HEK293 cells, and it has been hypothesized that GPR3 internalization may transport 
S1P to subcellular compartments to activate additional signaling pathways (Yang et al., 
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 2012). Thus, the idea of S1P as a ligand for GPR3 is controversial and GPR3 remains an 
orphan receptor.
The second possibility is that GPR3 exhibits constitutive activity.  It has been
proposed that constitutively active receptors favor an active conformation or some 
intermediate conformation between the inactive and the active state (Lefkowitz, 1993).
Several “hot spots”, when mutated on wild-type, inactive GPCRs, are known to confer 
constitutive signaling.  One of these hot spots is known as the DRY (Asp-Arg-Tyr) motif 
and is located at the interface of transmembrane domain III and the second intracellular 
loop.  It is the most highly conserved motif in the GPCR family and many studies have 
shown that mutation of this element renders receptors that are normally inactive to 
become constitutively active (Cohen et al., 1993; Pauwels and Wurch, 1998; Scheer et 
al., 1997).  GPR3 contains the entire DRY motif; therefore, differences in this region that 
might explain constitutive activity can be excluded (Eggerickx et al., 1995; Saeki et al., 
1993; Song et al., 1995; Uhlenbrock et al., 2002).  Another hot spot associated with 
constitutive signaling is the interface of transmembrane domain VI and the end of the 
third intracellular loop.  It is thought that this region contains residues critical for the 
interaction of the receptor with G proteins.  Mutation of these sites results in permanent 
exposure of the GPCR to G proteins, thereby resulting in constitutive signaling (Gether et 
al., 1997; Huang et al., 2001).  Whether GPR3 has alternative amino acids at these sites, 
or any other site that would allow for permanent coupling to GRsR, cannot be answered until 
the crystal structure of GPR3 is resolved.
Regulation of Constitutively Active GPCRs
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 ??????????????????????????????????????????????????????-???????????R2R-AR receptors 
and there is evidence that more than 60 GPCRs exhibit some level of basal activity in 
vitro. Depending on the receptor and the cell type, the levels of constitutive activity 
varies, and in some cases constitutive activity can be reversed by inverse agonists (Seifert 
and Wenzel-Seifert, 2002). It is not clear if a majority of these receptors also exhibit 
constitutive activity in vivo, because constitutive activity is often identified using in vitro
overexpression systems when the GPCR is expressed at significantly higher levels than 
what is physiological (Arvanitakis et al., 1998). Constitutive activity of endogenous 
GPCRs are kept low because a high level of activity can have deleterious effects on cells
(Seifert and Wenzel-Seifert, 2002).  In addition, several viral GPCRs are constitutively 
active and high activity of these receptors contributes to viral infection (Sherrill and 
Miller, 2008). There are very few native constitutively active GPCRs for which high 
activity has been observed in normal physiology (Hanf et al., 1993; Mehlmann et al., 
2004; Mewes et al., 1993; Morisset et al., 2000; Varma, 1999). GPR3 is a leading 
example of a GPCR in which high constitutive activity is important for physiological 
processes.
It is unknown if native constitutively active GPCRs are regulated. Our 
knowledge of how constitutively active receptors are regulated is limited to studies on 
wild type, inactive receptors that are either mutated experimentally or that acquire 
activating mutations during pathogenesis.  Thus, the mechanism regulating native 
constitutively active GPCRs is an area of research that has been largely unexplored.
Currently, there is little known about how GPR3 activity and cAMP levels are regulated 
in the oocyte and nervous system.  Understanding GPR3 signaling and activity could 
14 
 
 have important implications for not only understanding constitutively active receptors in 
general, but also therapeutically for treating reproductive and neurological disorders.
III. G Protein-Coupled Receptor Signaling and Regulation by GRK and 
Arrestin
GPCRs represent the largest family of integral membrane proteins and the most 
versatile group of signaling proteins (Bockaert and Pin, 1999).  GPCRs respond to a 
diverse range of extracellular messengers and are fundamentally important in many 
physiological processes such as sensory perception, cognition, muscle contraction, 
endocrine and exocrine secretion, metabolism, inflammation and immunity.  As a result, 
GPCRs have a huge impact in medicine and approximately 30% of current therapeutics 
target GPCRs (Brink et al., 2004). GPCRs are classified into five main families of 
receptors:  rhodopsin, secretin, glutamate, adhesion, and frizzled-taste-2 (Fredriksson et 
al., 2003).  Despite the diversity of the GPCR super family, they share a common 
structure of seven-transmembrane domains linked by extracellular and intracellular loops, 
an extracellular amino-terminus (N-terminus) and an intracellular carboxyl-terminal (C-
terminus or C-tail) domain.  
GPCRs receive extracellular stimuli and transmit signals to the interior of the cell 
by way of second messengers.  For many GPCRs, agonist binding to the extracellular 
domains of the receptor causes the receptor to adopt an active conformation, an event that 
involves a series of conformational changes within the transmembrane and intracellular 
domains.  This conformational change exposes intracellular binding sites for 
heterotrimeric GTP-binding proteins (G proteins).  The GPCR acts as a guanine exchange 
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 factor for G proteins and catalyzes the exchange of GDP for GTP on the GR?R subunit.  As 
a result, the G-protein complex dissociates, producing a GR?R-GTP subunit and a GR??R
heterodimer (Reiter and Lefkowitz, 2006).  Both of these active subunits can positively or 
negatively regulate the activity of downstream effectors (eg. adenylate cyclase, 
phospholipases, and ion channels) to generate second messenger molecules (eg. cAMP, 
inositol trisphosphate, and CaP2+P) that produce a variety of physiological responses (Neer, 
1995).  GPCRs can also signal independently of G-proteins.  The best characterized G 
protein-???????????? ???????????? ????????????-arrestins from endosomal 
compartments (Lefkowitz and Shenoy, 2005).
A majority of GPCRs become activated and signal at the cell surface where the 
receptor interacts with its agonist.  Therefore, the level of receptor present at the plasma 
membrane is thought to dictate the magnitude of GPCR signaling.  Expression levesl of 
GPCRs at the plasma membrane is the result of a balance of three highly regulated and 
dynamic intracellular trafficking processes:  export, internalization, and degradation 
(Duvernay et al., 2005). GPCRs are synthesized, folded, and assembled in the ER.  
Properly folded GPCRs migrate from the ER to the ERGIC (ER-golgi intermediate 
complex), to the Golgi, and to the TGN (transgolgi network). Mature GPCRs bud off the 
TGN and migrate to the plasma membrane, at which point they can interact with their
ligand and transduce a physiological response.  Once at the cell surface, GPCRs undergo 
internalization, which can be tonic or agonist-induced, and leads to either recycling or 
downregulation of the signaling response (Duvernay et al., 2005).
During trafficking to and from the plasma membrane, GPCRs associate with a
myriad of proteins (referred to as GPCR interacting proteins; GIPs) that influence GPCR 
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 function and signal transduction (Magalhaes, Dunn & Ferguson, 2011).  These proteins 
can be either transmembrane or cytosolic and are involved in signaling, receptor ligand 
specificity, receptor endocytosis, expression at the cell surface, receptor recycling, 
processing in the ER, and compartmentalization.  Of the many GPCR interacting 
proteins, G-protein receptor kinases (GRK) and arrestins will be the focus of this 
dissertation as they are the only two protein families that are able to specifically interact 
with the activated conformation of GPCRs and are involved in regulating GPCR activity 
at the cell surface (Lefkowitz and Shenoy, 2005).  There are 7 subtypes of GRKs and 4 
subtypes of arrestins.  GRKs 1 and 7 are limited to retinal rods and cones, respectively.  
GRK4 is expressed in the cerebellum, testis, and kidney whereas GRKs 2, 3, 5, and 6 are 
ubiquitously expressed (Reiter and Lefkowitz, 2006). Arrestins 1 and 2 are specific to
the visual system and arrestin-????-arrestin-???????????????????-arrestin-2) are widely 
expressed (Reiter and Lefkowitz, 2006). GRKs and arrestins coordinate GPCR activities 
in three ways: (1) silencing of G protein signaling by desensitization; (2) receptor 
internalization and trafficking; and (3) signaling independent of G proteins.  GPCR 
????????????????????????????-arrestin as a mechanism to regulate GPR3 activity will be 
the focus of this dissertation.
??????????-arrestins in GPCR Desensitization
Most cells have developed ways of limiting and regulating GPCR activity.  The 
most understood mechanism is receptor desensitization that silences GPCR signaling in 
response to acute or chronic receptor stimulation. Despite their diversity, most GPCRs
undergo desensitization that involves a universal mechanism orchestrated by GRKs and 
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 arrestins.  As mentioned previously, the GPCR undergoes a conformational change 
following ligand binding.  This conformational change not only allows for G protein 
activation, but it also unmasks sites for phosphorylation by GRKs.  GRKs phosphorylate 
serine and threonine residues at the C-terminus and/or the third intracellular loop.  
Phosphorylation of the activated receptor recruits arrestin with high affinity and arrestin 
acts through steric hindrance to uncouple G proteins from the receptor and to prevent 
further GPCR signaling (Kohout and Lefkowitz, 2003).  Studies have shown that arrestin 
binding can diminish receptor signaling by as much as 80% (Attramadal et al., 1992; 
Lohse et al., 1992)????????????????????????????????????????????????????????-arrestins can 
also interact with cAMP phosphodiesterases of the 4D family (Perry et al., 2002) to 
simultaneously prevent cAMP generation while enhancing cAMP degradation.  Thus, 
many GPCRs undergo desensitization following activation as a mechanism to regulate G 
protein activation and production of second messengers.  Whether there is a functional 
desensitization pathway in the oocyte and whether it regulates GPR3 activity is currently
unknown. 
Although phosphorylation of GPCRs by GRKs is an important event for arrestin 
recruitment and attenuation of G-protein activation, GRKs can also regulate GPCR 
signaling independently of phosphorylation.  Studies using kinase inactive GRK mutants
demonstrate that phosphorylation is not absolutely required for desensitization.  GRK2
and GRK3 possess a Regulator of G protein signaling (RGS)-like domain in the N-
terminus that can sequester activated GR?R subunits to prevent coupling to downstream 
effectors (Ferguson, 2007a). There is also evidence that GRK2 and GRK3 can diminish 
G protein signaling by simply interacting with the GPCR (Dhami et al., 2002).  For 
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 example, the expression of only the N-terminal domain that contains elements for GPCR 
binding is sufficient to desensitize some GPCRs (Ferguson, 2007a). GRK2 mediated 
phosphorylation-?????????????????????????????????????????????????????????????RsR-????RiR-
??????RqR-coupled receptors (Dicker et al., 1999; Lembo et al., 1999; Reiter et al., 2001).
The GRK/arrestin regulatory system is versatile and can be tailored to regulate 
physiological processes in a tissue-specific manner.  The extent of desensitization and the 
signaling outcome depend on the cell type, the receptor, the contribution of each 
individual GRK and arrestin subtype, the affinity to which arrestin binds, and the pattern
of GPCR phosphorylation (Reiter and Lefkowitz, 2006).  It should also be mentioned that 
GPCR desensitization is a complex situation that extends beyond the traditional role of 
??????????-arrestin.  Kinases other than GRK, such as protein kinase C (PKC), PKA, 
protein kinase B (AKT/PKB), and casein kinases have all been found to phosphorylate 
GPCRs and modulate their activity, with PKC and PKA more commonly contributing to 
desensitization.  Additional GIPs including calmodulin, RGS proteins, and optineurin can 
also regulate GPCR activity and act independently of phosphorylation by disrupting the 
interaction between GPCRs and G proteins (Tobin, 2008).
As mentioned previously, little is known about how constitutively active GPCRs 
are regulated, if they are regulated at all.  It is possible that constitutively active GPCRs 
are in an active state and in the appropriate conformation to be continuously 
phosphorylated and transiently desensitized (Leurs et al., 1998).  There is an example of 
at least one constitutively active GPCR, the 46Thuman cytomegalovirus chemokine receptor46T
(US28), that signals from the cell surface and is constitutively phosphorylated by GRK2
and transiently desensitized.  GRK???????-arrestin overexpression induces US28 
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 internalization and attenuates GRqR-mediated phospholipase signaling (Casarosa et al., 
2001; Fraile-Ramos et al., 2001; Miller et al., 2003b; Mokros et al., 2002). Because the 
constitutive activity of US28 appears to be regulated by GRKs, ?-arrestin, and membrane 
trafficking, it is possible that there are common mechanisms that regulate both ligand-
activated GPCRs and constitutively active GPCRs.  GPR3 contains multiple serine and 
threonine residues in the C-terminus and intracellular loops that could be sites for 
phosphorylation by GRKs or other kinases in the desensitization pathway.
??????????-arrestins in GPCR Trafficking
In addition to GPCR desensitiz?????????????????-arrestins have important roles 
in GPCR trafficking.  Although receptor internalization may not be necessary for 
desensitization, it can influence the signaling response and result in: (1) 
dephosphorylation and resensitization of the receptor, (2) targeting of the receptor to
lysosomes for degradation, or (3) activation of additional intracellular pathways (Reiter 
and Lefkowitz, 2006).  Clathrin-mediated endocytosis is the most common and 
understood mechanism by which GPCRs are internalized and it usually requires GPCR
???????????????????????????????????????-arrestin recruitment (Moore et al., 2007; 
Shenoy and Lefkowitz, 2003). However, GPCR internalization via caveolae and other 
uncoated vesicles has also been described (Claing et al., 2002).  Clathrin-mediated 
endocytosis will be the only pathway of GPCR internalization that will be discussed in 
this dissertation. Not only is there little known about desensitization of GPCRs in the 
oocyte, but there is also little known about receptor-mediated endocytosis in the oocyte
and the proteins that might be involved.
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 ?-arrestin facilitates internalization by targeting GPCRs to clathrin coated pits 
?????????????????????????????????????????????????????????????????????????????????????????????
adaptor AP-2 (Goodman et al., 1996; Laporte et al., 1999)????-arrestin can also interact 
with other proteins involved in clathrin-mediated endocytosis such as E3 ubiquitin 
ligases, the small G protein ADP-ribosylation factor 6 and its guanine nucleotide 
exchange factor ADP ribosylation factor nucleotide site opener, phosphatidylinositol 4,5-
bisphosphate (PIPR2R), phosphatidylinositol (3,4,5)-trisphosphate (PIPR3R), and 15TN15T46T-
15T46Tethylmaleimide-sensitive fusion protein15T (Claing et al., 2001; Goodman et al., 1996). In 
addition to ?-arrestin, GRKs may also promote GPCR internalization by interacting with 
endocytic proteins (eg. GTI1, PI3K, and ezrin) or by binding to clathrin heavy chain
(Ferguson, 2001; Shiina et al., 2001). Once the receptor is targeted to clathrin-coated 
pits, the vesicles pinch off from the membrane in a dynamin-dependent or -independent
manner and are trafficked to early endosomes.  At this point, GPCRs can either be sorted 
to recycling endosomes and transported back to the plasma membrane or to late 
endosomes that target receptors to lysosomes for degradation (Moore et al., 2007). The 
stability and affinity with ???????-arrestin binds to the GPCR can also influence post-
endocytic sorting and the kinetics of receptor recycling (Oakley et al., 2001; Reiter and 
Lefkowitz, 2006; Zhang et al., 1999).
Although GPCRs most commonly use arrestin as an adaptor for clathrin coated pit 
targeting, in some cases GPCRs contain specific internalization motifs within the C-
terminus (Bonifacino and Traub, 2003) that can bind to AP-2 (Honing et al., 2005; Ohno 
et al., 1995). The two most common and understood internalization motifs that bind to 
AP-2 complexes are dileucine- and tyrosine-?????? ??????????????????????????????????
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 amino acid with a bulky hydrophobic side chain).  Some GPCRs need both ?-arrestin and 
an internalization motif, but how these two mechanisms cooperate is currently unknown 
(Moore et al., 2007).  GPR3 contains a NPXY tyrosine-based internalization motif within 
the seventh transmembrane domain proximal to the C-terminus.  It is therefore possible
??????????????????????????????????? ?????????? ??????????????????????????? ????????-
arrestins are also required for GPR3 internalization is unknown.
Signaling by Internalized GPCRs
It has been assumed that G protein dependent cascades are activated exclusively 
at the cell surface and that receptor internalization terminates GPCR signaling and the 
production of second messengers.  However, several GPCRs remain intact and continue 
to signal or initiate new signaling pathways from endosomal membranes.  For example, 
the 46Tthyroid stimulating hormone receptor (46T SH) and parathyroid hormone receptor46T
(46TPTH) continue to signal following internalization.  These receptors remain associated 
with G proteins and adenylate cyclase at endosomal compartments where signaling is 
associated with a prolonged cAMP response following hormone treatment (Calebiro et 
al., 2009; Ferrandon et al., 2009; Calebiro et al., 2010).  These studies also found that 
signaling from internalized receptors elicits a different cellular response than signaling 
from receptors at the cell surface.  In addition to the TSH and PTH receptors, there is 
evidence that GRiR-dependent signaling from the S1P receptor may occur intracellularly 
(Mullershausen et al., 2009) and GPR6, a closely related constitutively active receptor to 
GPR3 (Kostenis, 2004b), is localized intracellularly rather than on the cell surface, 
suggesting that it signals from endosomes (Padmanabhan et al., 2009).  Intracellular
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 signaling seems to contradict the well-established process of desensitization; therefore, 
further studies are needed to reconcile these two concepts.  It is not known if intracellular 
cAMP signaling is a general feature of GRsR/GRiR coupled receptors or if it is a characteristic 
of only a few receptors. Additional studies are also needed to determine if other GPCRs 
exhibit intracellular signaling, in what cell types, and what are the consequences of 
intracellular signaling. It is not known where in the oocyte GPR3 signals.  An attractive 
idea is that endosomal signaling of GPR3 contributes to prolonged cAMP production and 
relay of the signal to the interior of the oocyte.
Dissertation Aims
It is clear that most cells have developed ways to limit and regulate GPCR 
signaling.  Because meiotic arrest is dependent upon constitutive GPR3 signaling, it 
raises the question of whether there is a functional desensitization pathway in the oocyte.  
The level of cAMP in a follicle-enclosed oocyte remains constant, even though there is 
continuous production of cAMP and low PDE3A activity (Norris et al., 2009).  This 
demonstrates that there is a balance between cAMP production and degradation.  Perhaps
the cAMP signaling pathway is regulated in order to prevent excessive cAMP
accumulation and this regulation could occur at the level of GPR3. Excessive cAMP 
may be problematic because it could affect oocyte quality or counteract LH-induced 
maturation. In order to address this, the first question that needs to be answered is where 
in the cell GPR3 signals.  As mentioned previously, endosomal signaling is associated 
with a prolonged signaling response for some receptors.  It is therefore possible that 
GPR3 signals intracellularly and is not desensitized.  Alternatively, GPR3 could signal 
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 from the cell surface and be continuously desensitized and internalized, leading to either 
recycling or degradation.  It is also possible that GPR3 is not internalized or targeted for 
desensitization, but rather GPR3 activity is regulated by its level of expression.  For 
example, in Pde3a-null mouse oocytes, Gpr3 mRNA is downregulated by more than 50% 
(Hinckley et al., 2005).
In Xenopus oocytes, vesicular trafficking at the cell membrane is important for 
maintaining meiotic arrest.  Blocking exocytosis promotes meiotic resumption 
independently of progesterone while inhibiting clathrin-mediated endocytosis prevents
meiotic resumption stimulated by progesterone (El-Jouni et al., 2007).  Furthermore, 
effects of overexpressed ?????????-arrestin on stimulating progesterone-independent 
maturation in Xenopus oocytes have also been reported (Wang and Liu, 2003). These 
findings support the argument that a cAMP-producing GPCR is regulated by a 
desensitization pathway and is actively recycled, although the role of the GPCR was not 
examined in this study. Membrane trafficking is also important for meiotic arrest in 
Caenorhabditis elegans (Cheng et al., 2008). In C. elegans oocytes, major sperm protein 
(MSP) is released from sperm in the oviduct where it directly binds to a transmembrane 
protein, VAB-1, on the oocyte and stimulates meiosis (Miller et al., 2003a). A study by 
Cheng, et al., 2008 demonstrated that VAB-1 receptor trafficking may regulate the MSP 
signal, although, it is unclear how the localization of VAB-1 is related to its activity.
Thus, receptor trafficking may be important for meiotic arrest in species other than 
Xenopus and C. elegans.
The following chapters examine the localization and membrane trafficking of 
GPR3 as a possible mechanism by which its constitutive activity is regulated.  Chapter 
24 
 
 two of this dissertation addresses the question of where GPR3 signals in the mouse 
oocyte.  We present evidence that GPR3 signaling at the plasma membrane is sufficient 
for meiotic arrest.  We use a FRET-based technique to measure the amount of cAMP in 
single oocytes treated with an endocytic inhibitor.  Chapter three further investigates the
localization and constitutive activity of GPR3 in HEK293 cells.  GPR3 localization and 
activity in response to endocytic inhibition and overexpression of GRK2 ?????-arrestin-2
is also examined as well as specific residues that may be involved in GPR3 activity and 
surface localization.
In the appendix of this dissertation, we examine whether nuclear and cytoplasmic 
changes are preserved in oocytes that are cryopreserved and matured in vitro.
Cytoplasmic maturation is assessed by microinjection of DiI to label the ER and the 
ability to release calcium is evaluated by microinjection of Calcium green and IPR3R. We 
found that vitrification of GV-stage oocytes does not affect nuclear maturation, continuity 
of the ER, or the ability to release calcium.  However, reorganization of the ER is 
disrupted in vitrified oocytes matured in vitro. We also found that the culture medium 
greatly influenced the ability of the ER to reorganize into distinct clusters during IVM of 
unfrozen oocytes.  Thus, before this technique can become a reliable method for treating
infertility, further studies are needed to improve the process of IVM.
The overall goal of this dissertation is to understand where GPR3 signals in mouse 
oocytes and HEK293 cells and whether the constitutive activity of GPR3 is regulated 
by a ?????-arrestin-mediated mechanism.
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 CHAPTER TWO
UEndocytosis in the Mouse Oocyte and its Contribution to cAMP Signaling During 
Meiotic Arrest
Abstract
Mammalian oocytes are arrested at prophase I of meiosis until a preovulatory 
surge of LH stimulates them to resume meiosis.  Prior to the LH surge, high levels of 
cAMP within the oocyte maintain meiotic arrest; this cAMP is generated in the oocyte 
through the activity of the constitutively active, GRsR-coupled receptor, G-protein-coupled 
receptor 3 (GPR3) or GPR12. Activated GPRs are typically targeted for desensitization 
through receptor-mediated endocytosis, but a continuously high level of cAMP is needed 
for meiotic arrest. The aim of this study was to examine whether receptor-mediated 
endocytosis occurs in the mouse oocyte and whether this could affect the maintenance of 
meiotic arrest. We found that constitutive endocytosis occurs in the mouse oocyte. 
Inhibitors of receptor-mediated endocytosis, monodansylcadaverine and dynasore, 
inhibited the formation of early endosomes and completely inhibited spontaneous meiotic 
resumption. A red fluorescent protein-tagged GPR3 localized in the plasma membrane 
and within early endosomes in the oocyte, demonstrating that GPR3 is endocytosed. 
However, overexpression of G-???????????????????????????????-arrestin-2 had only a 
modest effect on stimulating meiotic resumption, suggesting that these proteins do not 
play a major role in GPR3 endocytosis. Inhibition of endocytosis elevated cAMP levels 
within oocytes, suggesting that there is an accumulation of GPR3 at the plasma 
membrane. These results show that endocytosis occurs in the oocyte, leading to a 
decrease in cAMP production, and suggest that there is a balance between cAMP
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 production and degradation in the arrested oocyte that maintains cAMP levels at an 
appropriate level during the maintenance of meiotic arrest. 
Introduction
Mammalian oocytes become arrested at prophase I of meiosis during embryonic 
development. Oocytes remain in prophase I until a preovulatory surge of LH from the 
pituitary signals to the oocyte, via the surrounding follicle cells, to resume meiosis and 
progress to metaphase II, where they undergo a second arrest. It is at the MII stage that 
fertilization occurs. Meiotic resumption is coordinated with the LH surge, such that by 
the time ovulation occurs the oocyte has undergone nuclear maturation as well as changes 
in intracellular organization (cytoplasmic maturation) that prepare the mature, MII-stage
oocyte to be fertilized and initiate embryonic development. 
It is well established that maintenance of meiotic arrest prior to the LH surge 
depends on high levels of cAMP in the oocyte (Conti et al., 2002; Mehlmann, 2005b). In 
rodents, cAMP is produced in the oocyte by the activity of a constitutively active G-
protein-coupled receptor 3 (GPR3; mouse) or GPR12 (rat; (Hinckley et al., 2005; Ledent 
et al., 2005; Mehlmann et al., 2004; Vaccari et al., 2008), both of which stimulate a GR??R
G-protein to activate adenylate cyclase and thereby produce cAMP (Freudzon et al., 
2005; Hinckley et al., 2005; Horner et al., 2003; Mehlmann, 2005a). The removal or 
inactivation of any of the components of this signaling pathway causes the oocyte to 
undergo meiotic resumption in the absence of the LH surge (DiLuigi et al., 2008; Horner 
et al., 2003; Ledent et al., 2005; Mehlmann, 2005a; Mehlmann et al., 2002; Mehlmann et 
al., 2004; Vaccari et al., 2008).
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 Most GPCRs are inactive until they are stimulated by a ligand. Ligand binding 
triggers a conformational change in the receptor and allows the phosphorylation by G-
pro??????????????????????????????????????????????????????????????????-arrestins, which 
cause receptor internalization through clathrin-coated pits. The receptor can then be 
degraded or recycled back to the membrane (Moore et al., 2007; Reiter and Lefkowitz, 
2006). GPR3 is unusual, as it is constitutively active and is likely to signal in the absence 
of a ligand (Freudzon et al., 2005; Yin et al., 2009). As a constitutively active receptor, it 
is unclear whether GPR3 is internalized in a similar fashion and whether the receptor 
continues to signal internally to provide a constant level of cAMP to the interior of the 
oocyte. Recently, the TSH and PTH receptors, both of which act through the GRsR
signaling pathway, have been shown to continue to signal following endocytosis, within 
early endosomes (Calebiro et al., 2009; Calebiro et al., 2010b; Ferrandon et al., 2009).  In 
addition, GPR6, a constitutively active receptor closely related to GPR3 (Kostenis, 
2004a), is localized within cells rather than on the cell surface, suggesting that it signals 
within endosomes (Padmanabhan et al., 2009). Signaling within endosomes has been 
associated with the ability of the cell to maintain a prolonged response to hormone 
following receptor internalization. Because prolonged cAMP signaling is crucial for the 
maintenance of meiotic arrest, it is possible that endosomal signaling is required for 
sustained cAMP production. Alternatively, it is possible that GPR3 must continuously 
remain in the oocyte plasma membrane in order to be active, so that it would either not 
recycle or be endocytosed and rapidly recycled back to the membrane. Depletion of 
GPR3 in the follicle-enclosed mouse oocyte by RNAi causes oocytes to undergo 
spontaneous maturation in the absence of LH (Mehlmann, 2005a), indicating that GPR3 
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 endocytosis and degradation occur in the oocyte, concomitant with synthesis of new 
GPR3 and insertion into the plasma membrane. 
Receptor-mediated endocytosis is a critical process utilized by oocytes of non-
mammalian species, such as insects and frogs, to import yolk protein precursors (Opresko 
and Wiley, 1987). Import of vitellogenin occurs during oocyte growth through clathrin-
mediated endocytosis following binding to a receptor. Although mammalian oocytes do 
not produce yolk, it is possible that endocytosis could be important during oocyte growth. 
In addition, endocytosis of cell surface receptors could be important for the regulation of 
meiosis. Indeed, receptor trafficking is critical for the regulation of meiotic maturation in 
oocytes of Caenorhabditis elegans (Cheng et al., 2008).
Previous studies have shown that vesicular trafficking at the plasma membrane 
has an important role in maintaining meiotic arrest in Xenopus oocytes (El-Jouni et al., 
2007). Inhibiting exocytosis stimulated meiotic resumption in the absence of 
progesterone, whereas inhibiting endocytosis interfered with the ability of progesterone 
to stimulate meiotic resumption, indicating that some component that maintains meiotic 
arrest must be present in the plasma membrane. It was hypothesized that this component 
could be a constitutively active receptor, although the role of the receptor was not 
investigated. In this study, we examined whether active endocytosis occurs in the mouse 
oocyte and whether endocytosis impacts the maintenance of meiotic arrest. Our results 
demonstrate that trafficking at the membrane occurs and suggest that GPR3 signaling at 
the plasma membrane, rather than intracellularly, is necessary for the maintenance of 
meiotic arrest. 
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 Materials and Methods
UMedia and reagents
Except where noted, all chemicals were obtained from Sigma Chemical Co. The 
medium used to collect isolated oocytes was ????????vitrogen), supplemented with 20 
????????????? ?????????????????????? ???????????????????????????????????????????????
??? ?? ???????????????????????????????? ??????????????????? For extended culture, 
oocytes were placed in bicarbonate-????????? ?????s above, in which the HEPES was 
????????????????? ?????????????????????? The medium used to collect and culture 
follicle-????????????????????? ????????????????????????? ?????????????????????? ?????
streptomycin, and 5% fetal bovine serum (#12000-022, Invitrogen). 
Mouse GPR3-RFP was provided by Y Saeki (Ohio State University) in pHGCY 
and was linearized with PacI prior to in vitro transcription using the mMESSAGE 
mMACHINE T7 ultra kit from Invitrogen. GRK2 was provided by R Lefkowitz (Duke 
University Medical Center) in pRK5 and was subcloned into the EcoRI and BamHI sites 
of pBSSKP+P vector. RNA was linearized with BamHI prior to in vitro transcription. ?eta-
arrestin-2-GFP was obtained from M Caron (Duke University Medical Center) in pS65T 
and was subcloned into pSP64.5 and was linearized with SalI prior to in vitro
transcription. ?????R2R AR was obtained from N Ancellin (University of CT Health Center) 
in pBSSK+ and was linearized with NotI prior to in vitro transcription. MDC was 
?????????????????? ????????????????? Dynasore (Tocris Bioscience, Ellisville, MO, 
????????????????????????? ???????????????????? FM 1-43 (Invitrogen) was prepared as a 
?? ??????????????????
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 UMouse oocyte and follicle isolation and culture
All experiments were done with prior approval of the Animal Care and Use 
Committee at the University of Connecticut Health Center. 
Fully grown, GV-stage mouse oocytes were obtained from the ovaries of 6- to 12-
week old CF-1 mice (Harlan Sprague–Dawley, Indianapolis, IN, USA) that had been 
??????????????? ??????????????????????????????–??? ?????????????????????? Cumulus 
cells were removed by repeated pipetting through a small-bore pipette. Oocytes were 
cultured in ???? ??????????? ?????????????????? ??????????????????????????????????????? ??
(when in HEPES-????????? ??????????????????????????????????????????? ????????????R2R
and 95% air (when in bicarbonate-buffered medium). In some cases, the zonae 
pellucidae were re??????????????? ??????-chymotrypsin (type II). 
??????????????????????? ????????????????????????????????????????????????????- to 
25-day old B6SJL/F1 mice (Jackson Laboratories) as described previously (Jaffe et al., 
2009). Following isolation, follicles were placed on Millicell culture plate inserts 
(PICMORG50, Millipore, Billerica, MA, USA) and cultured in a humidified atmosphere 
?????? ????????????R2R and 95% air. ?????????? ?????????????????????????-enclosed oocytes 
were examined under an upright microscope for the presence of a GV. Only follicles 
containing oocytes with readily visible GVs were selected for use in these experiments. 
UMicroinjection
Microinjection of isolated and follicle-enclosed oocytes was carried out as 
described previously (Jaffe et al., 2009; Kline, 2009).  For isolated oocytes, oocytes were 
placed in HEPES-????????? ???????? ??????????????? For overnight culture, oocytes 
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 were incubated in bicarbonate-????????? ??????????????? ????????? Follicles were 
loaded into an injection chamber between two cover slips spaced ????? ?????????
Following microinjection, follicles were placed on Millicell membranes and incubated 
for 17–??? ??????????????????????????????????????????????????? ?????????????????????
presence or absence of a GV, assessed using a stereoscope.  Quantitative microinjection 
was carried out using pipettes backfilled with mercury and concentrations of injected 
???????????????????????????????????????????????????????????? ???
UImmunoblotting and immunofluorescence
For Western blots, oocyte samples were made by washing oocytes in PBS 
containing 0.1% polyvinyl alcohol (PVA) to remove serum. Oocytes were transferred to 
microcentrifuge tubes, gently pelleted, and excess culture medium was removed.
????????????????????????????????????????????????????????? ????????????? Western blotting 
was performed as described previously (Mehlmann et al., 1998). Except for anti-EEA1, 
which was obtained from Cell Signaling Technology (Danvers, MA, USA), primary and 
secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA). Blots were developed using ECL Plus reagents (Amersham). 
????????????????????????????????????????????????? ???????????????????????
???? ???????????? ??????????? ?? ???R4R, and 0.2% Triton X-?????????? ?? After 
fixation, oocytes were incubated in blocking buffer (PBS containing 0.01% Triton X-100,
0.1% PVA, and 3% BSA), then in primary antibody overnight, diluted 1:100 in blocking 
buffer, at room temperature. Oocytes were then washed in blocking buffer and were 
incubated in secondary antibody and finally in PBS containing 0.1% PVA. The 
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 secondary antibody was Alexa Fluor 488-conjugated anti-rabbit (Invitrogen). Oocytes 
were observed with a 40×, 1.2 NA lens (C-Apochromat; Carl Zeiss MicroImaging, Inc., 
Thornwood, NY, USA) on either a Zeiss 510 or a Zeiss Pascal confocal microscope. 
URT-PCR
RNA was extracted from oocytes or mouse brain using TRIzol reagent 
(Invitrogen), according to the manufacturer's instructions. cDNA was produced using the 
Superscript III Reverse Transcriptase kit (Invitrogen) using oligo-dT as the primer. A
????????????????????????????????????????? ?????????????????????????????????????????????
The cycling parameters were an initial denaturation ????? ??????? ??????????????????
????????????? ????????? ????? ????????? ????? ????????? ?????????????????????????????? ??????
?? ???????????????????????????????????????????????????????????????????????????????????
the gel with SYBRGold (Invitrogen), and photographed with a digital camera (Canon 
Power Shot A650). The primer sets used for each experiment are shown in Table 2.1.
UFM 1-43 membrane labeling
To examine endocytosis, zona-????????????????????????????????? ??????-43 
(Invitrogen). FM 1-43 was diluted in CaP2+P/MgP2+P-free Hank's buffered salt solution 
(HBSS; Gibco) containing 0.1% PVA and oocytes were examined with a Zeiss LSM 510 
confocal microscope after ?1–?? ?? ???????????????????????????????? ???????????????????
??????? ??????????????????????????????????????? 1.2 water immersion objective.  The 
method for quantifying plasma membrane and membrane to cytoplasmic ratios has 
previously been described in detail (supplemental material in (Freudzon et al., 2005)),
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 using MetaMorph Software (Molecular Devices Corp., Downington, PA, USA) and 
Microsoft Excel. 
UcAMP measurements
cAMP measurements were made using a cAMP sensor (Epac2-camps300) that 
has previously been described (Nikolaev et al., 2004; Norris et al., 2009). The sensor is 
FRET based and consists of YFP and CFP linked by the cAMP-binding domain of 
EPAC2. Epac2-???????????????????? ??????????????????????????????????????????????????
into isolated oocytes cultured in the presence of milrinone. Fluorescence was excited at 
???? ????????????????????????????? ?????????????????????? ?????????????????????
collected using a 40× NA 1.2 water immersion objective on a Zeiss Pascal confocal 
microscope. YFP and CFP intensities were quantified within a circular region of interest 
that was slightly smaller than the oocyte diameter using the Zeiss Pascal program. Data 
are reported as the ratio of YFP to CFP fluorescence after subtracting the background 
value from an uninjected oocyte and correcting for spectral bleed-through of CFP into the 
YFP channel (Norris et al., 2009).
UStatistical analysis
Student's t-tests or one-way ANOVA followed by Tukey's multiple comparison 
post-test were performed to determine statistical significance; P<0.05 was considered to 
be significant. 
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 Results
UComponents of endocytosis are expressed in mouse oocytes
Endocytosis of receptors in somatic cells occurs predominantly through the 
clustering and internalization of an activated receptor into clathrin-coated pits (Moore et 
al., 2007; Wolfe and Trejo, 2007).  However, little is known about the identity and 
function of recycling components in mammalian oocytes. Therefore, we first examined 
whether two of the most common proteins responsible for receptor endocytosis in 
somatic cells were expressed in mouse oocytes. Clathrin is a protein that plays an 
important role in the formation of coated pits in which receptors accumulate (Doherty 
and McMahon, 2009). The heavy chain of clathrin is present in mouse oocytes, as
determined by Western blotting. Indeed, we were able to detect clathrin in as few as ten 
oocytes (Figure 2.1A), indicating that it is abundant. Receptor endocytosis also requires 
the activity of dynamin, a GTPase that is necessary for excising clathrin-coated pits from 
the plasma membrane (Moore et al., 2007). We detected the expression of the 
ubiquitously expressed dynamin 2 in the oocyte. In contrast, neither dynamin 1, which is 
restricted to the nervous system, nor the more ubiquitously expressed dynamin 3, was 
detectable by RT-PCR using our cycling parameters (Figure 2.1B). Western blot analysis 
of oocyte lysate detected two bands at the expected size of ????? ?????????????????????
protein is expressed. The signal was not strong, even using lysate from 500+ oocytes, 
suggesting that the amount of dynamin in the oocyte is low. It is unclear why the protein 
was expressed as a doublet; it is possible that the two bands could represent different 
splice variants of dynamin 2 (Liu et al., 2008).
35 
 
 In addition to clathrin and dynamin, other major components of receptor recycling 
include the adaptor proteins AP-2 and amphiphysin, as well as the mediators of 
??????????????-arrestins and GRKs. We examined the expression of mRNAs encoding 
these proteins using RT-PCR. mRNA for one of the major AP-????????????????Ap2m1)
subunit of AP-2, and Amphiphysin were expressed (Figure 2.1C). In addition, ?-arrestin-
2 and Grk2 and Grk5 were present (Figure 2.1D and 2.1E), whereas ?-arrestin-1 and 
Grk3 and Grk6 RNAs were not detectable in oocytes. The visual GRK1 and GRK7, and 
the testis-specific GRK4, were not examined. 
UMonodansylcadaverine and dynasore inhibit endocytosis in mouse oocytes
As a prelude to examining whether endocytosis could have a role in meiotic 
regulation, we first determined that inhibitors of receptor-mediated endocytosis could 
prevent endocytosis in mouse oocytes using the inhibitors monodansylcadaverine (MDC) 
and dynasore (Macia et al., 2006). We used pharmacological inhibitors because in initial 
experiments we found that we were unable to deplete the amount of clathrin protein using 
RNAi, nor were we able to significantly deplete the amount of dynamin 2 RNA within 
our culture period of 4 days using follicle-enclosed oocytes (not shown). We chose 
compounds that inhibit endocytosis through two different mechanisms: MDC inhibits the 
protein cross-linker, tissue transglutaminase (Davies et al., 1980), and is thought to 
inhibit the clustering and internalization of clathrin (Schlegel et al., 1982) whereas 
dynasore inhibits the GTPase activity of dynamin without affecting the activity of other 
small GTPases (Macia et al., 2006).
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 To confirm that MDC blocked endocytosis in oocytes, we treated oocytes with 
FM 1-43, a dye that becomes fluorescent when it incorporates into membranes and 
retains its fluorescence when membrane is endocytosed. ?????????????? ???????????????????
???????????????????? ?? ?????????? ?? ????????????????????????????????????????
maturation), we incubated zona-free oocytes in FM 1-43 and examined them with a 
confocal microscope 1–?? ???????? Zona-free oocytes were used because the FM 1-43
labeled transzonal processes in the zona pellucida, making plasma membrane 
fluorescence difficult to quantify. Untreated oocytes were fluorescent in the plasma 
membrane and throughout the cytoplasm, often in punctate clusters (Figure 2.2A). In 
contrast, oocytes preincubated in MDC were mainly fluorescent in the plasma membrane.
The plasma membrane labeling was more intense than that in controls, suggesting that the 
treated oocytes had more membrane area due to the absence of endocytosis (Figure
2.2A). The total plasma membrane to cytoplasmic fluorescence ratio was significantly 
higher in oocytes treated with MDC than in controls (P<0.0001; Figure 2.2B), 
demonstrating an inhibition of endocytosis. We also attempted to examine whether 
dynasore inhibits endocytosis in oocytes using FM 1-43. However, plasma membrane 
labeling in the presence of dynasore was very faint, indicating that dynasore might 
interfere with the incorporation of FM 1-43 into the membrane. 
Endocytosed proteins enter early endosomes, after which they can be sorted into 
late endosomes and lysosomes, or can be recycled back to the membrane. We 
hypothesized that inhibiting endocytosis with MDC and dynasore would block the 
formation of early endosomes. For these experiments, we labeled early endosomes by 
immunofluorescence using a specific antibody against the early endosome marker, early 
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 endosome antigen 1 (EEA1; Figure 2.2C). In control oocytes, early endosomes were 
abundantly present in both the cortex and throughout the cytoplasm, excluding the 
germinal vesicle (GV; Figure 2.2C). The diameter of the fluorescent spots was generally 
much larger than the 50–???? ??????????????????????????????????????????? ????????????
cells (Jovic et al., 2010), reaching sizes of up to ??? ???Figure 2.2C). MDC dose 
dependently decreased the number of endos????????????????????????????????????????? ?
???????????????????????????????????????????????? ???????????????????????????????????
absent (Figure 2.2C). A similar reduction in ear??????????????????????????????? ??
dynasore, a concentration commonly used to inhibit endocytosis in somatic cells (Barrias 
et al., 2010; de Beco et al., 2009; Macia et al., 2006; Newton et al., 2006) Figure 2.2C). 
These results show that there is rapid endocytosis at the plasma membrane in mouse 
oocytes and that both MDC and dynasore effectively inhibit endocytosis. 
UInhibiting endocytosis prevents spontaneous meiotic resumption in mouse oocytes
To examine the effect of inhibiting endocytosis on spontaneous meiotic 
????????????????????????????????????????? ????????????????????? ????????????????????
milrinone, then were washed out of milrinone while maintained in MDC or dynasore, and 
were periodically scored for the presence of a GV. MDC dose dependently inhibited 
???????????? ????????????????????????????????? ??????????????????????????????????
milrinone (Figure 2.3A). Oocytes became unhealthy during overnight incubation in 
MDC, so later time points were not examined. ??????????? ??????? ????????????????
dependently inhibited spontaneous maturation in the absence of milrinone (Figure 2.3B). 
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 The effects of MDC and dynasore were reversible, as oocytes treated with MDC 
??????????????????? ??????????????????????? ??????????following the removal of MDC, 
dynasore, and milrinone (Figure 2.3C). There was a slight delay between the time the 
control oocytes underwent GVBD and those treated with MDC or dynasore. Although 
??????????????????????????????????????????????????????????? ??????????? ?????????
???????????????????????????????????????? ????????????????????????? ????????????????
The overall rate of GVBD was slower in the group treated with dynasore than in the 
group treated with MDC. The reason for this delay is unclear. However, almost 100% of 
??????????????????????????????????????????????????????????? ??????????????????????????
and 84% of the matured oocytes from the MDC group and 90% of matured oocytes from 
the dynasore group formed first polar bodies (n=25 and 30 oocytes respectively). 
To further characterize MDC and dynasore as reversible endocytosis inhibitors, 
we examined whether early endosomes reappear following MDC or dynasore washout.
?????????????????????????????? ?? ????????? ????????????????? ????????????????????
milrinone and then were washed into medium without MDC or dynasore. We kept 
milrinone in the culture medium for this experiment to rule out an effect of falling cAMP 
levels (caused by activation of phosphodiesterase (Norris et al., 2009) on the localization 
of endosomes. Early endosomes were completely absent in oocytes treated with MDC or 
dynasore (Figures 2.2D and 2.3D) and ??????????????????????????? ??????????? ??????
dynasore washout (Figure 2.3D). Endosomes were generally smaller than those seen in 
controls and were often concentrated around the cortex, where early endosomes are 
formed. The formation of early endosomes preceded GVBD in oocytes treated with 
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 MDC or dynasore, indicating that cAMP levels are higher in the oocyte when endocytosis 
is blocked and then fall when endocytosis resumes. 
To examine the possibility that falling cAMP levels due to removal of milrinone 
from medium that did not contain endocytosis inhibitors affects endosome localization, 
???????????????????????????????????????? ????????????????????????????????????????????? ?
following milrinone washout. Localization of endosomes was indistinguishable from 
those observed in the presence of milrinone (not shown), demonstrating that endosome 
formation is independent of cAMP levels in the oocyte.
UGPR3 undergoes endocytosis in the oocyte
Meiotic arrest depends on high levels of cAMP in the oocyte (Mehlmann, 2005b).
Because GPR3 is responsible for maintaining meiotic arrest prior to the LH surge, we 
were interested in knowing whether its localization is important for the regulation of 
meiotic arrest. Most GPCRs are internalized following agonist stimulation. However, as 
a constitutively active receptor, it is possible that GPR3 does not get internalized but 
remains at the plasma membrane and continuously signals. We examined GPR3 
internalization in the oocyte by expressing GPR3 fused to red fluorescent protein (GPR3-
RFP). Overexpressed GPR3-RFP localized both in the plasma membrane and in clusters 
throughout the cytoplasm of the oocyte (Figure 2.4) when incubated in the presence of 
milrinone. Double labeling with EEA1 showed that GPR3-RFP co-localized within early 
endosomes. These results demonstrate that GPR3 is internalized in the mouse oocyte. 
We attempted to examine the localization of GPR3-RFP in response to treatment 
of MDC and dynasore. However, there was no noticeable accumulation of GPR3-RFP in 
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 the plasma membrane in response to inhibitor treatment (not shown). This could be due 
to the large surface area of the oocyte and the high level of membrane labeling of 
overexpressed GPR3-RFP that would not permit the detection of small changes in plasma 
membrane fluorescence. 
U???????????????????-arrestin-2 and GRK2 into follicle-enclosed oocytes has a partial 
effect on stimulating GVBD
If GPR3 signaling at the plasma membrane is necessary to maintain meiotic 
arrest, then the removal of GPR3 from the membrane would be expected to cause GVBD.
Receptor-mediated endocytosis generally occurs by phosphorylation of an activated 
receptor by GRKs, foll????????????????????-arrestins that remove the receptor from the 
membrane and sort it into clathrin-coated pits (Moore et al., 2007; Reiter and Lefkowitz, 
2006). ??????????????????????????-arrestins are involved in GPR3 endocytosis by 
determ????????????????????????????????????????????-arrestin-2 and GRK2 in follicle-
enclosed oocytes. ???????????????????-arrestins/GRKs hyperphosphorylates and 
enhances endocytosis of a constitutively active viral receptor, US28, in somatic cells and 
decreases its activity (Miller et al., 2003b). We used follicle-enclosed oocytes for these 
experiments because unlike the above pharmacological inhibitors, which are cell 
?????????????????????????-arrestin-2-GFP proteins were not permeable, thereby 
allowing us to discern an effect of the proteins on the oocyte as opposed to the follicle. 
In addition, use of follicle-enclosed oocytes simulates the native environment of the 
oocyte, rather than using oocytes incubated in inhibitors that artificially raise cAMP 
levels. 
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 We microinjected RNA ?????????????????????????????????-arrestin-????-arrestin-
2-??????????????????????????????????????????????? ??????????????????????????????????????
oocytes that are competent to resume meiosis. After a 17–??? ??????????????????????????
for the proteins to be expressed, oocytes were removed from their follicles and the 
meiotic status evaluated. By the end of the culture period, 13% of the injected oocytes 
had undergone GV breakdown (GVBD) compared with 0% of control oocytes (n=24 and 
n=23 respectively; Figure 2.5A), despite the proteins being robustly expressed as 
determined by Western blot for GRK2 (Figure 2.5???????????????????? ???????????????-
arrestin-2-GFP (not shown). 
?????????????????????-arrestin-2 and/or GRK2 proteins were active, we examined 
????????????????-arrestin-2-GFP to translocate from the cytoplasm to the plasma membrane 
following stimulation of an exogenously expressed GRsR-coupled receptor. To do this, we 
co-???????????????????????????????????????????????????????????????????????????????
???????????-arrestin-2-GFP. Following an overnight culture to allow time for the 
oocytes to synthesize the proteins, we examined the oocytes before and after stimulating 
????????????????????? ????????????????? Before adding the isoproterenol, oocytes were 
fluorescent throughout the cytoplasm, excluding the GV (Figure 2.5B). ????????? ??????
???????????????????????????-arrestin-2-GFP translocated to the plasma membrane (Figure
2.5C). The localization to the membrane was transient, and fluorescence began to be lost 
????????? ?????????????????????????????????????? ?????????????????????????Figure
2.5C), indicating that the receptor was rapidly removed from the membrane. These 
?????????????????? ????????????????????????????????????????????-arrestin-dependent 
?????????????????????????????????????????????-arrestins have a role in clathrin-mediated 
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 receptor endocytosis of GPR3, it is not likely to be the primary mechanism by which this 
occurs in the oocyte. 
UInhibiting endocytosis raises cAMP levels in the oocyte
If GPR3 signaling at the cell membrane is necessary for maintaining meiotic 
arrest, we would expect to see an increase in cAMP concentration in oocytes in which 
endocytosis is inhibited. To examine the possibility that GPR3 activity at the plasma 
membrane increases cAMP levels, we measured cAMP levels in oocytes treated with 
dynasore. We used dynasore for this experiment because we found in preliminary 
experiments that MDC interfered with the cAMP sensor, whereas dynasore did not (not 
shown). To measure cAMP levels, we used a fluorescence resonance energy transfer 
(FRET)-based assay that has previously been described (Nikolaev et al., 2004; Norris et 
al., 2009). This assay uses an indicator consisting of yellow fluorescent protein (YFP) 
and cyan fluorescent protein (CFP) fused to the cAMP-binding domain of EPAC2 
(Epac2-camps300). cAMP levels are inversely proportional to FRET when CFP is 
excited with a laser (see Materials and Methods). 
We microinjected the cAMP indicator protein, Epac2-camps300, into oocytes and 
measured the YFP/CFP ratio following excitation of CFP, after treatment with dynasore. 
We found that oocytes held in the presence of milrinone throughout the course of the 
experiment maintained a constant fluorescence ratio (Figure 2.6). When oocytes were 
washed out of milrinone, the YFP/CFP ratio increased by ?20%, demonstrating that 
cAMP levels decreased. The baseline ratios that we observed, and the increase in FRET 
seen following removal of milrinone, are very similar to those reported previously in 
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 follicle-enclosed oocytes, in which cAMP levels corresponded to ????? ??prior to 
adding LH and dropped to ????? ?????????????????????????(Norris et al., 2009).
Oocytes treated with dynasore displayed a gradual decrease in FRET that was statistically 
sign???????????????? ???????????????Figure 2.6). The YFP/CFP ratio continued to decrease 
even after oocytes were washed out of milrinone but maintained in dynasore. These 
results show that inhibiting endocytosis increases cAMP levels and suggest that signaling 
at the plasma membrane is needed to maintain meiotic arrest prior to the LH surge. 
Discussion
Endocytosis is a ubiquitous process in somatic cells and is critically important for 
yolk production in the oocytes of non-mammalian species. However, endocytosis in 
mammalian germ cells and its possible contribution to their unique physiology is poorly 
understood. The aim of this study was to examine whether endocytosis occurs in the 
mouse oocyte and whether this affects the signaling properties of GPR3. We found that 
active, robust endocytosis occurs in the isolated mouse oocyte. Inhibiting endocytosis
had an effect on the oocyte's meiotic status, inhibiting spontaneous meiotic resumption in 
the absence of PDE inhibitors. We also found that GPR3 localizes in the oocyte plasma 
membrane as well as in early endosomes, indicating that it is actively endocytosed in the 
oocyte. Inhibiting endocytosis stimulated an increase in oocyte cAMP, suggesting that 
signaling at the plasma membrane, possibly through an accumulation of GPR3, is 
responsible for maintaining meiotic arrest. 
Mouse oocytes express several of the major proteins involved in receptor 
endocytosis, including clathrin, dynamin 2, AP-?????????????????-arrestin-2, and GRK2 
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 and GRK5. The well-characterized inhibitors of receptor-mediated endocytosis, MDC 
and dynasore, effectively prevented endocytosis in oocytes. These inhibitors blocked the 
formation of both endocytic vesicles and early endosomes, as well as spontaneous 
meiotic resumption. The effect of MDC is likely to be related to inhibition of the protein 
cross-linker, tissue transglutaminase (Davies et al., 1980) and is thought to inhibit the 
clustering and internalization of clathrin (Schlegel et al., 1982). Indeed, MDC does not 
inhibit endocytosis in cells lacking transglutaminase (Davies et al., 1984).  A previous 
study in mouse oocytes showed the presence of active tissue transglutaminase that was 
inhibited by MDC (Kim et al., 2001), and in that study, MDC inhibited GVBD in a dose-
dependent manner. However, endocytosis itself was not examined. As a second method 
of blocking endocytosis in oocytes, we used dynasore. In contrast to MDC, dynasore 
specifically inhibits dynamin by inhibiting its GTPase activity without affecting the 
activity of other small GTPases (Macia et al., 2006). Dynasore may therefore be the 
more specific inhibitor of endocytosis. The results showing that dynasore inhibits 
endocytosis in oocytes support the data using MDC, confirming that endocytosis was 
prevented using both inhibitors. 
Dynasore caused an increase in cytoplasmic cAMP levels in oocytes, suggesting 
that GPR3 signaling at the plasma membrane could be responsible for this increase. 
Recently, it has been shown that some GPRs are able to signal within endosomes 
(Calebiro et al., 2009; Calebiro et al., 2010b; Ferrandon et al., 2009; Mullershausen et al., 
2009) and that this signaling is necessary for prolonged cAMP signaling initiated by 
various hormones. Therefore, it is possible that GPR3 likewise signals within 
endosomes, perhaps to provide cAMP to the interior of the oocyte, which has a relatively 
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 large volume. Although our results do not exclude the possibility that endosomal 
signaling occurs within arrested oocytes, they support the hypothesis that signaling at the 
plasma membrane and not within endosomes is sufficient and necessary to maintain 
meiotic arrest. 
If signaling at the plasma membrane alone is needed to maintain meiotic arrest, 
how is cAMP able to transmit its signal to the interior of the oocyte, which has a large 
volume? Cyclic AMP is a freely diffusible molecule (Bacskai et al., 1993; Chen et al., 
1999), but its diffusion is restricted in many cases by the localized pools of PDEs and 
protein kinase A (PKA) tethered to the plasma membrane and various intracellular 
membranes by the A kinase anchoring proteins (AKAPs; (Dodge et al., 2001). It is 
thought that PDE activity stimulated by PKA is necessary for establishing cAMP 
microdomains (Fischmeister et al., 2006; Houslay et al., 2007). For example, stimulation 
????????-AR in neonatal cardiac myocytes generates microdomains of high concentrations 
of cAMP that act within a range as small as ??? ???????????????????????????????????????
that have been treated with PDE inhibitors (Zaccolo and Pozzan, 2002). On the other 
???????R1R-??????????????????????????????????????????????????????? ???????????????????
adult ventricular cardiomyocytes even in the absence of PDE inhibitors (Nikolaev et al., 
2006). AKAPs have been identified in mouse oocytes (Brown et al., 2002; Kovo et al., 
2006; Newhall et al., 2006) and the RI- and RII-type PKAs are tethered in the plasma 
membrane and the cytoplasm respectively (Brown et al., 2002; Newhall et al., 2006; 
Webb et al., 2008). However, PDE activity is kept low in oocytes by cGMP that is
produced in the somatic cells and diffuses into the oocyte through gap junctions (Norris 
et al., 2009). It is not until the surge of LH that cGMP levels in the oocyte fall, allowing 
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 the activation of PDE3A (Norris et al., 2009; Vaccari et al., 2009).  Therefore, it is 
possible that cAMP is able to readily diffuse throughout the oocyte cytoplasm prior to LH 
stimulation to activate intracellular PKAs. In support of this, the catalytic subunit of 
PKA is present both in the plasma membrane and throughout the cytoplasm (Brown et 
al., 2002).
If signaling at the plasma membrane is needed for maintenance of meiotic arrest, 
it is not clear why GPR3 might be targeted for endocytosis, or the mechanism(s) by 
which endocytosis occurs. Many GPCRs undergo a conformational change upon 
stimulation that allows the phosphorylation by GRKs and subsequent binding and 
????????????????????-arrestins. ????????????????????????????????????????????????-arrestin-2
with GRK2 caused GVBD in a small percentage of oocytes within our culture period, 
??????????????????????????-arrestins could interact with GPR3. However, because the 
percentage of oocytes that underwent GVBD was not significantly different from 
controls, it is not likely to be the primary mechanism by which endocytosis occurs. Other 
GPCRs (e.g. the PAR1 and MR2R muscarinic receptors; (Paing et al., 2002; Pals-
Rylaarsdam et al., 1997) are ?????????????????????-arrestin/GRK-independent 
mechanisms; it is possible that GPR3 endocytosis occurs through similar mechanisms.  It 
is also possible that GPR3 signals intracellularly either from endosomes or prior to 
membrane insertion.
Another constitutively active receptor, the herpes virus chemokine receptor US28, 
signals in the absence of an agonist (Fraile-Ramos et al., 2001) and could perhaps serve 
as a model for the regulation of the signaling of constitutively active receptors, including 
GPR3. US28 is constitutively phosphorylated when overexpressed in cultured cells 
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 (Mokros et al., 2002)????????????????????????????????????????????????????????-arrestin-
induced receptor internalization (Miller et al., 2003b). In addition, overexpressing GRKs 
????????-arrestins causes a decrease in US28 activity (Miller et al., 2003b). Furthermore, 
mutation of serines at the C-terminus impairs phosphorylation and receptor 
internalization, leading to an increase in surface expression and consequently to an 
increase in activity (Miller et al., 2003b; Mokros et al., 2002). Taken together, these 
results show that surface expression of a constitutively active GPCR is necessary for 
intracellular signaling. Interestingly, the internalization of US28 is enhanced by, but not 
???????????????-arrestins, although it is dependent on a clathrin-mediated pathway 
(Droese et al., 2004; Fraile-Ramos et al., 2003). It will be interesting to determine 
whether GPR3 activity is regulated by similar mechanisms. 
In summary, our results show that vesicular trafficking actively occurs at the 
mouse oocyte plasma membrane and that trafficking is a regulator of meiotic arrest. 
Although we were unable to observe an accumulation of overexpressed GPR3 at the 
plasma membrane following inhibition of endocytosis, our results showing an increase in 
cAMP concentration following inhibition of endocytosis are consistent with this 
possibility. In addition, our results suggest that even if GPR3 normally signals within 
endosomes, that signaling at the plasma membrane is sufficient for the maintenance of 
meiotic arrest prior to the LH surge, as cAMP levels increased following endocytosis 
inhibition, when endosomes were absent. It should be noted that due to the nature of the 
chemical inhibitors we used, which were membrane permeable, we were limited to 
examining isolated, rather than follicle-enclosed, oocytes. It would be interesting to 
determine whether inhibiting endocytosis affects LH-induced meiotic resumption in 
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 follicle-enclosed oocytes. Future experiments will be needed to examine the mechanisms 
by which endocytosis occurs in oocytes and how GPR3 might be regulated in order to 
maintain the proper concentration of cAMP that is necessary to maintain meiotic arrest in 
the oocyte. 
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 Figure 2.1.
Figure 2.1. Components of receptor-mediated endocytosis are expressed in mouse 
oocytes. (A) Expression of clathrin protein, as assessed by western blot using lysate from 
ten oocytes. (B) Expression of dynamin in mouse oocytes, as assessed by RT-PCR. O, 
oocyte; B, brain, used as a positive control. (C) Western blot showing two bands at 
????? ????????????????????????????????????????????????????????????????????????????????
mouse oocytes. (C, D and E) RT-PCRs showing expression of other components of 
endocytosis in mouse oocytes. 15TAp2m115T, AP-??????????????15TAmph15T????????????????-15Tarr15T???-
arrestin.
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 Figure 2.2.
Figure 2.2. Inhibitors of clathrin-mediated endocytosis inhibit endocytosis in mouse 
oocytes. (A?? ???????????????????????????????????????????????????????????????? ?? ????
???????????????????????????????????????????????????????? ??????-43 and imaged 1–?? ?
later with a confocal microscope. (B) Quantification of membrane to cytoplasmic 
fluorescence in control and MDC-treated oocytes. The membrane to cytoplasm ratio was 
significantly higher in MDC-treated than in control oocytes (***P<0.0001; error bars = 
mean ± S.E.M.). The number of oocytes is indicated in parentheses. (C) MDC and 
dynasore block the formation of early endosomes. (Left) Antibody against EEA1 that was 
used for these experiments specifically recognizes a single band from mouse oocyte 
lysate. (Right) Early endosomes are present throughout the oocyte excluding the GV in 
????????????????????????????????????????????????????? ?? ????????? ?????????????????
endosomes were completely absent. Bars = ??? ??
51 
 
 Figure 2.3.
Figure 2.3. MDC and dynasore inhibit spontaneous meiotic resumption in oocytes. 
Isolated oocytes were treated with the indicated concentrations of MDC (A) or dynasore 
(B????????????? ??????????????????????????????????????????????????? ?????????????
periodically scored for the presence or absence of a GV. (C) The effects on of MDC and 
dynasore on inhibiting GVBD are reversible. Oocytes were treated with MDC or 
??????????????? ???????????????????? ?????????????????????????????????????????????????D)
Early endosomes were ????????????????????? treatment with MDC or dynasore and re-
?????????????? ??????? ???????????????????????????????????????????? ?????????? =
??? ??
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 Figure 2.4.
Figure 2.4. GPR3-RFP localizes in the plasma membrane in oocytes and co-localizes 
with early endosomes. Isolated oocytes were injected with RNA encoding GPR3-RFP 
and cultured overnight prior to fixation. Early endosomes were labeled using 
immunofluorescence. GPR3-RFP (left). Early endosomes (middle). Merge (right). Bar = 
??? ???
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 Figure 2.5.
Figure 2.5. ????????????????????-arrestin 2 on meiotic resumption. (A) Follicle-
enclosed oocytes were injected with Grk2/?-arrestin-2-GFP mRNA. Follicles were 
cultured for 17–??? ??????????????????????????????????????????? ???????????????????
number above each bar is the total number of follicles per group. The experiment was 
repeated three times. (B) Immunoblot showing expression of GRK2 in follicle-enclosed 
oocytes. (C) ??????????-arrestin-2-GFP are active in mouse oocytes. Isolated oocytes 
were co-?????????????????????-arrestin-2-??????????????R2R-adrenergic receptor. After an 
overnight culture, oocytes were imaged with a confocal microscope before and after 
?????????? ???????????????????????????????? ???
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 Figure 2.6.
Figure 2.6. Inhibiting endocytosis with dynasore increases cAMP levels in oocytes. 
Measurement of cAMP levels in oocytes using the FRET-based cAMP sensor, Epac2-
???????????????????????????????????????????????? ???????-camps300 protein, cells were 
visualized with a confocal microscope at hourly intervals, and the YFP/CFP ratio was 
???????????????? ??????????????????????????????? ??????????????????????????????????
oocytes were maintained in milrinone throughout the course of the recordings. The arrow 
shows the point at which milrinone was washed out of the culture medium in the 
milrinone washout and dynasore-treated groups. Each point represents mean ± S.D. 
Statistical significance relative to controls is indicated by asterisks (*P<0.05; 
***P<0.0001). 
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 Table 2.1 Primer Sets used for RT-PCR
Dynamin 1 5’-ATCTGAAGCTGCGTGATGTG-3’
5’-GCCGATTCTTCCATCAGTGT-3’
Dynamin 2 5’-GACCTCCCAGGCATCACTAA-3’
5’-ACTCTCGGATGTGGTTGGTC-3’
Dynamin 3 5’-GCTTGTGTGCTGTGCTTTGT-3’
5’-ATCGCTGATGGATCACCTTC-3’ 
AP-2 5’-CTTCAAGCCCTCACTTCTGG-3’-
5’- TACTTGGACCTGTGGGAAGG-3’
Amphiphysin 5’-GGATTCTCAGGCAACTCTGC-3’
5’-TGCTCTTTCCCCTCTTCGTA-3’
?-arrestin-1 5’-CCCATGTGTGAAGGGCTAGT-3’
5’-AATGACTTCACGGGACAAGG-3’
?-arrestin-2 5’-CAACGTCCATGTCACCAACAA-3’
5’-ACCACCAGCTTCACCTTGA-3’ 
GRK2 5’-ACCAGGGAACTGTACCGCAAC-3’
5’-TGCGTTCCTTGATCTGTGTC-3’
GRK3 5’-AAGCTGGACAACGAAGAGGA-3’
5’-GTGTGGAAGGCGTAGGTCAT-3’
GRK5 5’-GGTGCTGGAGACTGAGGAAG-3’
5’-CCGTTAGGTCCGAACACATT-3’
GRK6 5’-ACTCTTCAGTCGCCAAAGGA-3’
5’-GCCCTAGAAGCCTGGAGTTT-3’
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 CHAPTER THREE
URegulation of Constitutive GPR3 Signaling and Surface Localization by Residues in the 
Third Intracellular Loop and C-terminus
Abstract
G protein-coupled receptor 3 (GPR3) is a constitutively active receptor that 
maintains high cAMP levels required for meiotic arrest in oocytes and CNS function.  
Ligand-activated GPCRs signal at the cell surface and are silenced by phosphorylation 
?????-arrestin recruitment upon endocytosis.  Some GPCRs can signal from the 
endosome.  Little is known about the localization, signaling, and regulation of 
constitutively active GPCRs.  We demonstrate herein that exogenously-expressed GPR3 
localizes to the cell membrane and undergoes internalization in HEK293 cells.  Inhibition 
of endocytosis increased cell surface-localized GPR3 and cAMP levels while 
overexpression of GPCR-???????????????????-arrestin-2 decreased cell surface-
localized GPR3 and cAMP levels.  To identify the residues that are targeted for 
desensitization, we mutated the serine and threonine residues in the third intracellular 
loop and C-terminus.  Mutation of residues in the third intracellular loop dramatically 
increased cAMP levels.  Mutation of residues in the C-terminus decreased the surface 
localization of GPR3 but did not change cAMP production.  These results demonstrate 
?????????????????????????????????? ?????????????????????????????????-arrestin.  
However, localization at the plasma membrane is not required for cAMP signaling and 
GPR3 may signal from other membranes.  These results also strongly implicate the serine 
and/or threonine residues in the third intracellular loop in the regulation of GPR3 activity.
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 Introduction
G protein-coupled receptors (GPCRs) represent the largest family of integral 
membrane proteins and regulate a wide variety of physiological processes.  GPCRs 
typically bind to an extracellular agonist and  causes the receptor to adopt an active 
conformation.  However, some receptors exhibit constitutive activity in the absence of a 
ligand.  The level of constitutive activity varies among receptors and also seems to 
depend on the cell type (Seifert and Wenzel-Seifert, 2002).  Constitutive activity can be a 
property of the receptor itself or the result of chronic stimulation by a ligand, as in the 
case of the dog adenosine A2a receptor (Maenhaut et al., 1990).
GPR3, GPR6, and GPR12 constitute a family of constitutively active GRsR-coupled 
GPCRs (Song et al., 1994).  The magnitude of constitutive activity of these receptors is 
reported to be the highest among all GPCRs and is similar in amplitude to a ligand-
stimulated GPCR (Eggerickx et al., 1995; Seifert and Wenzel-Seifert, 2002).  GPR3 is 
classified as an orphan receptor and it is thought to mediate sustained cAMP production 
in the absence of a ligand (Eggerickx et al., 1995; Freudzon et al., 2005; Yin et al., 2009),
although a membrane bound ligand cannot be ruled out completely.  In the mouse, GPR3 
is expressed highly in the brain, with lower amounts in the ovary, testis and eye 
(Eggerickx et al., 1995).  GPR3 is essential for maintaining prophase I meiotic arrest in 
mouse and pig oocytes (Hinckley et al., 2005; Ledent et al., 2005; Mehlmann et al., 2004; 
Yang et al., 2012) and may play a role in meiotic arrest in human and Xenopus oocytes 
(Deng et al., 2008; DiLuigi et al., 2008; Rios-Cardona et al., 2008).  GPR3 is also
important for several neurological processes including neurite outgrowth,  postnatal 
cerebellar development (Tanaka et al., 2007; Tanaka et al., 2009), emotional-like 
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 responses, Alzheimer’s disease, early phases of cocaine reinforcement, and neuropathic 
pain therapy (Ruiz-Medina et al., 2011; Thathiah et al., 2009; Tourino et al., 2012; 
Valverde et al., 2009).  Although the constitutive activity of GPR3/6 and 12 has long 
been recognized, little is known about the molecular details by which the signaling 
activity and subcellular localization of these receptors is controlled. Understanding 
GPR3 regulation may not only be important for understanding other constitutively active 
receptors, but it may also be important for treating reproductive and neurological 
disorders.
An important mechanism that regulates GPCR signaling is desensitization.  This 
process involves the G protein-coupled receptor kinases (GRKs) and the arrestins 
(Lefkowitz and Shenoy, 2005; Shenoy and Lefkowitz, 2003). GRKs selectively 
phosphorylate active GPCRs at serine and threonine residues within the C-terminus and 
third intracellular loop.  This leads to the recruitment of arrestins that prevent subsequent 
interactions with the receptor and G proteins and terminate G protein-mediated signaling 
(Kohout and Lefkowitz, 2003; Perry et al., 2002).  Arrestin binding can also promote 
internalization of the receptor through a clathrin-dependent pathway.  Following 
internalization, the receptor is either dephosphorylated and recycled back to the 
membrane or it is targeted to lysosomes for degradation.  Although it is assumed that 
receptor internalization terminates GPCR signaling, there are recent reports of cAMP 
signaling by internalized GPCRs.  The thyroid-stimulating hormone (TSH) and 
parathyroid hormone (PTH) receptors continue to signal following internalization where 
they remain associated with G proteins and adenylate cyclase at endosomal 
compartments.  Signaling from internalized receptors is associated with a prolonged 
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 cAMP response following hormone treatment, whereas signaling at the cell surface is 
more transient (Calebiro et al., 2009; Calebiro et al., 2010a; Ferrandon et al., 2009).  In 
addition to GRsR-dependent signaling, there is evidence that GRiR-dependent signaling 
stimulated by the S1P receptor may occur internally as well (Mullershausen et al., 2009).
Intracellular signaling seems to contradict the well-established process of desensitization; 
therefore, further studies are needed to reconcile these two concepts.  It is not known 
whether intracellular signaling to cAMP is a general feature of GRsR/GRiR coupled receptors 
or whether it is a characteristic of only a few receptors.
GPR3 behaves like agonist-occupied receptors in that it uses traditional GPCR 
pathways to transmit signals and is internalized by an endocytic pathway (Fraile-Ramos 
et al., 2003; Freudzon et al., 2005; Lowther et al., 2011).  However, it is unknown 
whether the activity and localization of GPR3 and other constitutively active GPCRs are 
regulated by GRKs and arrestins.  Since the constitutive activity of GPR3 is required to 
maintain high cAMP levels for meiotic arrest, it could signal following internalization in 
order to prolong cAMP signaling.  Our previous findings show that GPR3 is internalized 
in the oocyte and inhibition of endocytosis increases cAMP and delays oocyte maturation 
(Lowther et al., 2011).  This finding is consistent with signaling at the cell surface rather 
than continued signaling following internalization.  It is possible that GPR3 might not 
signal from intracellular sites and would need to be regulated in a manner similar to 
ligand-activated GPCRs in order to prevent excessive intracellular levels of cAMP.  Here, 
we investigated the localization and possible regulation of GPR3-cAMP signaling in 
cultured HEK293 cells.  GPCRs, in general, are difficult to study because native 
expression levels are very low.  Also, biochemical experiments with mouse oocytes are 
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 unfeasible due to the limited amount of sample that can be obtained.  Therefore, we used 
an overexpression system in HEK293 cells, which have been commonly used to study 
signaling and regulation of a variety of GPCRs, to study GPR3 localization and signaling.  
We found that GPR3 signals at the cell surface, is internalized by a dynamin-dependent 
??????????????????????????????????????????????????????????????-arrestin-2
overexpression.  Mutations of the serine and threonine residues in the third intracellular 
loop markedly increased cAMP levels and are not involved in desensitization by GRK2 
?????-arrestin-2.  Mutations of serines in the C-terminus decreased cell surface 
localization of GPR3 but did not affect cAMP production.  We also provide evidence that 
GPR3 is regulated by one or more protein kinase C isoforms.
47TExperimental Procedures
UCell culture and Transfection
HEK293 cells were cultured in Dulbecco's modified Eagle's (DMEM)/F-12 
medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum 
(Invitrogen), 100 U/mL penicillin and 100 μg/mL streptomycin (Invitrogen) at 37P?PC in a 
humidified 5% COR2R/95% air incubator.  Cells in 6-well dishes were transfected with 
plasmid DNA using Lipofectamine 2000 (Invitrogen) following the manufacturer's 
recommendations.  Experiments were performed 24 hr after transfection. 
Bisindolylmaleimide I (Bis I) and Phorbol 12-myristate 13-acetate (PMA) were 
purchased from Calbiochem (La Jolla, CA) and Tocris Bioscience (Minneapolis, MN), 
respectively.   Methyl-?-cyclodextrin was purchased from Sigma (St. Louis, MO).
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 UPlasmids
Mouse GPR3-RFP was provided by Y. Saeki (Ohio State University) in pHGCY.  
Human GPR3 in pCMV6-AC-HA-His (GPR3-HA) was purchased from Origene 
(Rockville, MD).   Dynamin 1 WT and K44A in pcDNA3.1 were purchased from ATCC 
(Manassas, VA).  GRK2 was provided by R. Lefkowitz (Duke University Medical 
Center) in pRK?????-arrestin-2-GFP was obtained from M. Caron (Duke University 
Medical Center) in pS65T and was subcloned into pSP64.5.  pcDNA3.1 empty vector 
was purchased from Invitrogen.  CFP-??????????-CD)-YFP was provided by K. Jalink 
(The Netherlands Cancer Institute).
UTransferrin Assay
Cells were washed in RPMI-1640 without bicarbonate (Invitrogen) + 0.2% BSA 
(Sigma), pH 7.4, for 30 min at 37°C.  Cells were incubated with 50 μg/mL Alexa Fluor 
488-labelled transferrin (Invitrogen) for 2 min at 37°C, placed on ice for 10 min, and 
washed with cold PBS.  Cells were fixed in 2% formaldehyde (Sigma) for 30 min at 
room temperature, washed twice with PBS, and transferrin internalization was examined 
with a 47TZeiss LSM 510 47Tconfocal microscope (Carl Zeiss Microimaging, Inc.).
Fluorescence was excited at 488 nm and detected at 530 nm.  Images were collected 
using a 40X NA 1.2 water immersion objective (C-Apochromat; Carl Zeiss 
MicroImaging, Inc., Thornwood, NY).
UBiotinylation 
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 Biotinylation was performed on cells in suspension according to the 
manufacturer’s recommendation.  Briefly, cells were trypsinized using 0.025% Trypsin-
EDTA, resuspended in growth medium, washed three times with ice cold PBS (pH 8.0), 
incubated in 0.5 mg/mL sulfo-NHS-LC-Biotin (Pierce Biotechnology, Rockford, IL) for 
30 min at 4°C, and washed with ice cold PBS (pH 8.0) + 100 mM glycine to remove 
unbound biotin.  For internalization assays, cell surface proteins were biotinylated with 
cleavable sulfo-NHS-SS-biotin (Pierce) as indicated above.  Cells were then incubated in 
regular medium at 37°C for 30 min or 1 hr to allow internalization.  Cleavage of surface 
biotin was performed as previously described (Cao et al., 1998).  Briefly, cells were 
incubated at 4°C with 3 washes of glutathione strip buffer (50 mM glutathione, 75 mM 
NaCl, 75mM NaOH, 10% FBS in HR2R0) for 15 min each.  Glutathione was quenched by 3 
washes of iodoacetamide buffer (50 mM iodoacetamide, 1% BSA in PBS, pH 7.4) for 15 
min each at 4°C.
Protein samples were prepared in RIPA buffer (Teknova, Hollister, CA) 
containing protease inhibitor cocktail (Pierce Biotechnology), sonicated, and rotated at 
4°C for 30 min.  Supernatants were collected following centrifugation at 14,000 x g for 
20 min at 4°C.    Protein concentrations were determined by BCA assay (Pierce 
Biotechnology).  
UAntigen Precipitation
Cell surface biotinylated proteins were precipitated from cell lysates using 
streptavidin agarose resin (Pierce).  Sixty μg of protein was added to 30 μl of agarose 
beads in a total volume of 200 μl with RIPA buffer.  Samples were rotated for 2 hr at 
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 4°C, spun at 1150xg for 5 min at 4°C, and washed four times with 500 μl RIPA buffer.  
After the final wash, the beads were resuspended in Laemmli sample buffer with 5% 2-
Mercaptoethanol and boiled for 5 min.  Five μl of the sample was analyzed by Western 
??????????????????????????????-actin in 0.5 μg of total lysate was used as a loading 
control.
UWestern Blot Analysis 
Western blot analysis was performed as described previously (Mehlmann et al., 
1998).  Proteins were resolved on a 4-15% Tris-HCl ready gel (Biorad, Hercules, CA), 
transferred onto a nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ), 
and blocked in 5% milk for 30 min.  The membrane was incubated in primary antibody 
overnight at room temperature, washed, incubated in horseradish peroxidase-conjugated 
secondary antibody for 1 hr, and washed.  Primary antibodies were anti-HA high affinity 
???????????????????????????????????????????????????????-actin (Abcam, Cambridge, 
MA) and were diluted 1:1000 in blocking buffer.  Anti-dynamin 1/2 (Santa Cruz 
Biotechnology, Santa Cruz, CA) was diluted 1:200 in blocking buffer.  Secondary 
antibodies were obtained from Santa Cruz and diluted 1:5000 in blocking buffer.  
Immunoreactive protein bands were detected using ECL Prime or ECL plus Western 
blotting detection system and visualized with GE Hyperfilm (Amersham Biosciences).  
Films were scanned and band intensities were analyzed by densitometry using Image J 
software (National Institutes of Health).  Densitometry values for surface and total GPR3 
????????????????????????????????????????-actin.  The normalized value for surface 
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 GPR3 was divided by the normalized value for total GPR3 to examine the ratio of surface 
vs. total GPR3.
15TUEIA cAMP Measurement
HEK293 cells were transfected with the indicated plasmid DNA using 
Lipofectamine 2000.  Twenty-four hr after transfection, cells were trypsinized as 
described above and 400,000 cells were washed with PBS, lysed in 225 μl of 0.1 M HCl 
for 10 min at room temperature, sonicated, and stored at -80°C until the assay was 
performed.  Levels of intracellular cAMP were measured using the cAMP enzyme 
immunoassay (EIA) kit, Direct (Sigma, or Enzo Life Sciences, Plymouth Meeting, PA), 
using the nonacetylation EIA procedure.  Similar results were obtained using both EIA 
kits.  Results are presented as pmol/mL cAMP.
U Fluorescence resonance energy transfer (FRET) measurement of cAMP 
To study changes in intracellular cAMP by FRET, HEK293 cells were plated on 
round glass cover slides and transfected 24 h later with the CFP-??????????-CD)-YFP 
(Ponsioen et al., 2004) sensor plasmid and, when indicated, with GPR3-RFP, Dynamin 
??????????????????????-arrestin-2 plasmids.  24-36 h after transfection, cells were 
washed once and maintained in a physiological buffer containing 144 mM NaCl, 5.4 mM 
KCl, 2 mM CaClR2R, 1 mM MgClR2R, and 20 mM HEPES, pH 7.4 at room temperature, and 
placed on a Zeiss Axio Observer A1 microscope equipped with Plan-Apochromat 63x/1.4 
oil immersion objective, Polychrome V light source, DV2 DualView beam splitter and 
CoolSNAP-HQ2 CCD-camera (Visitron Systems, Pullheim, Germany).  The YFP/CFP 
emission ratio upon 436 nm excitation (filters YFP 535 ± 15 nm, CFP 480 ± 20 nm) was 
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 measured before and after saturation of the sensor with 46Tisoproterenol46T plus 
44Tisobutylmethyl-xanthine44T (IBMX) or forskolin plus IBMX.  Measurements were 
monitored online and recorded by the VisiView software (Visitron).  After each 
measurement, emission values were corrected for bleedthrough of CFP into YFP channel 
and for photobleaching as described (Borner et al., 2011).  The data were analyzed with 
Excel and Origin 8.5 (OriginLab) packages to calculate percent change in YFP/CFP ratio.  
To convert FRET ratio data into absolute cAMP concentrations, the maximal response of 
the sensor in each cell stimulated with isoproterenol plus IBMX or with forskolin plus 
????????????????? ??????????????????????????????????????????????????????????????????
calculated as (55.4 -???????????????? ????????????????????? ??????????????????
?????????????? ??????? in empty vector-transfected cells. The degree of sensor 
activation (y) was used to calculate cAMP concentrations (x) based on the published 
concentration-response-dependence measured in vitro (Ponsioen et al., 2004) according 
to the equation x=13.21*y/(100-y) which describes the published curve.  Values are 
presented as mean ± SEM.  
UMutagenesis
GPR3-HA mutants, in which serine and threonine residues in the third 
intracellular loop and C-terminus were mutated to alanine, were generated using the 
QuikChange II site-directed mutagenesis Kit (Agilent, Cedar Creek, TX) according to the 
manufacturer’s protocol.  Amino acids at 237 and 242 in the third intracellular loop (S,T) 
and amino acids at 316, 317, 318, 324, 326, 328 in the C-terminus (1-6) were mutated to 
alanine.  HPLC purified primers for mutagenesis were purchased from Sigma (Table 1) 
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 and mutations were made in the order the primers are presented.  Three mutants were 
generated:  GPR3-HA ST/A, GPR3-HA S1-6A, GPR3-HA ST/A, S1-6-A.  A GRK2-
K220R catalytically inactive mutant where the lysine at position 220 was mutated to 
arginine was made using the QuikChange II site-directed mutagenesis kit and the 
primers: 5’CAAGATGTACGCCA-TGAGGTGTCTGGACAAGAAGC 3’ and 5’ 
GCTTCTTGTCCAGACACCTCATGGC-GTACATCTTG 3’.
UStatistical Analysis
Data are representative of at least three independent experiments, unless 
otherwise specified. Values were analyzed by One-way ANOVA, Repeated Measures 
ANOVA, or Student’s t test as described in each figure legend.  Statistical analysis was 
performed using Graph Pad Prism software and significance was assessed at P<0.05.
Results and Discussion
UInhibition of endocytosis in HEK293 cells by overexpressing a dominant negative form 
of dynamin (Dyn K44A) increases cell surface localization of GPR3
To confirm that GPR3 is endocytosed in HEK293 cells, cell surface proteins were 
biotinylated with cleavable sulfo-NHS-SS-biotin.  Following internalization, remaining 
biotinylated cell surface proteins were stripped and detected by streptavidin precipitation 
and Western blot.  Biotinylated GPR3 was detected at the cell surface (Lane 1 of Figure 
3.1) and in internalized samples at 30 min and 60 min (Lane 3 and 4 of Figure 3.1).  The 
internalized sample did not contain cell surface GPR3 because efficient stripping of 
biotinylated cell surface proteins was observed (Lane 2 of Figure 3.1).  
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 In order to examine whether GPR3 signals from the cell membrane and/or 
endosomes, we used Dyn K44A to inhibit endocytosis (van der Bliek et al., 1993).  Dyn 
K44A is mutated in the GTP binding domain, which blocks early events of endocytosis.  
To confirm that Dyn K44A effectively inhibits endocytosis in HEK293 cells, Dyn WT 
and K44A were expressed by transient transfection and 24 hr later, the cells were labeled 
with Alexa Fluor 488-labeled transferrin to evaluate receptor-mediated internalization.  
Confocal images show that cells transfected with Dyn K44A have lower levels of 
transferrin internalization with more accumulation at the cell surface compared to cells 
transfected with Dyn WT (Figure 3.2 A and B).  These results are consistent with 
previous findings that Dyn K44A inhibits receptor-mediated endocytosis (van der Bliek 
et al., 1993).
Localization of GPR3 in response to endocytic inhibition was evaluated using two 
methods.  First, HEK293 cells were co-transfected with GPR3-RFP and Dyn WT or Dyn 
K44A, and imaged by confocal microscopy.  In cells co-transfected with Dyn WT, 
GPR3-RFP is localized in the plasma membrane and also within intracellular clusters 
(Figure 3.2 C), similar to its localization in mouse oocytes (Lowther et al., 2011) and 
transfected Neuro2a cells (Tanaka et al., 2007).  Co-transfection of GPR3-RFP with Dyn 
K44A increased GPR3 fluorescence at the plasma membrane (Figure 3.2 D).  Western 
analysis confirmed that Dyn WT and Dyn K44A were expressed at equivalent levels 
(Figure 3.2 E).  Second, GPR3-HA localization at the plasma membrane was evaluated 
by biotinylation and precipitation of cell surface proteins and Western blot. Total GPR3-
HA expression normalized to GAPDH was similar in cells co-transfected with DynWT 
and DynK44A based on densitometry (Figure 3.2 F-G).  In support of the results from 
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 confocal microscopy, there is a ~2 fold increase in surface GPR3 precipitated from 
biotinylated cell lysates co-transfected with Dyn K44A compared to Dyn WT (Figure 3.2
H).  Similar results were obtained using methyl-?-?????????????????????????????????
selectively extracts cholesterol from the plasma membrane and inhibits receptor-mediated 
endocytosis by preventing invagination of caveolae and clathrin-coated pits (Rodal et al., 
1999) (Data not shown).  These results demonstrate that GPR3 is constitutively 
internalized by a dynamin-dependent mechanism and inhibition of endocytosis increased 
GPR3 surface expression.
UInhibition of endocytosis in cells transfected with GPR3-HA increases intracellular 
cAMP levels
GPCR internalization usually leads to signal termination.  However, recent studies 
have shown that several receptors including TSH and PTH receptors continue to signal 
following internalization (Calebiro et al., 2009; Calebiro et al., 2010a; Ferrandon et al., 
2009).  In these previous studies, cAMP levels returned to basal levels following ligand 
treatment and endocytic inhibition. Because constitutively active GPCRs signal in the 
absence of an agonist, it is possible that placement at the plasma membrane is not
required for GRsR activation and that they may be able to signal internally.  To determine 
whether GPR3 signals following endocytosis, we measured cAMP using an EIA assay in 
cells co-transfected with GPR3-HA and Dyn WT or K44A.  Transient transfection of 
HEK293 cells with GPR3-HA caused cAMP levels to increase significantly compared to 
empty vector-transfected cells, confirming the constitutive activity of GPR3.  When co-
transfected with Dyn K44A, cAMP levels significantly increased compared to cells co-
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 transfected with empty vector or Dyn WT (Figure 3.3 A).  These results demonstrate that 
an increase in GPR3 at the cell surface corresponds to an increase in cAMP levels, 
suggesting that GPR3 signals at the cell surface and not from endosomes.  Transfection 
of Dyn WT or K44A in the absence of GPR3-HA did not alter cAMP levels (data not 
shown).   Treatment of GPR3-HA tr????????????????????? ???, which prevents 
endocytosis and increases surface GPR3, also significantly increased cAMP levels (data 
not shown).
In order to corroborate the cAMP data obtained by EIA assay, we performed a 
FRET-based assay using a low affinity (KRdR = ~14 μM) Epac-based cAMP sensor (CFP-
??????????-CD)-YFP (Ponsioen et al., 2004)) that is not saturated in cells transfected 
with GPR3-RFP. This method is advantageous over standard EIA methods because only 
transfected cells are used for cAMP measurements.  Cells were co-transfected with 
GPR3-RFP, Epac sensor, and empty vector or Dyn WT or Dyn K44A.  GPR3-positive 
red cells of similar intensity were selected for all recordings.  The YFP/CFP emissions 
were recorded before and after isoproterenol/IBMX treatment and cAMP concentrations 
were calculated.  As expected, cells transfected with GPR3-RFP have a higher level of 
cAMP (~19μM) compared to empty vector (~0.1μM), demonstrating high constitutive 
activity of GPR3.  Cells co-transfected with GPR3-RFP and Dyn K44A have higher 
cAMP levels (~64 μM) compared to GPR3-RFP with Dyn WT (~9 μM) or empty vector 
(Figure 3.3 B), confirming that cAMP levels significantly increase when endocytosis is 
inhibited.  Together, these results demonstrate that GPR3 signals at the cell surface and 
does not signal from endosomal compartments.  This finding is in contrast to GPR6, a 
closely related receptor to GPR3, that is thought to signal internally because it is 
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 primarily localized in intracellular compartments (Padmanabhan et al., 2009).  GPR3 
seems to be largely localized on the cell surface in oocytes (Lowther et al., 2011),
Neuro2a cells (Tanaka et al., 2007), and HEK293 cells (Zhang et al., 2012) and this 
difference in localization between GPR3 and GPR6 may explain why they may signal 
from different membrane compartments.  
U????????????????????????????-arrestin-2 decreases surface localization of GPR3 and 
cAMP production
It is unknown whether GPR3 and other constitutively active GPCRs are regulated 
by similar mechanisms as ligand-activated GPCRs.  It is thought that constitutively active 
GPCRs are in the appropriate conformation to be continuously phosphorylated by GRKs 
and signaling is transiently silenced (Leurs et al., 1998).  To determine whether GPR3 
?????????????????????????????-arrestins, these proteins were co-expressed with GPR3 
and localization was evaluated by the same methods described above.  Overexpression of 
??????????-arrestin-2 appears to decrease GPR3-RFP cell surface localization as 
assessed by confocal microscopy (Figure 3.4 A and B).  The decrease in cell surface 
GPR3 is more obvious when detected by biotinylation and precipitation and Western 
analysis (Figure 3.4 C).  Using densitometry, total GPR3 expression was not significantly 
different (Figure 3.4 D).  However, surface expression of GPR3 as compared to total 
GPR3 expression was lower in cells co-???????????????????????????-arrestin-2 (Figure 
3.4 E), suggesting that these proteins induce GPR3 internalization.  Measurements of 
cAMP using EIA and FRET showed that cAMP levels decreased by more than 50% as a 
result of GPR3-HA co-??????????????????????????-arrestin-2 (Figure 3.5 A and B).
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 These results demonstrate that GPR3 is susceptible to desensitization by a 
GRK2- ?????-arrestin2-dependent mechanism.  There is an example of at least one 
constitutively active GPCR, the human cytomegalovirus (HCMV)-encoded receptor 
US28, that signals at the cell surface and is constitutively phosphorylated by GRKs.  
Following phosphorylation, US28 is rapidly internalized through a clathrin-mediated 
mechanism and ?????????????????????????-arrestins (Droese et al., 2004; Miller et al.,
2003b; Mokros et al., 2002), and internalization attenuates US28-induced GRqR-mediated 
phospholipase signaling (Casarosa et al., 2001; Fraile-Ramos et al., 2001; Miller et al., 
2003b; Mokros et al., 2002).  Deletion or mutation of the C-terminus of US28 so that it 
can no longer be phosphorylated results in an increase in phospholipase signaling and an 
increase in surface expression (Miller et al., 2003b; Mokros et al., 2002; Waldhoer et al., 
2003).  It has been speculated that this behavior allows HCMV entry into the cells and 
contributes to viral infection. Whether all constitutively active GPCRs are regulated in a
similar manner or whether it is unique to US28 is not understood.  GPR3 seems to be 
?????????????????????????????????????????????????????????????-arrestin overexpression 
attenuates cAMP signaling.  Whether GPR3 is regulated by this pathway under 
physiological conditions remains unknown.
UThe serine and threonine residues in the third intracellular loop and C-terminus have 
different functions in regulating GPR3 activity and surface localization
GPR3 contains two potential sites for phosphorylation by protein kinase C (PKC) 
as well as several serine residues that could be targets for GRKs.  To determine whether
GPR3 activity is regulated by any of these sites, we mutated all six serines in the C-
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 terminus and the serine and threonine residues in the third intracellular loop to alanine 
(Figure 3.6 A).  If GPR3 is desensitized due to the phosphorylation of these residues, then 
it is expected that mutations of these sites would prevent desensitization and increase 
cAMP levels.  Mutation of the six serines in the C-terminus (S1-6A) produced cAMP 
levels comparable to GPR3 WT.  In contrast, mutation of the serine and threonine 
residues in the third intracellular loop (ST/A) led to significantly higher cAMP levels 
compared to GPR3 WT (Figure 3.6 B), suggesting that these residues are important for 
phosphorylation and desensitization of GPR3.  It is expected that if the ST/A mutant is 
resistant to desensitization, internalization would be impaired, and surface localization 
would increase.  However, we found that surface localization of the ST/A mutant 
compared to total expression was lower, but not significantly different from GPR3 WT 
(Figure 3.6 D).  
Interestingly, the S1-6A mutant exhibited significantly lower surface expression 
compared to GPR3 WT but cAMP levels were unaffected (Figure 3.6 D). It is possible 
that reduced membrane expression of the S1-6A mutant is because the mutated receptor 
does not make it to the membrane.  Because decreased cell surface expression of the S1-
6A mutant does not prevent the receptor from activating cAMP, it suggests that surface 
localization is not a requirement for cAMP production and that GPR3 may be able to 
signal from other membranes.  This possibility is supported by the double mutant, ST/A, 
S1-6A, that has increased activity but lower cell surface localization compared to GPR3 
WT. Because some GPCRs can signal from endosomal compartments, it is conceivable 
that some GPCRs may also be able to signal internally prior to plasma membrane 
insertion, especially those that are constitutively active.  The 30T?R2R-adrenergic30T receptor 
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 ??R2RAR) forms a complex with GRsR and adenylate cyclase soon after leaving the ER in 
transit to the Golgi (Dupre et al., 2007; Dupre et al., 2006)?????????????R2RAR does not 
activate GRsR at this compartment because it does not interact with its ligand until it reaches 
the cell surface.  Because GPR3 is thought to signal in the absence of a ligand, it is 
possible that it could signal internally prior to membrane insertion; however, this has not 
been directly examined.  It has been shown that inhibition of exocytosis in Xenopus
oocytes results in premature meiotic resumption (El-Jouni et al., 2007), supporting the 
idea that GPR3 is actively trafficked to the cell surface but does not signal during 
exocytosis.  In HEK293 cells, GPR3 may be able to signal internally from other 
membranes because S1-6A mutant produces similar levels of cAMP compared to GPR3 
WT, even though surface expression is lower.
Together, these results demonstrate that the ST/A and S1-6A mutations have 
different effects on GPR3 localization and signaling.  The ST/A mutation produces a 
hyperactive receptor whereas the S1-6 residues in the C-terminus are important for 
surface localization but not cAMP production.  It is not understood why mutation of the 
serine and threonine residue in the third intracellular loop increases GPR3 activity.  One 
possibility is that these sites are involved in regulating GPR3 activity by phosphorylation.  
The total expression of the GPR3 WT and mutants varied but were not significantly 
different (Figure 3.6 C).  Therefore, it is unlikely that differences in cAMP production are 
due to differences in receptor expression because the ST/A and ST/A, S1-6A mutants are 
expressed at slightly lower levels but produce more cAMP than GPR3 WT and S1-6A 
mutant.  Further studies with fluorescently-tagged mutant receptors are needed in order to 
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 understand how these residues regulate surface localization of GPR3 and what 
membranes GPR3 can signal from.
UThe serine and/or threonine in the third intracellular loop are not targeted by GRK2 and 
?-arrestin-2
One possibility that may explain why the ST/A mutant is hyperactive is that it is 
resistant to desensitization.  To determine whether the serine and threonine residues in the 
???????????????????????????????????????????????????????????????????????????????????-
arrestin-2, cAMP levels were measured in cells co-transfected with the GPR3 ST/A 
?????????????????????-arrestin-2. We found that cAMP levels produced by the GPR3 
??????????????????????????????????????????????-arrestin-2 overexpression. cAMP levels 
decreased by ~76% and ~73% for GPR3 WT and ST/A, respectively (Figure 3.7 A and 
B).  Contrary to our expectations, these data demonstrate that mutation of potential 
phosphorylation sites in the third intracellular loop did not result in loss of regulation by 
??????????-arrestin-2 and these residues are not involved in desensitization by this 
pathway.  We also found that surface expression of GPR3 ST/A decreased in response to 
??????????-arrestin-2 overexpression but it was not as dramatic as what is observed 
with GPR3 WT (Figure 3.7 C).  Further studies are required to determine the role of the 
third intracellular loop in the regulation of GPR3 activity.  In addition to GRK 
phosphorylation, the third intracellular loop can regulate GPCR signaling by influencing 
G protein activation and binding of GPCR-interacting proteins such as 14-3-3,
sphinophilin, RGS2, and arrestin (Damaj et al., 1996; Prezeau et al., 1999; Richman et 
al., 2001; Wade et al., 1999; Wu et al., 1997).  The third intracellular loop is also thought 
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 to be involved in stabilizing the neuropeptide Y1 receptor in the inactive state and confers 
structural properties for regulating receptor activation (Chee et al., 2008).
Because the GPR3 ST/A mutant was susceptible to desensitization by GRK2 and 
?-arrestin overexpression, it is possible that other sites within GPR3 are phosphorylated 
by GRK or that GRK mediates desensitization independently of phosphorylation.  We 
constructed a catalytically inactive GRK2 mutant (GRK2-K220R), in which the lysine at 
residue 220 was mutated to arginine.  This mutation in the ATP binding domain inhibits
the kinase activity of GRK2 (Casarosa et al., 2001; Miller et al., 2003b). HEK293 cells 
were co-transfected with GPR3 WT or ST/A and GRK2-???????????-arrestin-2-GFP. 
GRK2-K220R significantly decreased cAMP for GPR3 WT and ST/A, although the 
decrease was not to the same extent as GRK2 WT (Figure 3.7 A and B).  This effect is 
not d???????-arrestin because transfection of GRK2-K220R alone is sufficient to decrease 
cAMP.  This result suggests that GRK2 desensitizes GPR3 activity independently of its 
kinase activity, which has been observed for other GPCRs including the metabotropic 
glutamate receptor,  parathyroid hormone receptor, and type 1A angiotensin II (Dhami et 
al., 2002; Dicker et al., 1999; Oppermann et al., 1996).  The amino terminus of GRK2 
contains a regulator of G-protein signaling (RGS) homology (RH) domain that can 
regulate G protein activation by binding to and sequestering GR Rproteins in the cytoplasm 
to prevent further interactions with GPCRs (reviewed in (Ferguson, 2007b).   Indeed, 
expression of the amino-terminal domain of GRK that contains the RH domain is 
sufficient to diminish cAMP activity without phosphorylation of several GPCRs (Carman 
et al., 1999; Damaj et al., 1996; Fernandez et al., 2011).  Based on our studies, it is 
unclear whether GPR3 phosphorylation by GRKs is important for GPR3 signaling, since 
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 both wild-type and kinase-inactive GRK2 inhibited cAMP production.  Future studies are 
needed to determine whether GPR3 is phosphorylated, whether this phosphorylation is 
diminished with the ST/A mutant, and whether the RH domain of GRK2 can reduce 
GPR3 activity.  Further studies are also required to understand whether ?-arrestin is 
required for GPR3 internalization.
UPKC inhibition increases GPR3-cAMP signaling and PKC activation decreases GPR3-
cAMP signaling 
As mentioned above, it is possible that other kinases are involved in regulating 
GPR3 activity.  In addition to GRK, second messenger-dependent kinases including PKA 
and PKC can also phosphorylate GPCRs (Tobin, 2008).  Signal termination in this 
manner involves a feedback loop in which second messengers produced by GPCR 
signaling activate PKA or PKC that then phosphorylate the receptor and lead to 
desensitization.   Unlike GRKs, these kinases do not discriminate between agonist-bound
and agonist-free GPCRs (Kohout and Lefkowitz, 2003).  PKA is not likely to be involved 
in regulating GPR3 because GPR3 does not contain a PKA consensus site; however, 
GPR3 has two predicted PKC sites within the third intracellular loop and the C-terminus 
(Eggerickx et al., 1995; Saeki et al., 1993).  The threonine in the third intracellular loop is 
of particular interest because when mutated, intracellular cAMP levels increase more than 
2-fold over WT.  To test whether GPR3-cAMP signaling can be mediated by PKC, we 
treated HEK293 cells transfected with GPR3-HA WT with a PKC inhibitor (Bis I) or a 
PKC activator (PMA).  In response to Bis I treatment, cAMP levels significantly 
increased compared to DMSO-treated cells (Figure 3.8 A).  In contrast, treatment with 
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 PMA significantly decreased cAMP levels compared to DMSO treatment, suggesting that 
PKC regulates GPR3 signaling (Figure 3.8 B).  Because the threonine in the third 
intracellular loop is a potential PKC site, it is possible that this mutant will not respond to 
Bis I or PMA treatment.  However, we found that Bis I treatment increased cAMP levels 
and PMA decreased cAMP levels for the ST/A mutant (Figure 3.8 C and D).  Together, 
these results demonstrate the potential for GPR3 regulation by PKC but the threonine 
residue in the third intracellular loop does not appear to be involved in this regulation.  
Further studies are needed to examine whether other PKC isoforms, not targeted by Bis I 
or PMA, can regulate GPR3 activity.   In addition, PKC is activated by GRqR-coupled 
receptors or by GR??R and there is currently no evidence that GPR3 can signal through these 
pathways.
In summary, GPR3 is a constitutively active receptor that is an important 
regulator of meiosis in oocytes (Hinckley et al., 2005; Ledent et al., 2005; Mehlmann et 
al., 2004) and has a variety of functions in the brain (Ruiz-Medina et al., 2011; Tanaka et 
al., 2007; Tanaka et al., 2009; Thathiah et al., 2009; Tourino et al., 2012; Valverde et al., 
2009).  In oocytes, GPR3 is localized in the plasma membrane and early endosomes and 
inhibiting endocytosis increases cAMP levels (Lowther et al., 2011).  However, the 
mechanisms controlling GPR3 activity and subcellular localization, if any, have not yet 
been characterized.  In the present study, we found that inhibition of endocytosis results 
in increased GPR3 at the cell surface and increased cAMP levels.  Conversely, 
????????????????????????????-arrestin-2 decreased both cell surface GPR3 and 
intracellular cAMP levels.  Together, these results are consistent with the hypothesis that 
GPR3 signals at the cell surface and is susceptible to desensitization by a GRK2- ?????-
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 arrestin-2-dependent mechanism. Although it appears that GPR3 signals from the cell 
membrane and does not continue to signal following internalization, surface localization 
is not required for cAMP production.  Mutation of the serine residues in the C-terminus 
diminished surface localization but did not affect cAMP production.  Therefore, GPR3 
can potentially activate cAMP prior to membrane insertion.  We also provide evidence 
that GRK2 and PKC regulate cAMP production by GPR3 but it is not via the 
phosphorylation of the serine or threonine residues in the third intracellular loop.  Future 
studies are needed to determine how GRK2, PKC, and the serine and threonine residues 
in the third intracellular loop regulate GPR3 activity and whether additional regulatory 
proteins interact with GPR3.  It will also be interesting to examine whether GPR3 is 
regulated by similar mechanisms in oocytes and whether GPR3 localization and 
trafficking is perturbed in women with reproductive problems such as fertility or primary 
ovarian insufficiency.  Several studies have examined whether mutations in GPR3 are 
present in women with primary ovarian insufficiency;  however, no perturbations were 
found in the coding region of GPR3 in the populations included in these studies (Kovanci 
et al., 2008; Zhou et al., 2009).  Whether GPR3 localization or activity in the ovary is 
abnormally regulated in these women remains to be explored.
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 Figure 3.1.
Figure 3.1. GPR3 is localized at the cell surface and undergoes internalization.  
HEK293 cells were transfected with GPR3-HA.  Twenty-four hr later, surface proteins 
were biotinylated (lane 1), allowed to internalize for 30 min (lane 3) or 60 min (lane 4) at 
37?C, and biotinylated proteins remaining at the cell surface were removed using a 
glutathione strip buffer.  Biotinylated proteins were precipitated from the total lysate and 
5μl of the sample was analyzed by Western blotting.  Lane 2 represents biotinylated
GPR3 stripped from the cell surface.  Detection of GAPDH in 0.5μg of total lysate was 
run on the same gel and served as a loading control to confirm that an equivalent amount 
of protein was used for precipitations.
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 Figure 3.2.
Figure 3.2. Inhibition of endocytosis increases cell surface GPR3.  (A and B)
HEK293 cells were transfected with Dyn WT (A) or Dyn K44A (B) and 24 hr later, the 
cells were incubated with Alexa Fluor 488-labelled transferrin and imaged with a 
confocal microscope.  (C and D) Cells were co-transfected with GPR3-RFP and Dyn WT 
(C) or Dyn K44A (D) and imaged using a confocal microscope 24 hr later.  Bar = 10 μm.  
(E) One μg of HEK293 lysate was used to detect Dyn WT and Dyn K44A 
overexpression by Western blot analysis.  (F) HEK293 cells were co-transfected with 
GPR3-HA and Dyn WT or Dyn K44A and 24 hr after transfection cell surface proteins 
were biotinylated, precipitated, and surface expression of GPR3-HA was detected by 
Western blot analysis.  0.5 μg of total lysate was used to detect total GPR3 and GAPDH 
expression.  Blot is representative of 4 separate experiments.  (G-H) Bands 
corresponding to surface GPR3 and total GPR3 expression were analyzed using 
densitometry and normalized to GAPDH.  G) Total GPR3 expression in cell lysates co-
transfected with Dyn WT or Dyn K44A.  H) Normalized surface GPR3 was divided by 
normalized total GPR3 expression to compare the amount of GPR3 at the surface 
compared to total GPR3.  Results are presented as mean ± S.E.M from 3 separate 
experiments.
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 Figure 3.3.
Figure 3.3. Inhibition of endocytosis increases intracellular cAMP.  A) HEK293 
cells were co-transfected with GPR3-HA and pcDNA (empty vector) or with Dyn WT or 
Dyn K44A.  Twenty-four hr after transfection, cells were harvested for cAMP EIA.  The 
results are presented as mean ± S.E.M from 4 separate experiments.  (a) indicates a 
significant increase in cAMP compared to “pcDNA” and (b) indicates a significant 
increase in cAMP compared to “GPR3 + pcDNA” and “GPR3 + Dyn WT”.  Significance 
was determined by One-way ANOVA followed by Newman-Keuls multiple comparison 
test (p<0.01).  B)  FRET measurements of red positive HEK293 cells co-transfected with 
GPR3-RFP and CFP-??????????-CD)-YFP and pcDNA, or Dyn WT or Dyn K44A 
following isoproterenol and IBMX treatment.  FRET measurements were converted to 
cAMP levels (μM) as described in the experimental protocol.  (a) indicates a significant 
increase in cAMP compared to “pcDNA”, (b) indicates a significant change in cAMP 
compared to “GPR3 + pcDNA”, and (c) indicates a significant increase in cAMP 
compared to “GPR3 + Dyn WT”.  Significance was determined by One-way ANOVA 
followed by Newman-Keuls Multiple Comparison Test (p<0.01).  Results were obtained 
from 15 different GPR3-RFP expressing cells per group.
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 Figure 3.4.
Figure 3.4. Overexpression of GRK2 and ?-arrestin-2 decreases cell surface GPR3 
expression.   A-B) HEK293 cells were co-transfected with GPR3-RFP and pcDNA (A)
or GPR3-RFP  and ??????????-arrestin-2 (B) and imaged using a confocal microscope 
24 hr after transfection.  Bar = 10 μm.  C)  HEK293 cells were co-transfected with 
GPR3-HA and pcDNA (-) or GPR3-?????????????????-arrestin-2 (+).  24 hr after 
transfection, cell surface proteins were biotinylated, precipitated, and cell surface 
expression of GPR3-HA was detected by Western blotting.  0.5 μg of total lysate was 
used to detect total GPR3 and GAPDH expression.  Blot is representative of 4 separate 
experiments. D-E) Bands corresponding to surface GPR3 and total GPR3 expression 
were analyzed using densitometry and normalized to GAPDH.  D) Total GPR3 
expression in cell lysates co-???????????????????????????-arrestin-2. E)  Normalized 
surface GPR3 was divided by normalized total GPR3 expression to compare the amount 
of GPR3 at the surface compared to total GPR3.  Results are presented as mean ± S.E.M. 
from 3 separate experiments.
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Figure 3.5. 
Figure 3.5.  Overexpression of GRK2 and ?-arrestin-2 decreases intracellular cAMP 
levels.  A)  HEK293 cells were co-transfected with GPR3-HA and pcDNA or GPR3-HA
??????????????-arrestin-2.  Twenty-four hr after transfection, cells were harvested for 
cAMP EIA.  The results are presented as mean ± S.E.M from 3 separate experiments.  (a) 
indicates a significant increase in cAMP level compared to “pcDNA” and (b) indicates a 
significant decrease in cAMP level compared to “GPR3 + pcDNA”.  Significance was 
measured by One-way ANOVA followed by Newman-Keuls Multiple Comparison Test 
(p<0.05).  B) FRET measurements of red positive HEK293 cells co-transfected with 
GPR3-RFP, CFP-??????????-CD)-YFP, and pcDNA or GPR3-RFP, CFP-??????????-
CD)-YFP, ??????????????-arrestin-2 following forskolin and IBMX treatment.  FRET 
measurements were converted to cAMP levels (μM) as described in the experimental 
protocol.  (*) indicates a significant decrease in cAMP levels compared to “GPR3-RFP”.  
Significance was determined by two-tailed unpaired T test (p<0.05).  Results were 
obtained from 13-18 different GPR3-RFP expressing cells per group.
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Figure 3.6 
Figure 3.6. Mutation of S and T residues in the third intracellular loop increases 
intracellular cAMP while mutation of S residues in the C-terminus decreases cell 
surface expression of GPR3. A) Schematic identifying potential serine and threonine 
residues in the third intracellular loop and C-terminus that could be targeted for 
regulation by phosphorylation.  These residues were mutated to alanine to create 3 
mutants:  ST/A, S1-6A, and ST/A, S1-6A.  B)  GPR3-HA WT and mutants were 
transfected into HEK293 cells and harvested 24 hr later for cAMP EIA.  Results are 
presented as mean ± S.E.M. from 6 separate experiments.  (a) indicates a significant 
increase in cAMP level compared to “WT”, (b) indicates a significant difference in 
cAMP compared to “ST/A”, and (c) indicates a significant difference in cAMP compared 
to “S1-6A” as determined by Repeated Measures ANOVA followed by Newman-Keuls 
Multiple Comparison Test (p<0.01).  C-D)  24 hr after transfection, cell surface proteins 
were biotinylated, precipitated, and surface expression of GPR3-HA was detected by 
Western blotting.  0.5 μg of total lysate was used to detect total GPR3 and actin 
expression.  Bands corresponding to surface GPR3 and total GPR3 expression were 
analyzed using densitometry and normalized to Actin.  C) Total GPR3 WT and mutant 
expression in cell lysates.  D) Normalized surface GPR3 was divided by normalized total 
GPR3 expression to compare the amount of GPR3 at the surface compared to total GPR3.  
Results are presented as mean ± S.E.M from 3 separate experiments. (*) indicates a 
significant difference in cell surface vs. total expression as compared to “WT”.  
Significance was determined by One-way ANOVA followed by Newman-Keuls Multiple 
Comparison Test (p<0.05).
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 Figure 3.7.
Figure 3.7. S and T residues in the third intracellular loop are not involved in 
GRK2/?-arrestin-2- mediated desensitization. A-B) GPR3-HA WT and ST/A were 
co-????????????????????????????????????-arrestin-2, or GRK2-K220R, or GRK2-
???????????-arr-2.  Twenty-four hr after transfection, cells were harvested for cAMP 
EIA.  Results are presented as mean ± S.E.M from 3-5 separate experiments. (*) indicates 
a significant decrease in cAMP compared to “pcDNA”.  Significance was determined by 
One-way ANOVA followed by Dunnett’s Multiple Comparison Test (p<0.05). (C)
GPR3-HA WT and ST/A were co-????????????????????????????????????-arrestin-2.
Twenty-four hr after transfection, cell surface proteins were biotinylated, precipitated 
from cell lysates, and analyzed by Western blotting.  Normalized surface GPR3 was 
divided by normalized total GPR3 expression to compare the amount of GPR3 at the 
surface compared to total GPR3.  Results are presented as mean ± S.E.M from 3 separate 
experiments.
87 
 
 Figure 3.8.
Figure 3.8. PKC inhibition increases intracellular cAMP and PKC activation 
decreases intracellular cAMP levels.  A-B).  HEK293 cells were transfected with 
GPR3-HA WT and 4 hr later treated with 5μM Bis I (A) or 10 nM PMA (B).  Following 
18 to 24 hr treatment, cells were harvested for cAMP EIA.  C-D) HEK293 cells were 
transfected with GPR3-HA ST/A and 4 hr later treated with 5μM Bis I (C) or 10 nM 
PMA (D).  Following 18 to 24 hr treatment, cells were harvested for cAMP EIA.  Results 
are presented as mean ± S.E.M from 3-4 separate experiments.  (*) indicates a significant 
difference in cAMP levels from “-” DMSO treated cells as determined by two-tailed 
paired Student’s t test (p<0.05).  ~170,000 cells lysed in 0.1M HCl were used in the EIA 
assay, except for the GPR3-HA ST/A treated with Bis I and DMSO where ~90,000 cells 
were used.
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 Table 3.1 Primer Sets used for GPR3-HA Mutagenesis
GPR3 S1-3A 5’-GGGCTGTCTGCTGCTGCTGATCCTCTTCCAAGATCCCCTTCC-3’
5’-GGAAGGGGATCTTGGAAGAGGATCAGCAGCAGCAGACAGCCC-3’
GPR3 S6A 5’-GATCCCGCTCCCCCAGTGATGTCACGCGTT-3’
5’-33TAACGCGTGACATCACTGGGGGAGCGGGATC33T-3’
GPR3 S4,5A 5’-GATCCCCTTCCGAGCCCGCGCCCCCGCTGATG-3’
5’-33TCATCAGCGGGGGCGCGGGCTCGGAAGGGGATC33T-3’
GPR3 T/A 5’-CACTATGTGGCCGCACGCAAGGGCATT-3’
5’-33TAATGCCCTTGCGTGCGGCCACATAGTG33T-3’
GPR3 S/A 5’-CCTGCTGCCTGCCGCCCACTATGTG-3’
5’-33TCACATAGTGGGCGGCAGGCAGCAGG33T-3’
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 CHAPTER FOUR
UConcluding Remarks and Future Directions
The projects described in this dissertation have begun our understanding of how 
the constitutively active receptor, GPR3, is regulated in mouse oocytes and HEK293
cells.  Similar to Xenopus and C. elegans oocytes (Cheng et al., 2008; El-Jouni et al., 
2007), membrane trafficking is important for meiotic arrest in mouse oocytes. The 
mouse oocyte undergoes active endocytosis and signaling at the cell surface is important 
for cAMP production and meiotic arrest.  In HEK293 cells, GPR3 signals at the cell 
surface and does not continue to signal following internalization.  GPR3-mediated cAMP 
production can be regulated by overexpressed GRK???????-arrestin in a manner that does 
not depend on the kinase activity of GRK2.  In addition, residues in the third intracellular 
loop may be sites for regulation by either phosphorylation or interaction with other G 
protein-coupled receptor interacting proteins (GIPs) and residues in the C-terminus are 
important for membrane expression.  In this chapter, I will provide a short summary of 
the conclusions from these studies, and introduce some avenues for further research.  I 
will also describe some preliminary data that explore these avenues.
UEndocytosis in the mouse oocyte and its contribution to cAMP signaling during meiotic 
arrest
The goal of this study was to examine whether receptor-mediated endocytosis 
occurs in the mouse oocyte and whether this could affect the maintenance of meiotic 
arrest due to GPR3 signaling.  We hypothesized that if GPR3 signals at the cell surface, 
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 then inhibition of endocytosis would delay or inhibit oocyte maturation due to an increase 
in GPR3 at the cell surface and an increase in cAMP signaling.  Because little is known 
about endocytosis in mammalian oocytes, we confirmed that oocytes express important 
components required for receptor-mediated endocytosis and that constitutive endocytosis 
occurs in the mouse oocyte.  To determine whether endocytosis contributes to cAMP 
signaling, we treated oocytes with inhibitors of receptor-mediated endocytosis, MDC and 
dynasore.  These endocytic inhibitors dose-dependently delayed spontaneous meiotic 
resumption for at least 7 hours following milrinone washout.  Dynasore treatment also 
significantly increased cAMP levels in the absence of milrinone, confirming that the 
delay or complete block in oocyte maturation in response to endocytic inhibition is 
attributed to elevated levels of cAMP.  We conclude from these experiments that cAMP 
signaling occurs at the plasma membrane and is sufficient for meiotic arrest.  If cAMP is 
generated from endosomal compartments in the oocyte, it would be expected that cAMP 
levels would decrease in response to dynasore treatment, as it does in thyroid follicles 
treated with dynasore and TSH (Calebiro et al., 2009).  Thus, endosomal signaling does 
not appear to contribute to cAMP production needed for meiotic arrest in the oocyte.
Our original hypothesis was that endocytic inhibition would cause GPR3 to 
accumulate at the plasma membrane and therefore increase cAMP production.  We 
examined GPR3 localization in mouse oocytes by microinjection of mRNA encoding 
GPR3-RFP.  GPR3-RFP localized in the plasma membrane and in clusters throughout the 
cytoplasm of the oocyte.  Fixation and labeling with EEA1 showed that GPR3-RFP co-
localized within early endosomes, demonstrating that it is internalized in the mouse 
oocyte.  In an attempt to determine whether GPR3 accumulates at the cell surface as a 
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 result of endocytic inhibition, we expressed GPR3-RFP in the oocyte and treated with 
MDC or dynasore.  We did not see any noticeable accumulation of GPR3 at the cell 
surface; therefore, we cannot correlate the increase in cAMP production in response to 
dynasore to increased GPR3 at the cell surface.  
Next, we examined whether GPR3 activity and internalization can be regulated by 
components of the desensitization pathway, GRK???????-arrestin-2.  We found that 
GRK???????-arrestin-2 overexpression stimulated meiotic resumption in a small number 
of oocytes, suggesting that these proteins can interact with GPR3 but likely do not play a 
major role in regulating GPR3 activity and endocytosis.  However, in this experiment the 
level of cAMP was not measured.  It is possible that GRK???????-arrestin-2
overexpression decreases cAMP levels in the oocyte, but not to the extent where it would 
cause maturation.  Because cAMP levels need to remain high for meiotic arrest, it is 
probable that whatever mechanism is regulating GPR3 activity acts to prevent excessive 
cAMP accumulation rather than to completely abolish cAMP production.  Otherwise, the 
oocyte would resume meiosis.  In summary, from these studies we conclude that 
endocytosis is an active process in mouse oocytes and is a regulator of meiotic arrest.  
These results are consistent with the hypothesis that GPR3-cAMP signaling at the cell 
surface, and not from endosomes, is necessary for maintaining meiotic arrest.  
UFuture Studies
There are still many unanswered questions about GPR3 signaling as well as 
general questions about membrane trafficking in the mouse oocyte. We present evidence 
that GPR3 does not signal from endosomes, at least not to the extent required for meiotic 
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 ???????????????????????????????? ??????????????????????????????????????????????R2R-AR 
receptor has been shown to preassemble with GRs Rand adenylate cyclase on the ER/Golgi 
(Dupre et al., 2007; Dupre et al., 2006), it presents the possibility that GPCRs can signal 
during the biosynthetic pathway prior to plasma membrane insertion and does not need to 
be present at the cell surface to mediate cAMP production.  The general mechanisms of 
endocytosis and exocytosis in the mouse oocyte are also poorly understood and warrant 
further investigation.
When is GPR3 expressed during meiosis?
Little is known about when GPR3 expression is turned on during follicle 
development and how this occurs.  We know that GPR3 needs to be expressed prior to 
the acquisition of meiotic competence, which occurs around the time of antrum 
???????????????????????RsR localization, GPR3 is fully active in preantral follicles (120-
190 μm diameter) (Freudzon et al., 2005). Using in situ hybridization, it was also 
demonstrated that Gpr3 is expressed in the oocyte during different stages of 
development; however, the stages were not defined in this study (Hinckley et al., 2005).
Thus, it is not known if GPR3 is expressed and active in earlier stage follicles.  As 
mentioned previously, Gpr3-deficient mice displayed increased rates of oocyte 
degeneration and reduced litter size (Ledent et al., 2005; Vaccari et al., 2008). This
phenotype could be the result of premature maturation.  However, this phenotype could 
also be the result of decreased developmental and meiotic competence of oocytes.  
Interestingly, cAMP has been shown to be important for the acquisition of meiotic 
competence (Chesnel et al., 1994; Eppig et al., 2004b), presenting the possibility that 
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 GPR3 and cAMP production are important during earlier stages of folliculogenesis.  It is 
also not known if GPR3 is active following GVBD and if it is needed for early 
development.  Gpr3 mRNA is present in eggs and early embryos at the one and two cell 
stage, but whether the protein is expressed is unknown.  Trace amounts of Gpr3 mRNA 
is detected in morulae and it is absent in blastocysts (Ledent et al., 2005), suggesting that 
GPR3 is not needed following the 8-cell stage. Thus, further studies are needed to 
determine whether GPR3 is expressed before and after prophase I arrest and how this 
expression might be regulated.
Does GPR3 signal during exocytosis?
The colocalization of GPR3 with early endosomes demonstrates that GPR3 is 
actively endocytosed in the oocyte and is not stably present at the cell surface.  Delivery
of GPCRs to the cell surface occurs by exocytosis regardless of whether GPCRs are 
recycled following internalization or newly synthesized.  Based on the original 
hypothesis, if GPR3 signals from the cell surface, then preventing exocytosis should 
decrease the amount of receptor at the cell surface, decrease cAMP levels, and stimulate 
meiotic resumption.  Alternatively, it is possible that GPR3 can signal from vesicles prior 
to exocytosis because it is constitutively active and may not need to be at the plasma 
membrane to activate GRsR.  To test whether GPR3 can signal prior to membrane insertion, 
we injected antral follicle-enclosed oocytes with mRNA encoding dominant negative 
???????????????????????????????????????????????????????-enclosed oocytes injected 
?????????????????????????????????????????????????????????????????????the 
uninjected or the SNAP25 WT-injected follicle-enclosed oocytes remained GV intact 
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 (Figure 4.1).  Whether the effect on stimulating maturation is due to decreased GPR3 at 
the cell surface and decreased cAMP levels is not currently understood.  It is likely that 
inhibiting exocytosis would prevent other proteins required for meiotic arrest from 
inserting into the membrane, such as adenylate cyclase or gap junction proteins.  
Nevertheless, this finding demonstrates the importance of membrane trafficking in 
maintaining meiotic arrest in the mouse oocyte.  Additional studies could examine 
whether GPR3 can signal during exocytosis prior to membrane insertion using 
mutagenesis to create a GPR3 mutant that exhibits impaired cell surface trafficking and
increased ER retention.  Using EIA or FRET assays, the effect of this mutant on cAMP 
levels can be measured.    
What proteins are involved in exocytosis?
Although our interest in this project is to understand GPR3 signaling, during the 
course of these experiments we realized that there is a lack of understanding about the 
mechanism of exocytosis in the oocyte.  The mammalian oocyte, like all cells, requires 
constitutive exocytosis to maintain appropriate proteins and lipids at the cell surface.  In 
addition, the oocyte secretes specific paracrine factors such as growth differentiation 
factor 9 (GDF9), bone morphogenetic protein 15 (BMP15), and fibroblast growth factor 
8B (FGF8B) that are essential for follicle development, cumulus cell metabolism, 
expansion, and ovulation (Dong et al., 1996; Elvin et al., 1999; Sugiura et al., 2007; Yan 
et al., 2001).  These paracrine factors are also important for the oocyte because they 
promote the expression of genes in cumulus cells that compensate for processes deficient 
in oocytes including the ability to transport certain amino acids, glycolysis, and 
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 cholesterol synthesis (Su et al., 2009).  During maturation, the oocyte transitions to a cell 
primed to undergo regulated, CaP2+P-dependent exocytosis of cortical granules.  Cortical 
granules are located in the cortex of mature eggs of many species and are released in 
response to a rise in intracellular CaP2+P upon fertilization (Kline, 1988; Kline and Kline, 
1992; Zucker and Steinhardt, 1978).  Cortical granules contain proteoglycans and 
enzymes that permanently modify the extracellular surface of the egg to prevent 
polyspermy (Wessel et al., 2001).  In sea urchin eggs, cortical granule exocytosis is 
associated with components of exocytic machinery including SNARE proteins, munc18, 
rab3, and synaptotagmin 1 (Conner et al., 1997; Conner and Wessel, 1998; Leguia et al., 
2006; Leguia and Wessel, 2004).  Similar studies in mammalian oocytes are currently 
lacking.
In preliminary experiments, SNARE proteins in the mouse oocyte were identified 
by RT-PCR. The oocyte expresses syntaxin1, syntaxin4, vamp3, vamp4, snap23, snap25,
synaptotagmin5, synaptotagmin9, and low amounts of synaptotagmin1. Although 
SNAP25 is involved in CaP2+P dependent exocytosis, we did not detect protein expression 
in oocytes or eggs. We did find that the oocyte abundantly expresses SNAP23 protein 
(unpublished data), a non-neuronal isoform of SNAP25 that is involved in both 
constitutive and regulated exocytosis (Hepp et al., 2005; Ravichandran et al., 1996; Suh 
et al., 2010; Suh et al., 2011). The finding that SNAP25 is not expressed is in contrast to 
a published report of SNAP25 being essential for cortical granule exocytosis in the 
mouse egg (Ikebuchi et al., 1998).
It is also possible that the oocyte utilizes a novel SNARE protein that has yet to be 
identified.  To identify novel SNARES, we performed RT-PCR using degenerate primers 
96 
 
 designed against a coiled coil domain, a characteristic motif of SNARE proteins.  This 
PCR amplified a product identified as TXLNG (taxilin gamma) from oocyte cDNA 
(unpublished data).  Taxilin has been shown to interact with syntaxin and be involved in 
CaP2+P dependent exocytosis in neuroendocrine cells (Nogami et al., 2003). In addition to 
taxilin, SNAP23 and SNAP25 were identified from this PCR.  Further studies are needed 
to determine the functional consequence of inhibiting SNAP23 and taxilin on follicle 
development, meiosis, ovulation, and cortical granule exocytosis.
Membrane transport ceases after meiotic resumption.  Is this process regulated and what 
is its importance?
Using EEA1 immunofluorescence, we found that early endosomes disappear 
following milrinone washout and GVBD.   The number of early endosomes appears to be 
lower in MII-arrested eggs than in oocytes and they are less concentrated in the cortex 
(Figure 4.2A).  Also, it appears that exocytosis stops during maturation.  When GPR3-
RFP mRNA is microinjected into oocytes undergoing meiotic resumption, it does not 
localize to the plasma membrane as it does in prophase I-arrested oocytes, indicating that 
insertion of plasma membrane proteins is inhibited (Figure 4.2B).  It is not surprising that 
membrane transport stops during oocyte maturation because there is dramatic 
reorganization of the ER and other cytoplasmic structures.  In Xenopus oocytes, 
membrane traffic to the surface is blocked during transition to MII and is associated with 
the disappearance of the Golgi apparatus (Colman et al., 1985). Also, because 
endocytosis and exocytosis are indirectly coupled processes, it is expected that if one 
process stops, so does the other.
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 It has been hypothesized that membrane trafficking stops during maturation in 
order to stock membranes for rapid cleavages that occur during early development 
(Gilbert, 1988; Singal and Sanders, 1974).  Two other thoughts that may explain why 
membrane transport stops are (1) all secretory vesicles are directed into a calcium-
dependent regulated pathway in preparation for cortical granule exocytosis at fertilization 
(Roberts et al., 1992); and (2) membrane transport ceases in preparation for the large
retrieval of membrane (compensatory endocytosis) that occurs following cortical granule 
exocytosis.  In support of this idea, the SNARE complex (VAMP1, Syntaxin 2, SNAP23, 
and complexin) and clathrin relocalize under the oocyte plasma membrane during 
maturation in porcine oocytes (Tsai et al., 2010).  Following fertilization, the proteins are 
released into the cytoplasm and there is compensatory endocytosis of VAMP1.  The
docking of this complex during maturation inhibits membrane trafficking until 
fertilization in order to prevent premature cortical granule exocytosis.  Proteins involved 
in other endocytic pathways do not relocalize during maturation, suggesting that clathrin-
mediated endocytosis is important for compensatory endocytosis (Tsai et al., 2010).
Further studies are needed to examine why membrane trafficking stops in mammalian 
oocytes and how this process is regulated. 
URegulation of Constitutive GPR3 Signaling and Surface Localization by Residues in the 
Third Intracellular Loop and C-terminus
Because we were not able to correlate inhibition of endocytosis and an increase in 
cAMP with GPR3 localization in the oocyte, we extended our studies to cultured 
HEK293 cells.  Using confocal microscopy and biotinylation of cell surface proteins, we 
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 found that inhibiting endocytosis using Dyn1 K44A increased the amount of GPR3 at the 
plasma membrane.  Inhibition of endocytosis also significantly increased cAMP levels as 
measured by EIA and FRET.  The next question that we addressed was whether GPR3 
activity and internalization is regulated by a GRK???????-arrestin-dependent mechanism.
Using the same methods stated above, we found that overexpression of GRK???????-
arrestin-2 decreased the amount of GPR3 at the cell surface as well as cAMP levels.  
From these results, we conclude that GPR3 signals at the plasma membrane and is 
actively internalized but does not continue to produce cAMP following internalization.  
Whether GPR3 is targeted for desensitization by GRK???????-arrestin 2 under 
physiological conditions and whether it is internalized by other pathways remains 
unknown. In addition, studies on the TSH receptor in thyroid follicles demonstrate that 
endosomal signaling and membrane signaling have different consequences on the cell.  
Thus, it is possible that GPR3 signals from endosomal compartments, but it may be 
required for a different signaling outcome other than cAMP production.
We also examined whether potential phosphorylation sites in the third 
intracellular loop and C-terminus regulate GPR3 activity.  GPR3 contains two potential 
sites for phosphorylation by protein kinase C (PKC) and several serine residues that 
could be targets for GRKs.  We mutated all six serines in the C-terminus and the serine 
and threonine residues in the third intracellular loop to alanine.  We found that mutation 
of the serine and threonine residues in the third intracellular loop (ST/A) led to 
significantly higher cAMP levels compared to GPR3 WT.  This result indicates that these 
residues are important for GPR3 regulation, although this regulation is independent of 
GRK???????-arrestin or PKC. Mutation of serines in the C-terminus did not have an 
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 effect on cAMP levels.  However, the S1-6A mutant exhibited lower levels of cell surface 
expression, suggesting that these residues are involved in GPR3 trafficking and that 
GPR3 localization at the plasma membrane is not a requirement for cAMP production.  It 
is possible that that GPR3 can signal from other membranes prior to membrane insertion,
as mentioned above. Interestingly, we also found that the kinase activity of GRK2 is not 
required to diminish cAMP signaling.  This raises the question of whether GPR3 is 
???????????????????????? ?????????-arrestin recruitment, if at all.
UFuture Studies
Many unanswered questions remain regarding the regulation of GPR3 activity.  
We know that the serine residues in the C-terminus are not involved in GPR3 activity,
whereas the serine and/or threonine residues in the third intracellular loop are.  Whether 
these residues in the third intracellular loop are targeted by some pathway to regulate 
GPR3 activity is unknown.   It is possible that these residues are sites for phosphorylation 
by other GRK isoforms or kinases.  It is also possible that they interact with a GIP or are 
involved in maintaining structural properties of GPR3.  Additionally, we present 
evidence that PKC can regulate cAMP production by GPR3, but how this occurs is not 
understood.  Further studies are needed to determine whether GPR3 is phosphorylated, 
contains regulatory elements in the C-terminus that interact with GIPs, and what the role 
????-arrestin is in regulating GPR3 activity and internalization. It should also be 
mentioned that GPR3 may behave differently in HEK293 cells than in oocytes, although
it is our hope that understanding GPR3 activity in HEK293 cells will be important for
future experiments in oocytes.
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 Is GPR3 phosphorylated?  
Almost all GPCRs are regulated by phosphorylation, a key process in regulating 
cellular distribution and signaling properties (Carman and Benovic, 1998; Lefkowitz and 
Whalen, 2004).  GPCRs can be phosphorylated by several types of kinases that recognize 
distinct sites on the C-terminus and intracellular loops.  We have shown that the serine 
residues in the C-terminus do not change cAMP production when mutated and are 
therefore not likely to be sites for phosphorylation-mediated desensitization, but they
appear to be involved in membrane expression of GPR3. Perhaps phosphorylation of 
these sites is required for trafficking of GPR3 to the cell surface.  The serine and 
threonine residues in the third intracellular loop could be phosphorylation sites involved 
in desensitization because mutation of these residues increases cAMP levels.  The serine 
and threonine residues in the second intracellular loop have not been examined. It is 
likely that GPR3 is not phosphorylated by GRK2 because the kinase inactive GRK2 
mutant is able to decrease cAMP production.  However, it remains to be explored 
whether GPR3 is phosphorylated by other GRK isoforms or by other kinases.  
Phosphorylation of GPCRs can be detected using several methods, including ProQ 
Diamond Phosphorylation Gel Stain (Invitrogen), metabolic labeling of cells with [P32P ] 
orthophosphate and autoradiography, or mass spectrometry.  Mass spectrometry can also 
be used to examine whether GPR3 undergoes other modifications such as glycosylation, 
palmitoylation, acetylation, ubiquitinylation, and myristoylation, which have been shown 
to regulate GPCR activity (Millar and Newton, 2010). GPR3 contains a potential N-
linked glycosylation site and a lysine residue in the C-terminus that could be targeted for
ubiquitinylation.
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 How does PKC Regulate GPR3 Activity?
The finding that PKC can regulate GPR3 activity in HEK293 cells suggested that 
the threonine residue in the third intracellular loop, a potential PKC site, could be 
targeted by PKC for phosphorylation.  Indeed, mutation of the threonine by itself is 
sufficient to increase cAMP production compared to GPR3 WT (Figure 4.3).  However, 
we found that the activity of the ST/A mutant, which presumably cannot be 
phosphorylated, can be modified by pharmacological manipulation of PKC similar to 
GPR3 WT.  Therefore, the threonine or the serine residues in the third intracellular loop 
are not targeted by PKC.  Further studies are required to determine whether PKC 
regulates GPR3 activity in other cell types and how this regulation occurs.  PKC could 
directly phosphorylate GPR3 to silence cAMP production.  Alternatively, PKC action 
could be indirect and it could phosphorylate a GIP that would then modulate GPR3 
activity.  In addition, it remains unknown how PKC is activated in HEK293 cells 
transfected with GPR3.  PKC is activated by the phospholipase C (PLC) signaling 
cascade in which PLC cleaves PIPR2R into IPR3R and diacylglycerol.  Depending on the 
isoform, PKC is activated by a combination of CaP2+P and/or DAG, and phospholipid 
phosphatidylserine, whereas atypical PKC isoforms require neither CaP2+P or DAG (Webb 
et al., 2000)???????????????????????????????? ????????????????Rq/11 Rsignaling but can also 
be activated by GR??R (Boyer et al., 1992).  There is currently no evidence that GPR3 
??????????????????Rq/11R or activates atypical PKC isoforms.  It is also not known if the GR??R
subunit mediates downstream signaling events, such as PKC activation.
What is th???????????-arrestin in GPR3 regulation?  
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 ?-arrestin coordinates GPCR activity in several ways, including desensitization, 
internalization and trafficking, and mediating G protein-independent signaling.  It is not 
clear if arrestin is involved in regulating any of these pathways for GPR3. For some 
??????????????????????????-arrestin can terminate G-protein signaling, but it is not 
absolutely required for internalization (Fraile-Ramos et al., 2003; Paing et al., 2002).
???????????????????????????-arrestin to GPR3 activity and internalization warrants further 
investigation.  The serine-rich cluster in the C-terminus of GPR3 classifies it as a Class B 
receptor (Class A and B are defined by the absence or presence of a Ser-Thr rich cluster, 
respectively).  Class A receptors are rapidly recycled followed internalization whereas
????????????????????????????????????????????????????????-arrestins and are internalized 
together, at which point they are either slowly recycled or degraded (Oakley et al., 2001).
We found that mutation of these serines (S1-6A mutant) decreased surface expression of 
the mutant. ???????????????????????????????????????????????????-arrestin for slow recycling 
or degradation, we would expect that the mutant would have increased expression at the 
cell surface.  Thus, further studies are needed to determine how the serine residues in the 
C-terminus are involved in membrane expression of GPR3 and whether they are involved 
in post-endocytic events mediated by ?-arrestin.
It should also be mentioned that phosphorylation is not an absolute requirement 
?????-arrestin recruitment.  ?-arrestin maintains multiple interactions with GPCRs such 
that it can recognize the active state separately from the phosphorylated state.  In the 
?????????????????????????????????????????????-arrestin may be reduced, but perhaps not to 
the extent where it would completely prevent binding (Tobin, 2008).  The presence of 
negatively charged residues can act as “phospho-???????????????-arrestin recruitment 
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 (Galliera et al., 2004; Mukherjee et al., 2002).  GPR3 does not contain any acidic amino 
acid clusters in the C-terminus or intracellular loops, but does have two aspartic acid 
residues in the C-terminus (amino acid #303 and #329) and a glutamic acid residue in the 
second intracellular loop (amino acid #147).  Even if GPR3 is not phosphorylated, it is 
?????????????????????-arrestins are involved in regulating its activity and internalization.  A
useful approach to determine whether ????????????????-arrestin changes GPR3 trafficking 
or signaling is to use embryonic fibroblasts derived fro???-arrestin1/2 knockout mice.
Does GPR3 contain regulatory regions within its C-terminus?  
In addition to sites for phosphorylation and arrestin binding, the C-termini of 
many GPCRs contain motifs that mediate internalization and association with other 
regulatory proteins.  The most understood sorting signals for cargo-selective clathrin 
adaptors are dileucine- and tyrosine-based motifs.  GPR3 contains an NPXY tyrosine-
based motif that is located in the seventh transmembrane domain next to the C-terminus.  
???????????????????????? ???????????????????????????????????????????????????????????????????-
arrestin-mediated internalization (as described in Chapter 1).  It would be interesting to
mutate this motif and examine the effect on GPR3 internalization and activity.  Also, 
several GIPs are known to associate with specific sequences in the C-terminus.  Of the 
consensus sequences established for GIPs, none are found in the C-terminus of GPR3; 
however, GPR3 contains sequences that may correspond to potential PDZ ligands (named 
after the first three proteins identified to share the domain; post synaptic density protein 
(PSD95), Drosophila disc large tumor suppressor (Dlg1), and zonula occludens-1 protein 
(zo-1) (Figure 4.4A). Many GPCRs express a PDZ ligand that corresponds to the last 3 
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 or 4 amino acids at the extreme end of the C-terminus and binds to proteins containing 
PDZ domains.  These proteins are involved in signaling specificity, spatial organization 
and receptor trafficking and targeting (Bockaert et al., 2003).  The C-terminus of GPR3 
may also contain a sequence that either mediates internalization or interaction with a 
regulatory protein that has yet to be identified.  
To determine whether the C-terminus of GPR3 is important for localization 
and/or activity, we constructed a truncated GPR3 mutant in which the last 15 amino acids 
were deleted by insertion of a stop codon (Figure 4.4B).  We found that the truncated 
mutant produced significantly less cAMP compared to the full length wild-type receptor 
(Figure 4.4C).  This result suggests that this region of the C-terminus is important for 
GPR3 activity.  We know that the reduced cAMP level produced by truncated GPR3 is
not due to deletion of the serine residues.  Additionally, if this sequence was important 
for binding of a protein(s) involved in internalization or diminishing cAMP production, it 
is expected that cAMP mediated by this mutant would increase, not decrease.  There are 
several explanations that could explain why truncated GPR3 produces less cAMP 
compared to the WT.  (1) GPR3 could bind to trafficking proteins such as NHERF, a 
PDZ-domain-containing protein that accelerates r??????????????-????????-opoid 
receptors (Cao et al., 1999).   If truncation of GPR3 prevents or slows recycling to the 
membrane, it is expected that cAMP levels would decrease.  (2) GPR3 could bind to a 
protein that promotes G protein-mediated signaling, and in the absence of this interaction, 
cAMP levels decrease. (3) An export motif required for proper membrane expression of 
GPR3 could be present in this region of the C-terminus.  Several reports have 
demonstrated that a dibasic motif in the C-terminus is required for cell surface expression 
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 and function of the rat melanin-concentrating hormone receptor 1 and CCR5 (Tetsuka et 
al., 2004; Venkatesan et al., 2001).  GPR3 contains a “RSR” dibasic motif at amino acids 
#323-325 that is deleted in the truncated mutant (underlined in Figure 4.4B).   
Interestingly, the dibasic motif is conserved in many Class A (Rhodopsin family) GPCRs 
and may have functional importance.  It has also been reported that a cysteine cluster in 
the C-terminus cooperates with the dibasic motif for optimal cell surface expression 
(Venkatesan et al., 2001).  GPR3 contains a cysteine cluster in the C-terminus at amino 
acids #312-315 (underlined in Figure 4.4B).  It would be interesting to examine whether
deleting both motifs has a more dramatic effect on lowering cAMP levels and surface 
expression. Thus, further experiments are needed to determine whether truncating GPR3 
reduces its membrane localization and interferes with intracellular trafficking. If we 
found that truncated GPR3 has lower membrane localization, this finding would need to 
be reconciled with the S1-6A mutant that has lower membrane expression but cAMP 
production is unaffected.  Perhaps the truncated mutant and the S1-6A mutant exhibit 
impaired trafficking and are localized at different sites within the cell.  Additionally, the 
importance of other residues in the C-terminus cannot be excluded, as the truncated 
GPR3 mutant only deleted the last 15 amino acids.  It is possible that there are other 
regions within the C-terminus that are also important for GPR3 activity and trafficking.  
This could be determined by serial truncations of additional residues in the entire C-
terminus. 
Does GPR3 interact with other G-protein interacting proteins (GIPs)?
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 The association of GIPs is emerging as a major mechanism contributing to the 
functioning of GPCRs.  There have been more than 50 GIPs identified that are membrane 
or intracellular proteins and can regulate GPCR signaling, cytoskeletal and extracellular 
matrix interactions, receptor internalization, and trafficking (reviewed in (Magalhaes et 
al., 2012).  For examples, proteins including ATRAP, phospholipase D2, Ral, NHERF, 
Nm23-H2, Rab5, calcyon, Filamin-A, PSD-95 and GASP interact with GPCRs and 
influence endocytosis and post-endocytic trafficking whereas proteins such as calmodulin 
and RGS proteins interact with GPCRs to attenuate GPCR signaling independently of 
phosphorylation (Ferguson, 2007a). Additionally, GPCRs can undergo homo- or hetero-
oligomerization, a process that can modify signaling and activate other receptors (Ferre et 
al., 2009; Millar and Newton, 2010).  Thus, it is possible that GPR3 associates with 
?????????????????????????????????????????-arrestins.  In preliminary experiments, RGS2 
was identified as a potential regulatory protein for GPR3 because the oocyte abundantly 
expresses RGS2 mRNA.  However, over expression or RNAi-mediated knock down of 
RGS2 did not affect oocyte maturation (unpublished data).  Whether RGS2 
overexpression or knockdown had any effect on cAMP levels was not examined.  It is 
also possible that GPR3 may interact with novel proteins that have yet to be 
characterized.  There are several approaches commonly used for identifying GPCR-
associated proteins including yeast two-hybrid and co-immunoprecipitation followed by 
mass spectrometry.
In summary, GPR3 is a constitutively active GPCR that mediates sustained cAMP 
production required for meiotic arrest and neurological processes.  How GPR3 and other 
constitutively active GPCRs are regulated is an area of research that has been largely 
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 unexplored.  The projects described in this dissertation have started our understanding of 
where GPR3 signals in the oocyte and HEK293 cells as well as potential mechanisms that 
could regulate its localization and activity.  It is well established that GPCR signaling and 
trafficking are highly flexible processes that depend on the cellular context.  At the same 
time, GPCR signaling is also very specific, such that the same GPCR can elicit different 
signaling responses and that multiple GPCRs can activate the same G protein.  It might 
be surprising that GRKs ?????-arrestins regulate such diverse processes; however, it 
should be appreciated that the contribution of each individual GRK and arrestin subtype, 
the affinity with which arrestin binds, and the pattern of GPCR phosphorylation can 
contribute to differential regulation of GPCRs by these common proteins.  Further fine 
tuning of GPCR activity can be achieved by additional receptor-interacting proteins that
are expressed differentially across cell types and are emerging as a major mechanism 
regulating GPCR activity.  It will be interesting to see how GPR3 activity and regulation 
may differ from other constitutively active receptors and how that might be 
physiologically important.  Additionally, the oocyte is a unique cell itself and may utilize 
novel mechanisms for regulating GPCR activity.
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 Figure 4.1
Figure 4.1. Inhibition of exocytosis stimulates spontaneous meiotic resumption.  Antral 
follicle-enclosed oocytes were microinjected with ~11 pg of mRNA encoding 
SNAP25WT or ?????????????????????? for 18-20 hours on Millicell membranes.  The 
oocytes were removed from the follicle and assessed for meiotic status based on the 
presence or absence of a GV.  A)  Confocal images of an uninjected oocyte and oocyte 
injected with SNAP25WT mRNA which were GV-intact upon isolation.  Oocytes 
???????????????????????? ?????????????????????B)  Percentage of oocytes that 
underwent GVBD within the culture period.  The total number of oocytes evaluated is 
indicated by the number above each bar. C)  Western blot using an anti-SNAP25 
anti????????????????????????????????????????????????????????
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 Figure 4.2
Figure 4.2. Membrane trafficking stops during oocyte maturation.  A)  Oocytes and in 
vitro matured eggs were fixed and labeled with an antibody specific for the early 
endosome marker, EEA1.  B)  Oocytes arrested at prophase I and oocytes undergoing in 
vitro maturation were microinjected with ~ 5 pg of GPR3-RFP mRNA and examined 
with a confocal microscope the next day.
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 Figure 4.3
Figure 4.3. Mutation of the threonine residue in the third intracellular loop of GPR3
increases cAMP production.   HEK293 cells were transfected with GPR3 WT or with
mutated GPR3 and 24 hrs later the cells were harvested in 0.1 M HCl.  cAMP levels were 
measured by EIA.  Results are presented as mean ± SEM of 7 different experiments.  (*) 
indicates a cAMP value that is significantly different compared to WT.  Significance was
determined by a paired Student’s T-test (P<0.001).
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 Figure 4.4
Figure 4.4. C-terminal truncation of GPR3 decreases cAMP production. A) Schematic 
illustrating the amino acid sequence of the C-terminus of GPR3that may contain potential 
PDZ ligands.  Highlighted amino acids correspond to potential PDZ ligands and are 
????????????????????????????????????????????????????????????????????????????????????B)
A truncated GPR3 mutant in which the last 15 amino acids are deleted was made by 
mutating the serine at amino acid 316 (indicated by arrow) to a stop codon.  Cysteine 
cluster and dibasic amino acid motifs are underlined.  C) HEK293 cells were transfected 
with GPR3 WT or with the truncated GPR3 and 24 hrs later the cells were harvested in 
0.1 M HCl.  cAMP levels were measured by EIA.  Results are presented as mean ± SEM 
of 5 different experiments.  (*) indicates a cAMP value that is significantly decreased 
compared to WT.  Significance was determined by a paired Student’s T-test (P<0.001).
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 APPENDIX
UA.1.  Methods for Chapter 4
UMedia and reagents
Except where noted, all chemicals were obtained from Sigma Chemical Co. The 
???????????????????????????????????????????? ????????????????????????????????????
??? ???????????? ?????????????????????? ???????????????????????????????????????????
??????? ?? ?????one to inhibit spontaneous meiotic resumption.  For extended culture, 
oocytes were placed in bicarbonate-????????? ?????????????????????????????????????
????????????????? ????????????????????????????????????????????????????????????????
fetal bovine serum (#12000-022, Invitrogen).  The medium used to collect and culture 
follicle-????????????????????? ????????????????????????? ?????????????????????? ?????
streptomycin, and 5% fetal bovine serum. 
Mouse GPR3-RFP was provided by Y Saeki (Ohio State University) in pHGCY.  
??????? ???????????????????????????K Machaca (Weill Cornell Medical College) in 
pcDNA3.  mRNA was transcribed in vitro using the Superscript III kit from Invitrogen.  
Human GPR3 in pCMV6-AC-HA-His (GPR3-HA) was purchased from Origene 
(Rockville, MD).
UMouse oocyte and follicle isolation and culture
All experiments were done with prior approval of the Animal Care and Use 
Committee at the University of Connecticut Health Center.  Fully grown, GV-stage 
mouse oocytes were obtained from the ovaries of 6- to 12-week old CF-1 mice (Harlan 
Sprague–???????????????????????????????????????????????????????????? ?????????????
or Calbiochem) 40–??? ??????????????????????????????????????????????????????????????
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 pipetting through a small-bore pipette.  Oocytes were ???????????????? ??????????? ??????
???????????? ??????????????????????????????????????? ????????????????-buffered 
medium).  Metaphase II-stage oocytes were collected from the ampullae of the oviduct 
from mice that were superovulated with 10 IU eCG, followed by 10 IU human chorionic 
gonadotropin 44–48 h later.  Oocytes were collected in Hepes-????????? ?????????
cumulus cells were removed using 0.3 mg/ml hyaluronidase (type IV-S).  Oocytes and 
eggs were cultured overnight in bicarbonate-buffered medium in a humidified 
????????????????? ????????????R2R and 95% air.
??????????????????????? ????????????????????????????????????????????????????- to 
25-day old B6SJL/F1 mice (Jackson Laboratories) as described previously (Jaffe et al., 
2009).  Following isolation, follicles were placed on Millicell culture plate inserts 
(PICMORG50, Millipore, Billerica, MA, USA) and cultured in a humidified atmosphere 
?????? ????????????R2R ???????????????????????? ?????????????????????????-enclosed oocytes 
were examined under an upright microscope for the presence of a GV.  Only follicles 
containing oocytes with readily visible GVs were selected for use in these experiments. 
UMicroinjection
Microinjection of isolated and follicle-enclosed oocytes was carried out as 
described previously (Jaffe et al., 2009; Kline, 2009).  For isolated oocytes, oocytes were 
placed in HEPES-????????? ???????? ???????????????????????????????????????????????
were incubated in bicarbonate-????????? ??????????????? ??????????????????????????
loaded into an injection chamber between two cover slips spaced ????? ??????????
Following microinjection, follicles were placed on Millicell membranes and incubated 
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 for 17–??? ??????????????????????????????????????????????????? ?????????????????????
presence or absence of a GV, assessed using a stereoscope.  Quantitative microinjection 
was carried out using pipettes backfilled with mercury and concentrations of injected 
???????????????????????????????????????????????????????????? ?????????????????????????
oocytes were microinjected during maturation, the oocytes were washed out of milrinone 
and injected 2-3 hours after GVBD.
UImmunoblotting
For Western blots, oocyte samples were made by washing oocytes in PBS 
containing 0.1% polyvinyl alcohol (PVA) to remove serum. Oocytes were transferred to 
microcentrifuge tubes, gently pelleted, and excess culture medium was removed. Oocytes 
????????????????????????????????????????????????? ????????????? ????????????????????
performed as described previously (Mehlmann et al., 1998).  Primary and secondary 
antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).  Anti-
SNAP 25 was diluted 1:200 in blocking buffer and secondary anti-mouse antibody was 
diluted 1:5000 in blocking buffer.  Blots were developed using ECL Plus reagents 
(Amersham). 
UEEA1 Immunofluorescence
????????????????????????? ??????????????????????????? ???????????? ??
????????? ?? ???R4R, and 0.2% Triton X-?????????? ????????????????????????????????
incubated in blocking buffer (PBS containing 0.01% Triton X-100, 0.1% PVA, and 3% 
BSA), then in anti-EEA1 antibody (Cell Signaling Technology , Danvers, MA) 
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 overnight, diluted 1:100 in blocking buffer, at room temperature.  Oocytes were then 
washed in blocking buffer, incubated in secondary antibody for 1 hr at room temperature, 
and finally washed in PBS containing 0.1% PVA.  The secondary antibody was Alexa 
Fluor 488-conjugated anti-rabbit (Invitrogen). Oocytes were observed with a 40x, 1.2 NA 
lens (C-Apochromat; Carl Zeiss MicroImaging, Inc., Thornwood, NY, USA) on a Zeiss 
510 confocal microscope. 
UMutagenesis
The C-terminus of GPR3 is 31 amino acids long.  To determine whether the C-
terminus contains residues important for GPR3 signaling, we constructed a mutant in 
which the last 15 amino acids were deleted.   Amino acid at residue 316 was mutated to a 
stop codon by point mutation (TGT?TGA) using the QuikChange II site-directed
mutagenesis Kit (Agilent, Cedar Creek, TX) according to the manufacturer’s protocol.  
HPLC purified primers were purchased from Sigma.  Primers were 5’-
GGGCTGTCTGCTGCTGCTGATCCTCTTCCAAGATCCCC-TTCC-3’ and 3’-
CCCGACAGACGACGACGACTAGGAGAAGGTTCTAGGGGAAGG-5’.
Mutation of the threonine residue in the third intracellular loop to alanine was achieved 
using the primers:  5’-CACTATGTGGCCGCACGCAAGGGCATT-3’ and 5’-
33TAATGCCCTTGCGTGCGGCCACATAGTG33T-3’
UHEK293 cell culture, TransfectionU15TU and EIA cAMP MeasurementU15T
HEK 293 cells were cultured in Dulbecco's modified Eagle's (DMEM)/F-12 
medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum 
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 (Invitrogen), 100 U/mL penicillin and 100 μg/mL streptomycin (Invitrogen) at 37P?PC in a 
humidified 5% COR2R/95% air incubator.  Cells were plated at 400,000 cells per well in 6-
well dishes and were transiently transfected the next day with 1 μg of plasmid DNA 
using 2.5 μl of Lipofectamine 2000 (Invitrogen) following the manufacturer's 
recommendations.
Twenty-four hr after transfection, cells were counted and 400,000 cells were 
washed with PBS and lysed in 225 μl of 0.1 M HCl.  The cells were incubated in 0.1 M 
HCl for 10 min at room temperature, sonicated, and stored at -80°C until the assay was 
performed.  Levels of intracellular cAMP were measured using the cAMP enzyme 
immunoassay (EIA) kit, Direct (Sigma), using the non-acetylation EIA procedure.  
Results are presented as pmol/mL cAMP.  
UStatistical Analysis
Tests of statistical significance were performed using GraphPad Prism Software.
Differences between groups were determined by Student t-test and significance was 
assessed at P < 0.05.
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 A.2.  Maturation, Fertilization, and the Structure and Function of the Endoplasmic 
Reticulum in Cryopreserved Mouse Oocytes
Abstract
Oocyte cryopreservation is a promising technology that could benefit women 
undergoing assisted reproduction. Most studies examining the effects of cryopreservation 
on fertilization and developmental competence have been done using metaphase II-stage 
oocytes, while fewer studies have focused on freezing oocytes at the germinal vesicle 
(GV) stage, followed by in vitro maturation. Herein, we examined the effects of vitrifying 
GV-stage mouse oocytes on cytoplasmic structure and on the ability to undergo 
cytoplasmic changes necessary for proper fertilization and early embryonic development. 
We examined the endoplasmic reticulum (ER) as one indicator of cytoplasmic structure, 
as well as the ability of oocytes to develop CaP2+P release mechanisms following
vitrification and in vitro maturation. Vitrified GV-stage oocytes matured in culture to 
metaphase II at a rate comparable to that of controls. These oocytes had the capacity to 
release CaP2+P following injection of inositol 1,4,5-trisphosphate, demonstrating that CaP2+P
release mechanisms developed during meiotic maturation. The ER remained intact during 
the vitrification procedure as assessed using the lipophilic fluorescent dye DiI. However, 
the reorganization of the ER that occurs during in vivo maturation was impaired in 
oocytes that were vitrified before oocyte maturation. These results show that vitrification 
of GV-stage oocytes does not affect nuclear maturation or the continuity of the ER, but 
normal cytoplasmic maturation as assessed by the reorganization of the ER is disrupted. 
Deficiencies in factors that are responsible for proper ER reorganization during oocyte 
maturation could contribute to the low developmental potential previously reported in 
vitrified in vitro-matured oocytes.
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 Introduction
Infertility is a widespread problem, affecting approximately 5%–15% of the 
population (Boivin et al., 2007).  The most common form of assisted reproductive 
technology is in vitro fertilization (IVF), in which metaphase II (MII)-stage oocytes are 
obtained from women following hormonally induced ovarian stimulation and are 
fertilized with sperm.  A few of the resulting embryos are usually implanted right away, 
but in many cases leftover embryos are frozen for later use. 
Cryopreservation of embryos is a well-established technique that has been used 
successfully for many years (Borini et al., 2008).  However, this method can introduce 
some practical and ethical issues, and the production of embryos requires that a woman 
have a partner's or donor's sperm.  Therefore, it is not a viable option for all infertile 
women. For these reasons, it would be preferable to cryopreserve unfertilized eggs or 
immature oocytes.
To date, attempts to produce high-quality embryos that develop to term following 
freezing and thawing of MII-stage oocytes have had limited success (Gardner et al., 
2007; Gomes et al., 2008; Huang et al., 2008).  Reasons for this may include low 
permeability of the oocyte membrane to cryoprotectants, susceptibility of the meiotic 
spindle to cooling (Huang et al., 2008; Huang et al., 2007; Larman et al., 2007a; 
Sathananthan et al., 1988; Zenzes et al., 2001), and toxic effects of cryoprotectants that 
affect various aspects of the oocyte's physiology (Gardner et al., 2007; Lane and Gardner, 
2001; Larman et al., 2007a; Larman et al., 2006).  The two main methods that have been 
used for cryopreservation are slow freezing/thawing and ultrarapid freezing 
(vitrification).  While both methods can yield high oocyte survival and fertilization rates 
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 following cryopreservation (Carroll et al., 1993; Coticchio et al., 2007; Endoh et al., 
2007; Gomes et al., 2008; Huang et al., 2007; Lane and Gardner, 2001), direct 
comparisons between slow and rapid freezing procedures have shown that vitrification is 
likely to be the more promising method (Huang et al., 2007; Ko et al., 2008; Lane and 
Gardner, 2001; Larman et al., 2007a; Larman et al., 2007b).  Although survival and 
fertilization rates of vitrified eggs have improved over the past several years, this 
procedure has resulted in only ?300–500 live births to date (Gardner et al., 2007; Jurema 
and Nogueira, 2006; Suikkari and Soderstrom-Anttila, 2007), suggesting that 
cryopreserved oocytes are compromised in other ways that do not affect survival and 
fertilizability.
Alternatively, the ability to cryopreserve immature oocytes that are at the 
germinal vesicle (GV) stage and then to mature them in vitro would represent a 
significant advance that could assist more groups of women.  The process of in vitro 
oocyte maturation (IVM) has many advantages over current standard IVF protocols, 
which necessitate injecting women with large doses of hormones that can have unwanted 
adverse effects.  With IVM, immature oocytes could be retrieved from the ovaries of 
women without prior hormone injection or with lower doses of hormones.  In recent 
years, this procedure has improved and shows promise as a treatment for infertility 
(Holzer et al., 2007; Jurema and Nogueira, 2006; Le Du et al., 2005; Mikkelsen, 2005; 
Soderstrom-Anttila et al., 2005).  Because GV-stage oocytes have not yet formed meiotic 
spindles and their chromatin is decondensed within the nuclear envelope, they may be 
less susceptible to freezing damage that would otherwise disrupt the spindle in an MII-
stage oocyte.  Therefore, the cryopreservation of GV-stage oocytes is an attractive 
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 alternative for freezing female gametes.  Although studies have shown that bovine 
oocytes frozen at the GV stage have lower survival rates and developmental competence 
than oocytes frozen at the MII stage (Abe et al., 2005; Diez et al., 2005; Kubota et al., 
1998; Men et al., 2002; Otoi et al., 1995; Suzuki et al., 1996; Vieira et al., 2008), live 
births have been obtained using this procedure (Abe et al., 2005; Diez et al., 2005; Suzuki 
et al., 1996; Vieira et al., 2008; Vieira et al., 2002).  Because the developmental 
competence of both cryopreserved GV-stage and MII-stage bovine oocytes is 
significantly lower than that of unfrozen controls, a more accurate comparison between 
freezing GV-stage vs. MII-stage bovine oocytes might be made after the overall 
cryopreservation procedure is improved.
There have been fewer studies examining the developmental competence in 
human and mouse oocytes following cryopreservation and IVM.  In the limited studies 
that have been done in the mouse, it has been shown that GV-stage oocytes can be 
successfully frozen and thawed (Aono et al., 2005; Aono et al., 2003; Eroglu et al., 
1998a), that they can subsequently mature in culture and form morphologically normal 
spindles (Eroglu et al., 1998a), and that they can develop after fertilization and produce 
live births (Aono et al., 2005; Aono et al., 2003).  However, as in bovine oocytes, the 
developmental competence in terms of blastocyst formation and live births is 
approximately 50% lower than that of unfrozen controls (Aono et al., 2005; Aono et al., 
2003).  Therefore, more studies need to be done to examine the cause of this lower 
developmental competence.  In addition, it is important to investigate other aspects of 
oocyte cryopreservation on oocyte physiology, particularly on components that are 
necessary for IVM.  Defects in cytoplasmic structures and meiotic competence that arise 
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 due to cryopreservation could contribute to the low success rates following oocyte 
freezing.
During maturation, the oocyte undergoes many cytoplasmic changes that prepare 
it for successful fertilization and early embryonic development.  One of these changes 
involves the development of the ability of the mature oocyte to release CaP2+P in response 
to sperm penetration (Fujiwara et al., 1993; Jones et al., 1995; Mehlmann and Kline, 
1994; Mehlmann et al., 1996).  CaP2+P release at fertilization is responsible for preventing 
polyspermy and for stimulating the oocyte to complete meiosis and to begin early 
development (Ducibella et al., 2006).  An important component of the CaP2+P release 
system is the endoplasmic reticulum (ER), which is a continuous membranous network 
throughout the egg that is the major site of CaP2+P storage (Han and Nuccitelli, 1990; Kline 
et al., 1999; Mehlmann et al., 1995; Shiraishi et al., 1995; Terasaki and Sardet, 1991).
The ER undergoes a dramatic change during oocyte maturation, such that clusters of ER 
form in the mature oocyte's cortex, and this reorganization is thought to be associated 
with the ability of the oocyte to release CaP2+P at fertilization (FitzHarris et al., 2007; 
Mehlmann and Kline, 1994).  The objectives of this study were to examine the meiotic 
competence of vitrified oocytes, the ability of oocytes to develop to the MII stage 
following IVM, and the ability of immature oocytes to develop CaP2+P release mechanisms 
during oocyte maturation.  We also used the structure of the ER as a cytoplasmic 
indicator to show the effects of vitrification on the ability of the ER to reorganize 
following IVM.
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 Materials and Methods
Preparation and Culture of Gametes
All experiments were performed in accord with the Center for Laboratory Animal 
Care at the University of Connecticut Health Center. Except where noted, all chemicals 
were purchased from Sigma (St. Louis, MO).
CF1 mice (Harlan Sprague-Dawley, Indianapolis, IN) were used for all 
experiments, and oocytes and sperm were collected as previously described (Kline, 
2009).  In brief, fully grown GV-stage oocytes were obtained from the ovaries of 6- to 
10-wk-old female mice that had been primed 40–46 h earlier with 10 IU equine chorionic 
gonadotropin (eCG).  Cumulus cells were removed by repeated pipetting through a small-
bore pipette.  Oocytes were cultured in 200-???????????? ?????????????????? ???????????
(Fisher Scientific, Pittsburgh, PA) at 37°C.  The collection medium was modified Eagle 
?????????????????????????–022; Invitrogen, Carlsbad, CA) supplemented with 20 
???????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????te maturation.  To 
initiate meiotic maturation, oocytes were washed into medium without dbcAMP.  For 
overnight cultures, oocytes were incubated in bicarbonate-????????? ????????????????
mM sodium bicarbonate was substituted for the Hepes and 5% fetal bovine serum (FBS) 
(Invitrogen) was substituted for the polyvinyl alcohol.  Oocytes were assessed for the 
meiotic stage (MII, GV breakdown (GVBD), or GV intact) after 18–20 h.
Metaphase II-stage oocytes were collected from the ampullae of the oviduct from 
mice that were superovulated with 10 IU eCG, followed by 10 IU human chorionic 
gonadotropin 44–48 h later.  Oocytes were collected in Hepes-????????? ?????????
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 cumulus cells were removed using 0.3 mg/ml hyaluronidase (type IV-S).  Oocytes were 
used on the same day they were collected.
?????????????????????????????????????????????????????????????????????????-wk-
old CF1 mice in IVF medium (Mehlmann et al., 1998) containing 3% bovine serum 
albumin (BSA) (fraction V; Calbiochem, La Jolla, CA).  Sperm were capacitated for 1–2
h in a humidified atmosphere of 5% COR2R/95% air before insemination.  For insemination, 
sperm were diluted to a final concentration of ?2–5 × 10P5P sperm/ml.  Sperm and oocytes 
were incubated together for 1.5–2 h, and then the oocytes were washed out and incubated 
further in bicarbonate-????????? ?????????????????????????????????R2R incubator.  
Fertilized oocytes were observed periodically for the presence of second polar bodies and 
pronuclei.
Oocyte Vitrification and Warming
For vitrification, isolated GV-stage oocytes were placed into IVF medium 
supplemented with 20% FBS (holding medium) for ?1 min. The oocytes were washed 
into holding medium containing 1.0 M ethylene glycol and 1.0 M 1,2-propanediol for 5 
min and were then transferred to vitrification medium composed of holding medium 
containing 2.0 M ethylene glycol, 2.0 M 1,2-propanediol, and 0.5 M sucrose for 5 min.  
Oocytes were loaded onto the center of a vapor-chilled polyethylene terephthalate plastic 
strip (thickness, ?100–??????????????????????????????????-L Poland Spring Water  bottle
(Wilkes Barre, PA).  The initial volume of the drops containing the oocytes was ?1–??????
then the oocytes were spread out on the slide, and the remaining medium was removed 
using a small-?????????????????????????????????????????????????????????????????????????????
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 were then plunged directly into liquid nitrogen and placed in cryovials for storage in 
liquid nitrogen.  All steps before vitrification were carried out at 37°C.
For warming, the strips containing the vitrified oocytes were removed from liquid 
nitrogen and immediately immersed in holding medium containing 0.5 M sucrose for 1 
min.  Oocytes were transferred to holding medium containing 0.25 M sucrose for 3 min 
and then were transferred to holding medium containing 0.125 M sucrose for 3 min.  All 
steps during warming were carried out at 37°C.  Oocytes were washed twice in holding 
medium and twice in culture medium.  The oocytes were then cultured in a 37°C 
incubator with 5% COR2R/95% air.
Microinjection, Confocal Microscopy, and CaP2+P Measurements
Quantitative microinjection was performed as previously described using 
mercury-filled micropipettes (Kline, 2009)????????????????????????????????????-
dihexadecyl-?????????-tetramethylindocarbocyanine perchlorate; Invitrogen) was prepared 
in soybean oil (Wesson Oil; ConAgra Foods, Inc., Memphis, TN) and stored at 4°C.  The 
DiI solution was front-loaded into a beveled mercury-filled pipette connected to a 
micrometer syringe system filled with Fluorinert FC-70 (Sigma).  The same pipette was 
used to inject several oocytes with ?2.5–5 pl of solution, which formed an oil droplet 
inside the oocytes.  This 2-fold range in the amount of DiI did not affect the qualitative 
results to be described.  The volume injected was calculated based on the diameter of the 
sphere that forms in the oocyte cytoplasm during microinjection.  DiI-labeled GV-stage 
and MII-stage oocytes were observed using a confocal microscope (Pascal; Carl Zeiss 
Microimaging, Inc., Thornwood, NY) ?30 min to 2 h after microinjection.  Fluorescence 
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 was excited with the 543-nm line of a HeNe laser and was detected using a 560-nm 
emission filter.  Images were collected using a 40× NA 1.2 water immersion objective 
(C-Apochromat; Carl Zeiss MicroImaging, Inc.).  Cortical ER clusters were evaluated by
examining the pattern of DiI labeling at the bottom edge of the cortex, just beneath the 
plasma membrane.  The optical section thickness was ?????????????????????????????????
????????????????????????????????????????????????????????????????????????????????r, was 
evaluated blindly by two different people.
Injected concentrations of calcium green 10-kDa dextran (Invitrogen) and inositol 
1,4,5-trisphosphate (IPR3R; Calbiochem) were based on an oocyte volume of 200 pl.  CaP2+P
measurements were performed as previously described (Mehlmann et al., 1998) using a 
photodiode with a built-in amplifier (Oriel Instruments, Stratford, CT) mounted on an 
inverted microscope and connected to a chart recorder.  Figures were made using Adobe 
Photoshop (Adobe Systems Inc., San Jose, CA) after scanning the chart records into a 
computer.
Immunofluorescence
In vitro-matured oocytes were fixed for 1 h in 2% formaldehyde in 100 mM 
Hepes, 50 mM ethyleneglycoltetracetic acid, 10 mM MgSOR4R, and 0.2% Triton X-100 at 
37°C.  After fixation, oocytes were washed into PBS containing 1% Triton X-100,
incubated for 5 h at 4°C, and then washed into blocking buffer (PBS containing 0.01% 
Triton X-100, 0.1% polyvinyl alcohol, and 3% BSA) for 15 min.  Oocytes were 
incubated in primary antibody (anti-tubulin, YL1/2; Serotec Inc., Raleigh, NC) diluted 
1:100 in blocking buffer overnight at room temperature.  Following primary antibody 
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 incubation, oocytes were washed with blocking buffer and incubated for 2 h with 
secondary antibody (Alexa Fluor 488-conjugated anti-rat IgG; Invitrogen) diluted 1:200 
???????????????????????????????????????????????????????????????????????????????????
Hoechst 33528 (Invitrogen) was included and incubated for 15 min.  Labeled oocytes 
were observed with the 40× NA 1.2 lens on a Zeiss 510 confocal microscope (Carl Zeiss 
Microimaging, Inc.).  Fluorescence was excited at 488 nm for tubulin and at 364 nm for 
Hoechst and was detected at 505 nm and 435–485 nm for tubulin and Hoechst, 
respectively.
Statistical Analysis
Tests of statistical significance were performed using InStat software (GraphPad 
Software, Inc., San Diego, CA).  Differences between groups were determined by 
Student t-test or Fisher exact test. P < 0.05 was considered statistically significant.
Results
Vitrified GV-Stage Oocytes Are Morphologically Normal and Are Meiotically 
Competent
Vitrified, warmed (hereafter referred to as vitrified) GV-stage oocytes (n = 265) 
were morphologically indistinguishable from freshly isolated oocytes when examined 
live by transmitted light microscopy (Figure A.1).  After washing dbcAMP from the 
culture medium, the vitrified oocytes resumed meiotic maturation, underwent GVBD, 
and extruded a first polar body (Figure A.1).  The time to GVBD in vitrified oocytes was 
slightly slower than that in control fresh oocytes, with only 54% of vitrified oocytes 
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 undergoing GVBD within 2 h compared with 94% of controls (Figure A.2).  However, by 
6.5 h after removal of dbcAMP, similar numbers of oocytes in the vitrified (n = 89) and 
control (n = 400) groups had undergone GVBD (97% and 95%, respectively) (Figure
A.2), demonstrating that almost all of the vitrified oocytes were meiotically competent.  
Seventy-eight percent of those GV-stage oocytes (n = 253) that underwent GVBD went 
on to extrude first polar bodies compared with 80% of fresh control oocytes (n = 221).  
Vitrified oocytes (n = 12) that were matured in vitro to the MII stage formed MII spindles 
that were morphologically identical to those of freshly isolated in vivo-matured MII-stage 
oocytes (n = 21) (92% vs. 95%) (Figure A.3).
Vitrified Oocytes Develop the Ability to Release CaP2+P in Response to IPR3R Following In 
Vitro Maturation and Are Fertilizable
Release of intracellular CaP2+P at fertilization is critical for polyspermy prevention, 
meiotic resumption, and initiation of early embryonic development.  The ability to release 
CaP2+P develops during oocyte maturation; immature GV-stage oocytes are unable to 
release a comparable amount of CaP2+P as mature oocytes at the MII stage (Jones et al., 
1995; Mehlmann and Kline, 1994).  To examine if vitrified oocytes matured in vitro can 
initiate a normal pattern of CaP2+P release in response to a physiological stimulus, we 
injected oocytes with the CaP2+P-sensitive indicator dye calcium green dextran and 
monitored intracellular CaP2+P during injection of 100 nM IPR3R.  This concentration of IPR3R
has previously been shown to induce a transient CaP2+P release in MII-stage oocytes that is 
occasionally followed by a series of repetitive CaP2+P oscillations lasting ?10–15 min 
(Mehlmann and Kline, 1994). Injection of IPR3R into freshly ovulated MII-stage oocytes 
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 stimulated the following two types of CaP2+P release: (1) a single transient (Figure A.4A) or 
(2) an initial CaP2+P transient that was followed by one or more oscillations (Figure A.4B).  
IPR3R injection into vitrified oocytes that were matured in vitro also stimulated CaP2+P
release, with an initial CaP2+P transient that was followed by repetitive CaP2+P oscillations 
that were more prolonged than in fresh in vivo-matured MII-stage oocytes (Figure A.4C).  
The mean ± SD duration of the first transients was not significantly different between the 
freshly ovulated and vitrified in vitro-matured GV-stage oocytes (2.3 ± 0.5 and 1.6 ± 0.2 
min, respectively; P > 0.05).  However, the average number of transients was 
significantly higher in the vitrified group, with an average of eight oscillations vs. two 
oscillations in freshly ovulated MII-stage oocytes.  The amplitude of the first transient 
above baseline was variable but did not differ significantly between the two groups.  
Although the number of oscillations differed between the fresh and vitrified groups, these 
data show that vitrified in vitro-matured oocytes can produce a series of CaP2+P transients 
in response to IPR3R.
We also fertilized vitrified, in vitro-matured MII-stage oocytes and examined the 
presence of second polar bodies and pronuclei (Table A.1).  For these experiments, we 
used zona-free oocytes because of previous evidence that the zona can harden in response 
to vitrification (Carroll et al., 1990; Gardner et al., 2007; Ko et al., 2008; Lane and 
Gardner, 2001; Larman et al., 2006). Consistent with these observations, we found that it 
was necessary to remove the zonae before vitrification, as we were unable to remove 
them with acid Tyrode or chymotrypsin following vitrification.  Eighty-six percent of 
control, freshly ovulated MII-stage oocytes (n = 35) formed second polar bodies within 2 
h after insemination, and 87% of those oocytes with second polar bodies went on to form 
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 pronuclei (Table A.1).  Similarly, 72% of control (unfrozen), in vitro-matured MII-stage 
oocytes (n = 29) formed second polar bodies, and 67% of those went on to form 
pronuclei.  Vitrified oocytes (n = 43) that were matured in vitro had 67% polar body 
formation, and 76% of those formed pronuclei (Table A.1).  No statistical differences 
were found among any of these groups.  These results show that vitrified, in vitro-
matured oocytes are able to initiate the early events of egg activation following 
fertilization and, by extension, suggest that the CaP2+P releasing ability of vitrified oocytes 
is functional because of this.
The Continuity of the ER Is Preserved Following Oocyte Vitrification
To examine the effects of cryopreservation on ER structure, we observed the 
structure of the ER following vitrification.  The ER was visualized using the lipophilic 
fluorescent dye DiI and confocal microscopy (Carroll et al., 1990; FitzHarris et al., 2007; 
Kline et al., 1999; Mehlmann et al., 1995; Shiraishi et al., 1995; Terasaki and Jaffe, 1993; 
Terasaki and Jaffe, 2004; Terasaki and Sardet, 1991).  To label the ER, DiI was prepared 
as a saturated solution in soybean oil and microinjected into the oocyte, where it contacts 
intracellular membranes.  Because the ER is a continuous network, the dye will spread 
throughout the entire ER if it is intact.  As reported previously (Kline et al., 1999; 
Terasaki and Jaffe, 1993), control, unfrozen GV-stage oocytes contained a fine reticular 
network throughout the oocyte that had no distinct clusters of ER in the cortex (Figure
A.5, A and B).  Clusters of ER were present throughout the oocyte interior (Figure A.5B). 
The ER in vitrified GV-stage oocytes remained intact, as indicated by dye spreading, and 
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 the structure was similar to controls, with no distinct ER clusters in the oocyte cortex but 
with clusters throughout the cytoplasm (Figure A.5, C and D).
Optimization of Culture Conditions to Obtain ER Reorganization During In Vitro 
Maturation
The ER undergoes dramatic reorganization during meiotic maturation in vivo, 
such that large clusters of ER form in the cortex opposite the meiotic spindle (Han and 
Nuccitelli, 1990) (Figure A.6A).  Therefore, we next examined the ability of the ER to 
reorganize during spontaneous maturation of fresh (unfrozen) oocytes in vitro.  
???????????????????????????????????????????????????????????????? ????????????????????
distinct cortical ER clusters following IVM, while the rest contained no apparent ER 
clusters (Table A.2).  Because of this, we next examined the ER structure in oocytes that 
were matured in a different culture medium, CZB (Chatot et al., 1989). In contrast to 
???????? ?????????? ???????????????????? ??????????????????????????????????????????
clusters (Figure A.6B and Table A.2) compared with 94% of freshly ovulated MII-stage 
oocytes (n = 18) (Table A.2).  This is not significantly different from the number of 
cortical clusters present in freshly ovulated MII-stage oocytes.
Because CZB contained 20% FBS and ????????????? ???? ????????????????
only 5% serum, we examined whether the amount of serum in the culture medium 
affected the formation of cortical clusters during in vitro maturation.  Sixty-eight percent 
???????????????????? ?????????? ???????????????????FBS exhibited cortical ER clusters 
(Table A.2).  This percentage was not significantly different from that of CZB-matured 
oocytes but is somewhat lower than the percentage of clusters present in freshly ovulated 
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 MII-stage oocytes.  These data show that the amount of serum and the particular culture 
medium used are important factors for successful reorganization of the ER during in vitro 
maturation of mouse oocytes.
Cryopreservation Adversely Affects the Reorganization of Cortical ER Clusters During 
In Vitro Maturation
We next examined the formation of ER clusters in oocytes that were vitrified 
before IVM. For these experiments, we matured vitrified oocytes in CZB medium, as 
oocytes matured in CZB most closely resembled those of in vivo-matured oocytes.  We 
found that a significantly lower percentage, only 29%, of vitrified oocytes had cortical 
ER clusters following in vitro maturation compared with 78% of controls (n = 46) (Table 
A.3).  This result was unexpected because the continuity of the ER was not disrupted in 
immature oocytes following vitrification (Figure A.5B) and suggests that some 
components necessary for the reorganization and stability of the ER during oocyte 
maturation are disrupted by the vitrification process.  These factors could contribute to 
the lower developmental competence of vitrified in vitro-matured oocytes that has been 
reported previously (Aono et al., 2005; Vieira et al., 2002).  We also examined if 
vitrification affects the structure of cortical ER clusters in vitrified in vivo-matured MII-
stage oocytes.  Significantly fewer of these oocytes had cortical ER clusters compared 
with fresh oocytes (56% vs. 94%) (Table A.3), showing that this process can also 
interfere with the ER organization in mature oocytes that have previously formed ER 
clusters.
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 Discussion
In this study, we confirmed previous reports showing that mouse oocytes 
cryopreserved at the GV stage can be vitrified to yield morphologically normal GV-stage 
oocytes, that they mature at a high rate in vitro after vitrification, and that they 
subsequently form morphologically normal bipolar meiotic spindles.  We then extended 
previous studies by examining if cytoplasmic structure is preserved during the 
vitrification procedure.  We found that the structure of the ER remains intact during 
vitrification of GV-stage oocytes, indicating that this process does not damage these 
intracellular membranes.  In addition, oocytes vitrified at the GV stage and matured in 
vitro are capable of releasing CaP2+P in response to IPR3R and can be fertilized.  Because the 
ability to release CaP2+P develops during oocyte maturation, vitrification does not appear to 
adversely affect this important component of cytoplasmic maturation.  However, the 
reorganization of the ER that normally occurs during oocyte maturation was impaired by 
this process.  Although vitrification of immature oocytes followed by in vitro maturation 
yields morphologically normal oocytes that exhibit some of the properties of early 
development following fertilization, cytoplasmic maturation is disrupted, and this could 
account for the reduced developmental potential observed previously following 
vitrification and in vitro maturation (Abe et al., 2005; Aono et al., 2005; Kubota et al., 
1998; Suzuki et al., 1996; Vieira et al., 2008; Vieira et al., 2002).
During meiotic maturation in vivo, the ER undergoes reorganization, such that 
clusters of ER form in the oocyte cortex opposite the meiotic spindle (FitzHarris et al., 
2007; Mehlmann et al., 1995).  However, we found that the majority of oocytes that were 
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 ??????????????????????? ??????????????????????? ???? ????????????????????????????sters 
in the mature oocyte cortex (Figure A.6 and Table A.2).  In contrast, the ER in oocytes 
?????????????????????? ??????????????????????????????????????????????????????????
clusters, similar to those seen in freshly ovulated MII-stage oocytes (Figure A.6B).  
These latter results are in agreement with a recent study (FitzHarris et al., 2007) that 
showed normal pattern and size of cortical ER accumulations in the mouse oocyte cortex 
following in vitro maturation, although this study did not indicate the percentage of 
oocytes that formed cortical ER.  It is not clear in our study what effect an increased 
amount of FBS in the culture medium has on the ability of oocytes to exhibit ER 
reorganization during meiotic maturation.  However, the difference in ER structure 
following IVM in different culture media herein underscores the importance of 
establishing culture conditions that yield consistent results during IVM before
cryopreservation.  The ability to form normal ER clusters that are retained after 
cryopreservation and in vitro maturation could be used as one criterion to assay how 
closely various culture conditions simulate in vivo meiotic maturation.
The structure of the ER in GV-stage oocytes was similar between control and 
vitrified oocytes, with continuous ER throughout the oocyte and around the GV in both 
groups, as well as aggregations of ER throughout the cytoplasm (Figure A.5).  The ability 
of the ER to remain a continuous network throughout the vitrification process indicates 
that at least one important component of the cytoplasmic structure can remain intact 
following cryopreservation.  However, the ability of the ER to reorganize into cortical ER 
clusters following vitrification and in vitro maturation was impaired, even in oocytes 
matured in CZB.  This suggests that other components of cytoplasmic maturation could 
134 
 
 be affected by the vitrification process.  The spindle morphology observed following 
vitrification and IVM appeared normal, suggesting that microtubules are possibly 
unaffected by this procedure.  In oocytes maturing in vitro, microtubules are important 
for ER reorganization during GVBD, but microfilaments are necessary for ER 
remodeling into cortical clusters (FitzHarris et al., 2007).  It is possible that 
microfilaments or other proteins needed for actin polymerization could be disrupted by 
vitrification, such that they are no longer able to regulate ER reorganization during 
maturation.  Moreover, a few studies (Albarracin et al., 2005; Rojas et al., 2004; Wu et 
al., 2006) have shown that vitrification is detrimental to microfilament structure in bovine 
and porcine oocytes.  To date, it is unknown what the role of microfilaments might be for 
ER reorganization. Other unknown proteins needed for the process of ER reorganization 
could also be impaired.
It is also possible that microtubules are damaged during vitrification, at least 
initially.  This could explain why fewer oocytes vitrified at the MII stage displayed 
cortical ER clusters compared with fresh MII-stage oocytes, as the ER and microtubules 
are interdependent structures (Terasaki et al., 1986).  Some studies (Eroglu et al., 1998b; 
Gomes et al., 2008; Rienzi et al., 2004) have shown that, although microtubules are 
disrupted immediately after cryopreservation of MII-stage oocytes, they are able to 
reform after culturing at 37°, such that morphologically normal meiotic spindles become 
apparent.  In our study, we examined the ER in vitrified MII-stage oocytes 1–2 h after 
oocyte warming.  Even if microtubules are disrupted and a spindle is able to reform 
within a few hours after oocyte warming, it is possible that the association between the 
ER and microtubules does not reestablish within this time.  However, other findings show 
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 no disruption of microtubules following cryopreservation (Larman et al., 2007a).
Nevertheless, disruption of microtubules could contribute to the lack of cortical clusters 
seen in vitrified MII-stage oocytes and could help explain why cortical clusters do not 
form in vitrified oocytes following in vitro maturation of GV-stage oocytes.
Despite the inability of the majority of oocytes c??????????? ??????????????????
FBS to form cortical ER clusters during IVM, vitrified in vitro-matured oocytes released 
CaP2+P on injection of IPR3R, which is the physiological stimulus for CaP2+P release at 
fertilization (Runft et al., 2002).  Indeed, these oocytes exhibited more transients than in 
vivo-matured freshly ovulated MII-stage oocytes (Figure A.4).  Because CaP2+P release is 
essential for several aspects of successful fertilization, including polyspermy prevention, 
completion of meiosis, and early development (Ducibella et al., 2006), it is critical for 
vitrified/in vitro-matured oocytes to develop the ability to release CaP2+P during oocyte 
maturation.  While the ER is a major site of CaP2+P storage (Han and Nuccitelli, 1990; 
Terasaki and Sardet, 1991) and IPR3R receptors have been localized to the cortical ER 
clusters (Mehlmann et al., 1996; Shiraishi et al., 1995), IPR3R receptors are also located on 
the ER that does not form clusters (Kline et al., 1999).  Because the amount of IPR3R
receptor protein doubles during oocyte maturation (Mehlmann et al., 1996), it is possible 
that the increased number of IPR3R receptors provides the oocyte with enough CaP2+P
releasing ability to allow for a normal pattern of CaP2+P release in response to IPR3R following 
IVM, even in the absence of cortical ER clusters.  Moreover, vitrified in vitro-matured 
oocytes formed second polar bodies and pronuclei, events that depend on release of 
intracellular CaP2+P (Ducibella et al., 2006).
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 Deficiencies in the ability of the ER to reorganize following IVM and/or other 
components of cytoplasmic maturation could help explain the low developmental rates 
reported by others following oocyte cryopreservation and IVM (Abe et al., 2005; Aono et 
al., 2005; Kubota et al., 1998; Suzuki et al., 1996; Vieira et al., 2008; Vieira et al., 2002).
Additional causes of low developmental competence in some cryopreserved oocytes 
could be that the zona pellucida is modified, such that it hardens and prevents fertilization 
in some cases (Carroll et al., 1990; Gardner et al., 2007; Ko et al., 2008; Larman et al., 
2007a; Larman et al., 2006).  In this study, we were unable to remove zonae from oocytes 
following cryopreservation using acid Tyrodes, suggesting that the zonae were modified 
by some aspect of the vitrification procedure. The cause of zona hardening could be the 
use of the cryoprotectants ethylene glycol and/or 1,2-propanediol, both of which have 
been shown to cause CaP2+P release when added to unfrozen oocytes (Larman et al., 2007a; 
Larman et al., 2006).  This, in turn, could cause premature release of cortical granules and 
modification of the zona (Ghetler et al., 2006) and the plasma membrane.  The ability of 
zona-free oocytes to be fertilized in this study demonstrates that, even if release of 
cortical granules modified the zona pellucida, sperm interaction with the plasma 
membrane was not impaired by the vitrification procedure in most cases.  Nevertheless, 
release of CaP2+P by cryoprotectants could potentially affect other aspects of egg activation
(Gardner et al., 2007).
Additional components of cytoplasmic maturation that are independent of 
cryopreservation could also contribute to the low developmental potential following in 
vitro maturation.  For example, mouse oocytes matured in vitro have been shown to have 
lower mitogen-activated protein kinase activity than those in controls, and this could 
137 
 
 contribute to a higher rate of parthenogenetic activation and reduced developmental 
competence seen in in vitro-matured oocytes (Combelles et al., 2005).  More studies will 
be needed to clarify the normal events of cytoplasmic maturation (e.g., the effects on 
other organelles and protein synthesis) to determine how well IVM mimics these events.  
Development of culture media that more accurately simulate these normal cytoplasmic 
events will be essential for obtaining in vitro-matured oocytes, whether cryopreserved or 
not, that closely resemble those of freshly ovulated oocytes.
In summary, our results show that cryopreservation of GV-stage mammalian 
oocytes can preserve intracellular membranes and that nuclear maturation of immature 
oocytes matured following vitrification appears to be normal.  However, this technique 
disrupts the ability of the ER to reorganize during oocyte maturation, and this could 
contribute to the low developmental competence that has been observed following 
cryopreservation.  Before this technique can become a reliable method for treating 
infertility, further studies will need to be performed to improve the process of IVM in 
fresh and frozen oocytes, as well as to assess other aspects of cytoplasmic maturation that 
might contribute to the developmental competence of in vitro-matured oocytes.
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 Figure A.1
Figure A.1. Vitrified GV-stage oocytes are morphologically indistinguishable from fresh 
oocytes and mature to the MII stage in culture. A) Fresh oocyte. B) Vitrified oocyte. C)
Vitrified MII-stage oocyte following IVM. Note GVBD and first polar body formation. 
Representative photographs from 265 vitrified oocytes are shown in B and C. Original 
magnification ×120.
Figure A.2
Figure. A.2.  Time course of GVBD following vitrification and in vitro maturation. 
Fresh (n = 400) or frozen (n = 89) oocytes were incubated in medium containing 
dbcAMP, and the time to GVBD was noted after washing the dbcAMP out of the culture 
medium. Black squares, control oocytes; black circles, vitrified oocytes. 
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 Figure A.3
Figure A.3.  In vitro-matured oocytes form morphologically normal MII spindles. Left: 
in vivo-matured MII-stage oocyte. Right: vitrified in vitro-matured MII-stage oocyte. 
Green, tubulin; blue, chromosomes. Original magnification ×120. 
Figure A.4
Figure A.4.  Vitrified oocytes matured in vitro develop the ability to release CaP2+P in 
response to IPR3.R Oocytes were injected with the CaP2+P indicator dye calcium green 10-kDa 
dextran. The fluorescence intensity showing the relative CaP2+P level in the oocyte 
cytoplasm was measured during a subsequent injection of IPR3R (100 nM total in the 
oocyte). A and B) Representative tracings from control freshly ovulated MII-stage 
oocytes (n = 8). C) Representative tracing from vitrified oocytes matured in vitro (n = 5). 
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 Figure A.5
Figure A.5.  The ER structure in GV-stage oocytes. The ER was labeled using the 
lipophilic fluorescent dye DiI. A and B) Representative photograph from 25 fresh 
oocytes showing a continuous ER but the absence of cortical ER clusters that are 
characteristic of MII-stage oocytes  in the cortex (A) and equator (B). C and D)
Representative photograph from 19 vitrified oocytes showing the absence of cortical 
clusters in sections of the cortex (C) and equator (D). ????????????A and C????????????
for (B and D). 
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 Figure A.6
Figure A.6.  The structure of the ER following in vitro maturation in fresh oocytes. A)
Distinct ER clusters in an in vivo-matured oocyte are shown for reference. B and C)
Distinct ER clusters were found in the majority of oocytes matured in CZB medium (B)
but were sometimes absent (C). ????????????
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 Table A.1. Comparison of second polar body and pronuclear formation in fresh or 
vitrified oocytes at the MII stage
Group Treatment No. oocytes 
examined
Second polar 
bodies (%)
Pronuclei
(%)†
Ovulated Fresh 35 86 87
In vitro matured Fresh 29 72 67
In vitro matured Vitrified 43 67 76
*No significant differences were observed among any of the groups (p<0.05; Fisher’s 
Exact Test).
†Pronuclear formation was determined as a percentage of oocytes that formed second 
polar bodies.  
Table A.2. Comparison of cortical endoplasmic reticulum clusters in oocytes at the 
metaphase II stage.
Group Culture Medium No. oocytes 
examined
Percentage with 
distinct clusters
In vivo matured ????-HEPES 18 94% Pa
In vitro matured ??????????? 48 42% Pb
In vitro matured ???????????? 47 68% Pc
In vitro matured CZB 46 78% Pa,c
*Experiments were repeated at least 3 times.  
P
a,b,c
PValues with different superscript letters are significantly different (p<0.05; Fisher’s 
Exact Test).
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 Table A.3. Comparison of cortical endoplasmic reticulum clusters in in vivo- and in 
vitro- matured oocytes following vitrification.
Group Treatment No. oocytes 
examined
Percentage with 
distinct clusters
In vitro matured† Fresh‡ 46 78% Pa
In vitro matured† Vitrified 49 29% Pb
In vivo matured Fresh‡ 18 94% Pa,c
In vivo matured Vitrified 16 56% Pa
* Experiments were repeated at least 2 times.  
† Oocytes were matured in CZB medium.  
‡ For comparison, the fresh oocytes matured in CZB, as well as the fresh, in vivo 
matured MII-stage oocytes, were taken from Table 2.    
P
a,b,c
PValues with different superscript letters are significantly different (p<0.05; Fisher’s 
Exact Test).
144 
 
 References
Abe, Y., K. Hara, H. Matsumoto, J. Kobayashi, H. Sasada, H. Ekwall, H. Rodriguez-
Martinez, and E. Sato. 2005. Feasibility of a nylon-mesh holder for vitrification of 
bovine germinal vesicle oocytes in subsequent production of viable blastocysts. 
Biol Reprod. 72:1416-20.
Albarracin, J.L., R. Morato, C. Rojas, and T. Mogas. 2005. Effects of vitrification in open 
pulled straws on the cytology of in vitro matured prepubertal and adult bovine 
oocytes. Theriogenology. 63:890-901.
Aono, N., Y. Abe, K. Hara, H. Sasada, E. Sato, and H. Yoshida. 2005. Production of live 
offspring from mouse germinal vesicle-stage oocytes vitrified by a modified 
stepwise method, SWEID. Fertil Steril. 84 Suppl 2:1078-82.
Aono, N., T. Naganuma, Y. Abe, K. Hara, H. Sasada, E. Sato, and H. Yoshida. 2003. 
Successful production of blastocysts following ultrarapid vitrification with step-
wise equilibriation of germinal vesicle-stage mouse oocytes. J Reprod Dev.
49:501-6.
Arvanitakis, L., E. Geras-Raaka, and M.C. Gershengorn. 1998. Constitutively signaling 
G-protein-coupled receptors and human disease. Trends Endocrinol Metab. 9:27-
31.
Attramadal, H., J.L. Arriza, C. Aoki, T.M. Dawson, J. Codina, M.M. Kwatra, S.H. 
Snyder, M.G. Caron, and R.J. Lefkowitz. 1992. Beta-arrestin2, a novel member of 
the arrestin/beta-arrestin gene family. J Biol Chem. 267:17882-90.
Bacskai, B.J., B. Hochner, M. Mahaut-Smith, S.R. Adams, B.K. Kaang, E.R. Kandel, and 
R.Y. Tsien. 1993. Spatially resolved dynamics of cAMP and protein kinase A 
subunits in Aplysia sensory neurons. Science. 260:222-6.
Barrias, E.S., L.C. Reignault, W. De Souza, and T.M. Carvalho. 2010. Dynasore, a 
dynamin inhibitor, inhibits Trypanosoma cruzi entry into peritoneal macrophages. 
PLoS One. 5:e7764.
Bockaert, J., P. Marin, A. Dumuis, and L. Fagni. 2003. The 'magic tail' of G protein-
coupled receptors: an anchorage for functional protein networks. FEBS Lett.
546:65-72.
Bockaert, J., and J.P. Pin. 1999. Molecular tinkering of G protein-coupled receptors: an 
evolutionary success. Embo J. 18:1723-9.
Boivin, J., L. Bunting, J.A. Collins, and K.G. Nygren. 2007. International estimates of 
infertility prevalence and treatment-seeking: potential need and demand for 
infertility medical care. Hum Reprod. 22:1506-12.
Bonifacino, J.S., and L.M. Traub. 2003. Signals for sorting of transmembrane proteins to 
endosomes and lysosomes. Annu Rev Biochem. 72:395-447.
Borini, A., M. Cattoli, C. Bulletti, and G. Coticchio. 2008. Clinical efficiency of oocyte 
and embryo cryopreservation. Ann N Y Acad Sci. 1127:49-58.
Borner, S., F. Schwede, A. Schlipp, F. Berisha, D. Calebiro, M.J. Lohse, and V.O. 
Nikolaev. 2011. FRET measurements of intracellular cAMP concentrations and 
cAMP analog permeability in intact cells. Nat Protoc. 6:427-438.
Boyer, J.L., G.L. Waldo, and T.K. Harden. 1992. Beta gamma-subunit activation of G-
protein-regulated phospholipase C. J Biol Chem. 267:25451-6.
145 
 
 Brink, C.B., B.H. Harvey, J. Bodenstein, D.P. Venter, and D.W. Oliver. 2004. Recent 
advances in drug action and therapeutics: relevance of novel concepts in G-
protein-coupled receptor and signal transduction pharmacology. Br J Clin 
Pharmacol. 57:373-87.
Brown, R.L., T. Ord, S.B. Moss, and C.J. Williams. 2002. A-kinase anchor proteins as 
potential regulators of protein kinase A function in oocytes. Biol Reprod. 67:981-
7.
Calebiro, D., V.O. Nikolaev, M.C. Gagliani, T. de Filippis, C. Dees, C. Tacchetti, L. 
Persani, and M.J. Lohse. 2009. Persistent cAMP-signals triggered by internalized 
G-protein-coupled receptors. PLoS Biol. 7:e1000172.
Calebiro, D., V.O. Nikolaev, and M.J. Lohse. 2010a. Imaging of persistent cAMP 
signaling by internalized G protein-coupled receptors. J Mol Endocrinol. 45:1-8.
Calebiro, D., V.O. Nikolaev, L. Persani, and M.J. Lohse. 2010b. Signaling by 
internalized G-protein-coupled receptors. Trends Pharmacol Sci. 31:221-8.
Cao, T.T., H.W. Deacon, D. Reczek, A. Bretscher, and M. von Zastrow. 1999. A kinase-
regulated PDZ-domain interaction controls endocytic sorting of the beta2-
adrenergic receptor. Nature. 401:286-90.
Cao, T.T., R.W. Mays, and M. von Zastrow. 1998. Regulated endocytosis of G-protein-
coupled receptors by a biochemically and functionally distinct subpopulation of 
clathrin-coated pits. J Biol Chem. 273:24592-24602.
Carman, C.V., and J.L. Benovic. 1998. G-protein-coupled receptors: turn-ons and turn-
offs. Curr Opin Neurobiol. 8:335-44.
Carman, C.V., J.L. Parent, P.W. Day, A.N. Pronin, P.M. Sternweis, P.B. Wedegaertner, 
A.G. Gilman, J.L. Benovic, and T. Kozasa. 1999. Selective regulation of 
Galpha(q/11) by an RGS domain in the G protein-coupled receptor kinase, GRK2. 
J Biol Chem. 274:34483-92.
Carroll, J., H. Depypere, and C.D. Matthews. 1990. Freeze-thaw-induced changes of the 
zona pellucida explains decreased rates of fertilization in frozen-thawed mouse 
oocytes. J Reprod Fertil. 90:547-53.
Carroll, J., K. Swann, D. Whittingham, and M. Whitaker. 1994. Spatiotemporal dynamics 
of intracellular [Ca2+]i oscillations during the growth and meiotic maturation of 
mouse oocytes. Development. 120:3507-17.
Carroll, J., M.J. Wood, and D.G. Whittingham. 1993. Normal fertilization and 
development of frozen-thawed mouse oocytes: protective action of certain 
macromolecules. Biol Reprod. 48:606-12.
Casarosa, P., R.A. Bakker, D. Verzijl, M. Navis, H. Timmerman, R. Leurs, and M.J. 
Smit. 2001. Constitutive signaling of the human cytomegalovirus-encoded 
chemokine receptor US28. J Biol Chem. 276:1133-7.
Chatot, C.L., C.A. Ziomek, B.D. Bavister, J.L. Lewis, and I. Torres. 1989. An improved 
culture medium supports development of random-bred 1-cell mouse embryos in 
vitro. J Reprod Fertil. 86:679-88.
Chee, M.J., K. Morl, D. Lindner, N. Merten, G.W. Zamponi, P.E. Light, A.G. Beck-
Sickinger, and W.F. Colmers. 2008. The third intracellular loop stabilizes the 
inactive state of the neuropeptide Y1 receptor. J Biol Chem. 283:33337-33346.
Chen, C., T. Nakamura, and Y. Koutalos. 1999. Cyclic AMP diffusion coefficient in frog 
olfactory cilia. Biophys J. 76:2861-7.
146 
 
 Cheng, H., J.A. Govindan, and D. Greenstein. 2008. Regulated trafficking of the 
MSP/Eph receptor during oocyte meiotic maturation in C. elegans. Curr Biol.
18:705-14.
Chesnel, F., K. Wigglesworth, and J.J. Eppig. 1994. Acquisition of meiotic competence 
by denuded mouse oocytes: participation of somatic-cell product(s) and cAMP. 
Dev Biol. 161:285-95.
Cho, W.K., S. Stern, and J.D. Biggers. 1974. Inhibitory effect of dibutyryl cAMP on 
mouse oocyte maturation in vitro. J Exp Zool. 187:383-6.
Claing, A., W. Chen, W.E. Miller, N. Vitale, J. Moss, R.T. Premont, and R.J. Lefkowitz. 
2001. beta-Arrestin-mediated ADP-ribosylation factor 6 activation and beta 2-
adrenergic receptor endocytosis. J Biol Chem. 276:42509-13.
Claing, A., S.A. Laporte, M.G. Caron, and R.J. Lefkowitz. 2002. Endocytosis of G 
protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-
arrestin proteins. Prog Neurobiol. 66:61-79.
Clarke, P.R., and E. Karsenti. 1991. Regulation of p34cdc2 protein kinase: new insights 
into protein phosphorylation and the cell cycle. J Cell Sci. 100 ( Pt 3):409-14.
Cohen, G.B., T. Yang, P.R. Robinson, and D.D. Oprian. 1993. Constitutive activation of 
opsin: influence of charge at position 134 and size at position 296. Biochemistry.
32:6111-5.
Colman, A., E.A. Jones, and J. Heasman. 1985. Meiotic maturation in Xenopus oocytes: 
a link between the cessation of protein secretion and the polarized disappearance 
of Golgi apparati. J Cell Biol. 101:313-8.
Combelles, C.M., R.A. Fissore, D.F. Albertini, and C. Racowsky. 2005. In vitro 
maturation of human oocytes and cumulus cells using a co-culture three-
dimensional collagen gel system. Hum Reprod. 20:1349-58.
Conner, S., D. Leaf, and G. Wessel. 1997. Members of the SNARE hypothesis are 
associated with cortical granule exocytosis in the sea urchin egg. Mol Reprod 
Dev. 48:106-18.
Conner, S., and G.M. Wessel. 1998. rab3 mediates cortical granule exocytosis in the sea 
urchin egg. Dev Biol. 203:334-44.
Conti, M., C.B. Andersen, F. Richard, C. Mehats, S.Y. Chun, K. Horner, C. Jin, and A. 
Tsafriri. 2002. Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell 
Endocrinol. 187:153-9.
Coticchio, G., M.A. Bonu, R. Sciajno, E. Sereni, V. Bianchi, and A. Borini. 2007. Truths 
and myths of oocyte sensitivity to controlled rate freezing. Reprod Biomed 
Online. 15:24-30.
Damaj, B.B., S.R. McColl, K. Neote, N. Songqing, K.T. Ogborn, C.A. Hebert, and P.H. 
Naccache. 1996. Identification of G-protein binding sites of the human 
interleukin-8 receptors by functional mapping of the intracellular loops. Faseb J.
10:1426-1434.
Davies, P.J., M.M. Cornwell, J.D. Johnson, A. Reggianni, M. Myers, and M.P. Murtaugh. 
1984. Studies on the effects of dansylcadaverine and related compounds on 
receptor-mediated endocytosis in cultured cells. Diabetes Care. 7 Suppl 1:35-41.
Davies, P.J., D.R. Davies, A. Levitzki, F.R. Maxfield, P. Milhaud, M.C. Willingham, and 
I.H. Pastan. 1980. Transglutaminase is essential in receptor-mediated endocytosis 
of alpha 2-macroglobulin and polypeptide hormones. Nature. 283:162-7.
147 
 
 de Beco, S., C. Gueudry, F. Amblard, and S. Coscoy. 2009. Endocytosis is required for 
E-cadherin redistribution at mature adherens junctions. Proc Natl Acad Sci U S A.
106:7010-5.
Deng, J., S. Lang, C. Wylie, and S.R. Hammes. 2008. The Xenopus laevis isoform of G 
protein-coupled receptor 3 (GPR3) is a constitutively active cell surface receptor 
that participates in maintaining meiotic arrest in X. laevis oocytes. Mol 
Endocrinol. 22:1853-65.
Dhami, G.K., P.H. Anborgh, L.B. Dale, R. Sterne-Marr, and S.S. Ferguson. 2002. 
Phosphorylation-independent regulation of metabotropic glutamate receptor 
signaling by G protein-coupled receptor kinase 2. J Biol Chem. 277:25266-72.
Dicker, F., U. Quitterer, R. Winstel, K. Honold, and M.J. Lohse. 1999. Phosphorylation-
independent inhibition of parathyroid hormone receptor signaling by G protein-
coupled receptor kinases. Proc Natl Acad Sci U S A. 96:5476-81.
Diez, C., P. Duque, E. Gomez, C.O. Hidalgo, C. Tamargo, A. Rodriguez, L. Fernandez, 
S. de la Varga, A. Fernandez, N. Facal, and M. Carbajo. 2005. Bovine oocyte 
vitrification before or after meiotic arrest: effects on ultrastructure and 
developmental ability. Theriogenology. 64:317-33.
DiLuigi, A., V.N. Weitzman, M.C. Pace, L.J. Siano, D. Maier, and L.M. Mehlmann. 
2008. Meiotic arrest in human oocytes is maintained by a Gs signaling pathway. 
Biol Reprod. 78:667-72.
Dodge, K.L., S. Khouangsathiene, M.S. Kapiloff, R. Mouton, E.V. Hill, M.D. Houslay, 
L.K. Langeberg, and J.D. Scott. 2001. mAKAP assembles a protein kinase 
A/PDE4 phosphodiesterase cAMP signaling module. Embo J. 20:1921-30.
Doherty, G.J., and H.T. McMahon. 2009. Mechanisms of endocytosis. Annu Rev 
Biochem. 78:857-902.
Dong, J., D.F. Albertini, K. Nishimori, T.R. Kumar, N. Lu, and M.M. Matzuk. 1996. 
Growth differentiation factor-9 is required during early ovarian folliculogenesis. 
Nature. 383:531-5.
Droese, J., T. Mokros, R. Hermosilla, R. Schulein, M. Lipp, U.E. Hopken, and A. Rehm. 
2004. HCMV-encoded chemokine receptor US28 employs multiple routes for 
internalization. Biochem Biophys Res Commun. 322:42-9.
Ducibella, T., R.M. Schultz, and J.P. Ozil. 2006. Role of calcium signals in early 
development. Semin Cell Dev Biol. 17:324-32.
Duckworth, B.C., J.S. Weaver, and J.V. Ruderman. 2002. G2 arrest in Xenopus oocytes 
depends on phosphorylation of cdc25 by protein kinase A. Proc Natl Acad Sci U 
S A. 99:16794-9.
Dupre, D.J., A. Baragli, R.V. Rebois, N. Ethier, and T.E. Hebert. 2007. Signalling 
complexes associated with adenylyl cyclase II are assembled during their 
biosynthesis. Cell Signal. 19:481-489.
Dupre, D.J., M. Robitaille, N. Ethier, L.R. Villeneuve, A.M. Mamarbachi, and T.E. 
Hebert. 2006. Seven transmembrane receptor core signaling complexes are 
assembled prior to plasma membrane trafficking. J Biol Chem. 281:34561-34573.
Duvernay, M.T., C.M. Filipeanu, and G. Wu. 2005. The regulatory mechanisms of export 
trafficking of G protein-coupled receptors. Cell Signal. 17:1457-65.
Edwards, R. 1965. Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and 
human ovarian oocytes. Nature:349-351.
148 
 
 Eggerickx, D., J.F. Denef, O. Labbe, Y. Hayashi, S. Refetoff, G. Vassart, M. Parmentier, 
and F. Libert. 1995b. Molecular cloning of an orphan G-protein-coupled receptor 
that constitutively activates adenylate cyclase. Biochem J. 309 ( Pt 3):837-843.
El-Jouni, W., S. Haun, R. Hodeify, A. Hosein Walker, and K. Machaca. 2007. Vesicular 
traffic at the cell membrane regulates oocyte meiotic arrest. Development.
134:3307-15.
Elvin, J.A., C. Yan, P. Wang, K. Nishimori, and M.M. Matzuk. 1999. Molecular 
characterization of the follicle defects in the growth differentiation factor 9-
deficient ovary. Mol Endocrinol. 13:1018-34.
Endoh, K., K. Mochida, N. Ogonuki, M. Ohkawa, A. Shinmen, M. Ito, N. Kashiwazaki, 
and A. Ogura. 2007. The developmental ability of vitrified oocytes from different 
mouse strains assessed by parthenogenetic activation and intracytoplasmic sperm 
injection. J Reprod Dev. 53:1199-206.
Eppig, J.J., M.M. Vivieros, C. Marin-Bivens, and R. De La Fuente. 2004a. Regulation of 
mammalian oocyte maturation. In In The Ovary. P.L.E. Adashi, editor. Elsevier, 
Amsterdam. 113-129.
Eppig, J.J., M.M. Vivieros, C. Marin-Bivens, and R. De La Fuente. 2004b. Regulation of 
mammalian oocyte maturation. In In The Ovary. E.P.L.E. Adashi, editor. Elsevier 
Academic Press, Amsterdam.
Eppig, J.J., K. Wigglesworth, F. Pendola, and Y. Hirao. 1997. Murine oocytes suppress 
expression of luteinizing hormone receptor messenger ribonucleic acid by 
granulosa cells. Biol Reprod. 56:976-84.
Eroglu, A., M. Toner, L. Leykin, and T.L. Toth. 1998a. Cytoskeleton and polyploidy 
after maturation and fertilization of cryopreserved germinal vesicle-stage mouse 
oocytes. J Assist Reprod Genet. 15:447-54.
Eroglu, A., T.L. Toth, and M. Toner. 1998b. Alterations of the cytoskeleton and 
polyploidy induced by cryopreservation of metaphase II mouse oocytes. Fertil 
Steril. 69:944-57.
Ferguson, S.S. 2001. Evolving concepts in G protein-coupled receptor endocytosis: the 
role in receptor desensitization and signaling. Pharmacol Rev. 53:1-24.
Ferguson, S.S. 2007a. Phosphorylation-independent attenuation of GPCR signalling. 
Trends Pharmacol Sci. 28:173-9.
Ferguson, S.S. 2007b. Phosphorylation-independent attenuation of GPCR signalling. 
Trends Pharmacol Sci. 28:173-179.
Fernandez, N., F.L. Gottardo, M.N. Alonso, F. Monczor, C. Shayo, and C. Davio. 2011. 
Roles of phosphorylation-dependent and -independent mechanisms in the 
regulation of histamine H2 receptor by G protein-coupled receptor kinase 2. J
Biol Chem. 286:28697-28706.
Ferrandon, S., T.N. Feinstein, M. Castro, B. Wang, R. Bouley, J.T. Potts, T.J. Gardella, 
and J.P. Vilardaga. 2009. Sustained cyclic AMP production by parathyroid 
hormone receptor endocytosis. Nat Chem Biol. 5:734-42.
Ferre, S., R. Baler, M. Bouvier, M.G. Caron, L.A. Devi, T. Durroux, K. Fuxe, S.R. 
George, J.A. Javitch, M.J. Lohse, K. Mackie, G. Milligan, K.D. Pfleger, J.P. Pin, 
N.D. Volkow, M. Waldhoer, A.S. Woods, and R. Franco. 2009. Building a new 
conceptual framework for receptor heteromers. Nat Chem Biol. 5:131-4.
149 
 
 Fischmeister, R., L.R. Castro, A. Abi-Gerges, F. Rochais, J. Jurevicius, J. Leroy, and G. 
Vandecasteele. 2006. Compartmentation of cyclic nucleotide signaling in the 
heart: the role of cyclic nucleotide phosphodiesterases. Circ Res. 99:816-28.
FitzHarris, G., P. Marangos, and J. Carroll. 2007. Changes in endoplasmic reticulum 
structure during mouse oocyte maturation are controlled by the cytoskeleton and 
cytoplasmic dynein. Dev Biol. 305:133-44.
Fraile-Ramos, A., T.N. Kledal, A. Pelchen-Matthews, K. Bowers, T.W. Schwartz, and M. 
Marsh. 2001. The human cytomegalovirus US28 protein is located in endocytic 
vesicles and undergoes constitutive endocytosis and recycling. Mol Biol Cell.
12:1737-49.
Fraile-Ramos, A., T.A. Kohout, M. Waldhoer, and M. Marsh. 2003. Endocytosis of the 
viral chemokine receptor US28 does not require beta-arrestins but is dependent on 
the clathrin-mediated pathway. Traffic. 4:243-53.
Fredriksson, R., M.C. Lagerstrom, L.G. Lundin, and H.B. Schioth. 2003. The G-protein-
coupled receptors in the human genome form five main families. Phylogenetic 
analysis, paralogon groups, and fingerprints. Mol Pharmacol. 63:1256-72.
Freudzon, L., R.P. Norris, A.R. Hand, S. Tanaka, Y. Saeki, T.L. Jones, M.M. Rasenick, 
C.H. Berlot, L.M. Mehlmann, and L.A. Jaffe. 2005. Regulation of meiotic 
prophase arrest in mouse oocytes by GPR3, a constitutive activator of the Gs G 
protein. J Cell Biol. 171:255-65.
Fujiwara, T., K. Nakada, H. Shirakawa, and S. Miyazaki. 1993. Development of inositol 
trisphosphate-induced calcium release mechanism during maturation of hamster 
oocytes. Dev Biol. 156:69-79.
Galliera, E., V.R. Jala, J.O. Trent, R. Bonecchi, P. Signorelli, R.J. Lefkowitz, A. 
Mantovani, M. Locati, and B. Haribabu. 2004. beta-Arrestin-dependent 
constitutive internalization of the human chemokine decoy receptor D6. J Biol 
Chem. 279:25590-7.
Gardner, D.K., C.B. Sheehan, L. Rienzi, M. Katz-Jaffe, and M.G. Larman. 2007. 
Analysis of oocyte physiology to improve cryopreservation procedures. 
Theriogenology. 67:64-72.
Gether, U., S. Lin, P. Ghanouni, J.A. Ballesteros, H. Weinstein, and B.K. Kobilka. 1997. 
Agonists induce conformational changes in transmembrane domains III and VI of 
the beta2 adrenoceptor. Embo J. 16:6737-47.
Ghetler, Y., E. Skutelsky, I. Ben Nun, L. Ben Dor, D. Amihai, and R. Shalgi. 2006. 
Human oocyte cryopreservation and the fate of cortical granules. Fertil Steril.
86:210-6.
Gilbert, S. 1988. Developmental Biology. Sinauer Associates Inc., Sunderland, MA. 787-
789 pp.
Gomes, C.M., C.A. Silva, N. Acevedo, E. Baracat, P. Serafini, and G.D. Smith. 2008. 
Influence of vitrification on mouse metaphase II oocyte spindle dynamics and 
chromatin alignment. Fertil Steril. 90:1396-404.
Goodman, O.B., Jr., J.G. Krupnick, F. Santini, V.V. Gurevich, R.B. Penn, A.W. Gagnon, 
J.H. Keen, and J.L. Benovic. 1996. Beta-arrestin acts as a clathrin adaptor in 
endocytosis of the beta2-adrenergic receptor. Nature. 383:447-50.
Goud, P.T., A.P. Goud, P. Van Oostveldt, and M. Dhont. 1999. Presence and dynamic 
redistribution of type I inositol 1,4,5-trisphosphate receptors in human oocytes 
150 
 
 and embryos during in-vitro maturation, fertilization and early cleavage divisions. 
Mol Hum Reprod. 5:441-51.
Gougeon, A. 1996. Regulation of ovarian follicular development in primates: facts and 
hypotheses. Endocr Rev. 17:121-55.
Han, J.K., and R. Nuccitelli. 1990. Inositol 1,4,5-trisphosphate-induced calcium release 
in the organelle layers of the stratified, intact egg of Xenopus laevis. J Cell Biol.
110:1103-10.
Han, S.J., and M. Conti. 2006. New pathways from PKA to the Cdc2/cyclin B complex in 
oocytes: Wee1B as a potential PKA substrate. Cell Cycle. 5:227-31.
Hanf, R., Y. Li, G. Szabo, and R. Fischmeister. 1993. Agonist-independent effects of 
muscarinic antagonists on Ca2+ and K+ currents in frog and rat cardiac cells. J
Physiol. 461:743-65.
Hepp, R., N. Puri, A.C. Hohenstein, G.L. Crawford, S.W. Whiteheart, and P.A. Roche. 
2005. Phosphorylation of SNAP-23 regulates exocytosis from mast cells. J Biol 
Chem. 280:6610-20.
Hinckley, M., S. Vaccari, K. Horner, R. Chen, and M. Conti. 2005. The G-protein-
coupled receptors GPR3 and GPR12 are involved in cAMP signaling and 
maintenance of meiotic arrest in rodent oocytes. Dev Biol. 287:249-61.
Holzer, H., E. Scharf, R.C. Chian, E. Demirtas, W. Buckett, and S.L. Tan. 2007. In vitro 
maturation of oocytes collected from unstimulated ovaries for oocyte donation. 
Fertil Steril. 88:62-7.
Honing, S., D. Ricotta, M. Krauss, K. Spate, B. Spolaore, A. Motley, M. Robinson, C. 
Robinson, V. Haucke, and D.J. Owen. 2005. Phosphatidylinositol-(4,5)-
bisphosphate regulates sorting signal recognition by the clathrin-associated 
adaptor complex AP2. Mol Cell. 18:519-31.
Horner, K., G. Livera, M. Hinckley, K. Trinh, D. Storm, and M. Conti. 2003. Rodent 
oocytes express an active adenylyl cyclase required for meiotic arrest. Dev Biol.
258:385-96.
Houslay, M.D., G.S. Baillie, and D.H. Maurice. 2007. cAMP-Specific phosphodiesterase-
4 enzymes in the cardiovascular system: a molecular toolbox for generating 
compartmentalized cAMP signaling. Circ Res. 100:950-66.
Huang, J.Y., H.Y. Chen, J.Y. Park, S.L. Tan, and R.C. Chian. 2008. Comparison of 
spindle and chromosome configuration in in vitro- and in vivo-matured mouse 
oocytes after vitrification. Fertil Steril. 90:1424-32.
Huang, J.Y., H.Y. Chen, S.L. Tan, and R.C. Chian. 2007. Effect of choline-supplemented 
sodium-depleted slow freezing versus vitrification on mouse oocyte meiotic 
spindles and chromosome abnormalities. Fertil Steril. 88:1093-100.
Huang, P., J. Li, C. Chen, I. Visiers, H. Weinstein, and L.Y. Liu-Chen. 2001. Functional 
role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively 
active and inactive receptors result from substitutions of Thr6.34(279) with Lys 
and Asp. Biochemistry. 40:13501-9.
Ikebuchi, Y., N. Masumoto, T. Matsuoka, T. Yokoi, M. Tahara, K. Tasaka, A. Miyake, 
and Y. Murata. 1998. SNAP-25 is essential for cortical granule exocytosis in 
mouse eggs. Am J Physiol. 274:C1496-500.
151 
 
 Jaffe, L.A., and R.P. Norris. 2010. Initiation of the meiotic prophase-to-metaphase 
transition in mammalian oocytes. In Ooogensis:  The Universal Process. M.-H. 
Verhlac and A. Villeneuve, editors. John Wiley & Sons.
Jaffe, L.A., R.P. Norris, M. Freudzon, W.J. Ratzan, and L.M. Mehlmann. 2009. 
Microinjection of follicle-enclosed mouse oocytes. Methods Mol Biol. 518:157-
73.
Jones, K.T., J. Carroll, and D.G. Whittingham. 1995. Ionomycin, thapsigargin, ryanodine, 
and sperm induced Ca2+ release increase during meiotic maturation of mouse 
oocytes. J Biol Chem. 270:6671-7.
Jovic, M., M. Sharma, J. Rahajeng, and S. Caplan. 2010. The early endosome: a busy 
sorting station for proteins at the crossroads. Histol Histopathol. 25:99-112.
Jurema, M.W., and D. Nogueira. 2006. In vitro maturation of human oocytes for assisted 
reproduction. Fertil Steril. 86:1277-91.
Kawamura, K., Y. Cheng, N. Kawamura, S. Takae, A. Okada, Y. Kawagoe, S. Mulders, 
Y. Terada, and A.J. Hsueh. 2011. Pre-ovulatory LH/hCG surge decreases C-type 
natriuretic peptide secretion by ovarian granulosa cells to promote meiotic 
resumption of pre-ovulatory oocytes. Hum Reprod. 26:3094-101.
Kim, S.W., Z.W. Lee, C. Lee, K.S. Im, and K.S. Ha. 2001. The role of tissue 
transglutaminase in the germinal vesicle breakdown of mouse oocytes. Biochem 
Biophys Res Commun. 286:229-34.
Kline, D. 1988. Calcium-dependent events at fertilization of the frog egg: injection of a 
calcium buffer blocks ion channel opening, exocytosis, and formation of 
pronuclei. Dev Biol. 126:346-61.
Kline, D. 2000. Attributes and dynamics of the endoplasmic reticulum in mammalian 
eggs. Curr Top Dev Biol. 50:125-54.
Kline, D. 2009. Quantitative microinjection of mouse oocytes and eggs. Methods Mol 
Biol. 518:135-56.
Kline, D., and J.T. Kline. 1992. Repetitive calcium transients and the role of calcium in 
exocytosis and cell cycle activation in the mouse egg. Dev Biol. 149:80-9.
Kline, D., L. Mehlmann, C. Fox, and M. Terasaki. 1999. The cortical endoplasmic 
reticulum (ER) of the mouse egg: localization of ER clusters in relation to the 
generation of repetitive calcium waves. Dev Biol. 215:431-42.
Ko, C.S., D.C. Ding, T.W. Chu, Y.N. Chu, I.C. Chen, W.H. Chen, and G.J. Wu. 2008. 
Changes to the meiotic spindle and zona pellucida of mature mouse oocytes 
following different cryopreservation methods. Anim Reprod Sci. 105:272-82.
Kohout, T.A., and R.J. Lefkowitz. 2003. Regulation of G protein-coupled receptor 
kinases and arrestins during receptor desensitization. Mol Pharmacol. 63:9-18.
Kostenis, E. 2004a. A glance at G-protein-coupled receptors for lipid mediators: a 
growing receptor family with remarkably diverse ligands. Pharmacol Ther.
102:243-57.
Kostenis, E. 2004b. Novel clusters of receptors for sphingosine-1-phosphate, 
sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for 
"old" ligands. J Cell Biochem. 92:923-36.
Kovanci, E., J.L. Simpson, P. Amato, J. Rohozinski, M.J. Heard, C.E. Bishop, and S.A. 
Carson. 2008. Oocyte-specific G-protein-coupled receptor 3 (GPR3): no 
152 
 
 perturbations found in 82 women with premature ovarian failure (first report). 
Fertil Steril. 90:1269-71.
Kovo, M., M. Kandli-Cohen, M. Ben-Haim, D. Galiani, D.W. Carr, and N. Dekel. 2006. 
An active protein kinase A (PKA) is involved in meiotic arrest of rat growing 
oocytes. Reproduction. 132:33-43.
Kubota, C., X. Yang, A. Dinnyes, J. Todoroki, H. Yamakuchi, K. Mizoshita, S. Inohae, 
and N. Tabara. 1998. In vitro and in vivo survival of frozen-thawed bovine 
oocytes after IVF, nuclear transfer, and parthenogenetic activation. Mol Reprod 
Dev. 51:281-6.
Lane, M., and D.K. Gardner. 2001. Vitrification of mouse oocytes using a nylon loop. 
Mol Reprod Dev. 58:342-7.
Laporte, S.A., R.H. Oakley, J. Zhang, J.A. Holt, S.S. Ferguson, M.G. Caron, and L.S. 
Barak. 1999. The beta2-adrenergic receptor/betaarrestin complex recruits the 
clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci U S A. 96:3712-7.
Larman, M.G., M.G. Katz-Jaffe, C.B. Sheehan, and D.K. Gardner. 2007a. 1,2-
propanediol and the type of cryopreservation procedure adversely affect mouse 
oocyte physiology. Hum Reprod. 22:250-9.
Larman, M.G., M.G. Minasi, L. Rienzi, and D.K. Gardner. 2007b. Maintenance of the 
meiotic spindle during vitrification in human and mouse oocytes. Reprod Biomed 
Online. 15:692-700.
Larman, M.G., C.B. Sheehan, and D.K. Gardner. 2006. Calcium-free vitrification reduces 
cryoprotectant-induced zona pellucida hardening and increases fertilization rates 
in mouse oocytes. Reproduction. 131:53-61.
Le Du, A., I.J. Kadoch, N. Bourcigaux, S. Doumerc, M.C. Bourrier, N. Chevalier, R. 
Fanchin, R.C. Chian, G. Tachdjian, R. Frydman, and N. Frydman. 2005. In vitro 
oocyte maturation for the treatment of infertility associated with polycystic 
ovarian syndrome: the French experience. Hum Reprod. 20:420-4.
Ledan, E., Z. Polanski, M.E. Terret, and B. Maro. 2001. Meiotic maturation of the mouse 
oocyte requires an equilibrium between cyclin B synthesis and degradation. Dev 
Biol. 232:400-13.
Ledent, C., I. Demeestere, D. Blum, J. Petermans, T. Hamalainen, G. Smits, and G. 
Vassart. 2005. Premature ovarian aging in mice deficient for Gpr3. Proc Natl 
Acad Sci U S A. 102:8922-6.
Lefkowitz, R.J. 1993. G-protein-coupled receptors. Turned on to ill effect. Nature.
365:603-4.
Lefkowitz, R.J., and S.K. Shenoy. 2005. Transduction of receptor signals by beta-
arrestins. Science. 308:512-7.
Lefkowitz, R.J., and E.J. Whalen. 2004. beta-arrestins: traffic cops of cell signaling. Curr 
Opin Cell Biol. 16:162-8.
Leguia, M., S. Conner, L. Berg, and G.M. Wessel. 2006. Synaptotagmin I is involved in 
the regulation of cortical granule exocytosis in the sea urchin. Mol Reprod Dev.
73:895-905.
Leguia, M., and G.M. Wessel. 2004. Selective expression of a sec1/munc18 member in 
sea urchin eggs and embryos. Gene Expr Patterns. 4:645-57.
Lembo, P.M., M.H. Ghahremani, and P.R. Albert. 1999. Receptor selectivity of the 
cloned opossum G protein-coupled receptor kinase 2 (GRK2) in intact opossum 
153 
 
 kidney cells: role in desensitization of endogenous alpha2C-adrenergic but not 
serotonin 1B receptors. Mol Endocrinol. 13:138-47.
Leurs, R., M.J. Smit, A.E. Alewijnse, and H. Timmerman. 1998. Agonist-independent 
regulation of constitutively active G-protein-coupled receptors. Trends Biochem 
Sci. 23:418-22.
Lincoln, A.J., D. Wickramasinghe, P. Stein, R.M. Schultz, M.E. Palko, M.P. De Miguel, 
L. Tessarollo, and P.J. Donovan. 2002. Cdc25b phosphatase is required for 
resumption of meiosis during oocyte maturation. Nat Genet. 30:446-9.
Liu, Y.W., M.C. Surka, T. Schroeter, V. Lukiyanchuk, and S.L. Schmid. 2008. Isoform 
and splice-variant specific functions of dynamin-2 revealed by analysis of 
conditional knock-out cells. Mol Biol Cell. 19:5347-59.
Lohse, M.J., S. Andexinger, J. Pitcher, S. Trukawinski, J. Codina, J.P. Faure, M.G. 
Caron, and R.J. Lefkowitz. 1992. Receptor-specific desensitization with purified 
proteins. Kinase dependence and receptor specificity of beta-arrestin and arrestin 
in the beta 2-adrenergic receptor and rhodopsin systems. J Biol Chem. 267:8558-
64.
Lowther, K.M., V.O. Nikolaev, and L.M. Mehlmann. 2011. Endocytosis in the mouse 
oocyte and its contribution to cAMP signaling during meiotic arrest. 
Reproduction. 141:737-747.
Macia, E., M. Ehrlich, R. Massol, E. Boucrot, C. Brunner, and T. Kirchhausen. 2006. 
Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 10:839-50.
Maenhaut, C., J. Van Sande, F. Libert, M. Abramowicz, M. Parmentier, J.J. 
Vanderhaegen, J.E. Dumont, G. Vassart, and S. Schiffmann. 1990. RDC8 codes 
for an adenosine A2 receptor with physiological constitutive activity. Biochem 
Biophys Res Commun. 173:1169-1178.
Magalhaes, A.C., H. Dunn, and S.S. Ferguson. 2012. Regulation of GPCR activity, 
trafficking and localization by GPCR-interacting proteins. Br J Pharmacol.
165:1717-36.
Magnusson, C., and T. Hillensjo. 1977. Inhibition of maturation and metabolism in rat 
oocytes by cyclic AMP. J Exp Zool:139-147.
Masciarelli, S., K. Horner, C. Liu, S.H. Park, M. Hinckley, S. Hockman, T. Nedachi, C. 
Jin, M. Conti, and V. Manganiello. 2004. Cyclic nucleotide phosphodiesterase 
3A-deficient mice as a model of female infertility. J Clin Invest. 114:196-205.
Mehlmann, L.M. 2005a. Oocyte-specific expression of Gpr3 is required for the 
maintenance of meiotic arrest in mouse oocytes. Dev Biol. 288:397-404.
Mehlmann, L.M. 2005b. Stops and starts in mammalian oocytes: recent advances in 
understanding the regulation of meiotic arrest and oocyte maturation. 
Reproduction. 130:791-9.
Mehlmann, L.M., G. Carpenter, S.G. Rhee, and L.A. Jaffe. 1998. SH2 domain-mediated 
activation of phospholipase Cgamma is not required to initiate Ca2+ release at 
fertilization of mouse eggs. Dev Biol. 203:221-32.
Mehlmann, L.M., T.L. Jones, and L.A. Jaffe. 2002. Meiotic arrest in the mouse follicle 
maintained by a Gs protein in the oocyte. Science. 297:1343-5.
Mehlmann, L.M., and D. Kline. 1994. Regulation of intracellular calcium in the mouse 
egg: calcium release in response to sperm or inositol trisphosphate is enhanced 
after meiotic maturation. Biol Reprod. 51:1088-98.
154 
 
 Mehlmann, L.M., K. Mikoshiba, and D. Kline. 1996. Redistribution and increase in 
cortical inositol 1,4,5-trisphosphate receptors after meiotic maturation of the 
mouse oocyte. Dev Biol. 180:489-98.
Mehlmann, L.M., Y. Saeki, S. Tanaka, T.J. Brennan, A.V. Evsikov, F.L. Pendola, B.B. 
Knowles, J.J. Eppig, and L.A. Jaffe. 2004. The Gs-linked receptor GPR3 
maintains meiotic arrest in mammalian oocytes. Science. 306:1947-50.
Mehlmann, L.M., M. Terasaki, L.A. Jaffe, and D. Kline. 1995. Reorganization of the 
endoplasmic reticulum during meiotic maturation of the mouse oocyte. Dev Biol.
170:607-15.
Men, H., R.L. Monson, and J.J. Rutledge. 2002. Effect of meiotic stages and maturation 
protocols on bovine oocyte's resistance to cryopreservation. Theriogenology.
57:1095-103.
Mewes, T., S. Dutz, U. Ravens, and K.H. Jakobs. 1993. Activation of calcium currents in 
cardiac myocytes by empty beta-adrenoceptors. Circulation. 88:2916-22.
Mikkelsen, A.L. 2005. Strategies in human in-vitro maturation and their clinical outcome. 
Reprod Biomed Online. 10:593-9.
Millar, R.P., and C.L. Newton. 2010. The year in G protein-coupled receptor research. 
Mol Endocrinol. 24:261-74.
Miller, M.A., P.J. Ruest, M. Kosinski, S.K. Hanks, and D. Greenstein. 2003a. An Eph 
receptor sperm-sensing control mechanism for oocyte meiotic maturation in 
Caenorhabditis elegans. Genes Dev. 17:187-200.
Miller, W.E., D.A. Houtz, C.D. Nelson, P.E. Kolattukudy, and R.J. Lefkowitz. 2003b. G-
protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin 
recruitment regulate the constitutive signaling activity of the human 
cytomegalovirus US28 GPCR. J Biol Chem. 278:21663-71.
Mokros, T., A. Rehm, J. Droese, M. Oppermann, M. Lipp, and U.E. Hopken. 2002.
Surface expression and endocytosis of the human cytomegalovirus-encoded 
chemokine receptor US28 is regulated by agonist-independent phosphorylation. J
Biol Chem. 277:45122-8.
Moore, C.A., S.K. Milano, and J.L. Benovic. 2007. Regulation of receptor trafficking by 
GRKs and arrestins. Annu Rev Physiol. 69:451-82.
Morgan, D.O. 1995. Principles of CDK regulation. Nature. 374:131-4.
Morisset, S., A. Rouleau, X. Ligneau, F. Gbahou, J. Tardivel-Lacombe, H. Stark, W. 
Schunack, C.R. Ganellin, J.C. Schwartz, and J.M. Arrang. 2000. High constitutive 
activity of native H3 receptors regulates histamine neurons in brain. Nature.
408:860-4.
Mukherjee, S., V.V. Gurevich, A. Preninger, H.E. Hamm, M.F. Bader, A.T. Fazleabas, L. 
Birnbaumer, and M. Hunzicker-Dunn. 2002. Aspartic acid 564 in the third 
cytoplasmic loop of the luteinizing hormone/choriogonadotropin receptor is 
crucial for phosphorylation-independent interaction with arrestin2. J Biol Chem.
277:17916-27.
Mullershausen, F., F. Zecri, C. Cetin, A. Billich, D. Guerini, and K. Seuwen. 2009. 
Persistent signaling induced by FTY720-phosphate is mediated by internalized 
S1P1 receptors. Nat Chem Biol. 5:428-34.
Neer, E.J. 1995. Heterotrimeric G proteins: organizers of transmembrane signals. Cell.
80:249-57.
155 
 
 Newhall, K.J., A.R. Criniti, C.S. Cheah, K.C. Smith, K.E. Kafer, A.D. Burkart, and G.S. 
McKnight. 2006. Dynamic anchoring of PKA is essential during oocyte 
maturation. Curr Biol. 16:321-7.
Newton, A.J., T. Kirchhausen, and V.N. Murthy. 2006. Inhibition of dynamin completely 
blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci U S A.
103:17955-60.
Nikolaev, V.O., M. Bunemann, L. Hein, A. Hannawacker, and M.J. Lohse. 2004. Novel 
single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem.
279:37215-8.
Nikolaev, V.O., M. Bunemann, E. Schmitteckert, M.J. Lohse, and S. Engelhardt. 2006. 
Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-
adrenergic but locally confined beta2-adrenergic receptor-mediated signaling. 
Circ Res. 99:1084-91.
Nogami, S., S. Satoh, M. Nakano, H. Shimizu, H. Fukushima, A. Maruyama, A. Terano, 
and H. Shirataki. 2003. Taxilin; a novel syntaxin-binding protein that is involved 
in Ca2+-dependent exocytosis in neuroendocrine cells. Genes Cells. 8:17-28.
Norris, R.P., M. Freudzon, L.M. Mehlmann, A.E. Cowan, A.M. Simon, D.L. Paul, P.D. 
Lampe, and L.A. Jaffe. 2008. Luteinizing hormone causes MAP kinase-dependent 
phosphorylation and closure of connexin 43 gap junctions in mouse ovarian 
follicles: one of two paths to meiotic resumption. Development. 135:3229-38.
Norris, R.P., W.J. Ratzan, M. Freudzon, L.M. Mehlmann, J. Krall, M.A. Movsesian, H. 
Wang, H. Ke, V.O. Nikolaev, and L.A. Jaffe. 2009. Cyclic GMP from the 
surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte. 
Development. 136:1869-78.
Oakley, R.H., S.A. Laporte, J.A. Holt, L.S. Barak, and M.G. Caron. 2001. Molecular 
determinants underlying the formation of stable intracellular G protein-coupled 
receptor-beta-arrestin complexes after receptor endocytosis*. J Biol Chem.
276:19452-60.
Oh, J.S., S.J. Han, and M. Conti. 2010. Wee1B, Myt1, and Cdc25 function in distinct 
compartments of the mouse oocyte to control meiotic resumption. J Cell Biol.
188:199-207.
Ohno, H., J. Stewart, M.C. Fournier, H. Bosshart, I. Rhee, S. Miyatake, T. Saito, A. 
Gallusser, T. Kirchhausen, and J.S. Bonifacino. 1995. Interaction of tyrosine-
based sorting signals with clathrin-associated proteins. Science. 269:1872-5.
Oppermann, M., N.J. Freedman, R.W. Alexander, and R.J. Lefkowitz. 1996. 
Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled 
receptor kinases and protein kinase C. J Biol Chem. 271:13266-72.
Opresko, L.K., and H.S. Wiley. 1987. Receptor-mediated endocytosis in Xenopus 
oocytes. I. Characterization of the vitellogenin receptor system. J Biol Chem.
262:4109-15.
Otoi, T., K. Yamamoto, N. Koyama, and T. Suzuki. 1995. In vitro fertilization and 
development of immature and mature bovine oocytes cryopreserved by ethylene 
glycol with sucrose. Cryobiology. 32:455-60.
Padmanabhan, S., A.G. Myers, and B.M. Prasad. 2009. Constitutively active GPR6 is 
located in the intracellular compartments. FEBS Lett. 583:107-12.
156 
 
 Paing, M.M., A.B. Stutts, T.A. Kohout, R.J. Lefkowitz, and J. Trejo. 2002. beta -
Arrestins regulate protease-activated receptor-1 desensitization but not 
internalization or Down-regulation. J Biol Chem. 277:1292-300.
Pals-Rylaarsdam, R., V.V. Gurevich, K.B. Lee, J.A. Ptasienski, J.L. Benovic, and M.M. 
Hosey. 1997. Internalization of the m2 muscarinic acetylcholine receptor. 
Arrestin-independent and -dependent pathways. J Biol Chem. 272:23682-9.
Pauwels, P.J., and T. Wurch. 1998. Review: amino acid domains involved in constitutive 
activation of G-protein-coupled receptors. Mol Neurobiol. 17:109-35.
Peng, X.R., A.J. Hsueh, P.S. LaPolt, L. Bjersing, and T. Ny. 1991. Localization of 
luteinizing hormone receptor messenger ribonucleic acid expression in ovarian 
cell types during follicle development and ovulation. Endocrinology. 129:3200-7.
Perry, S.J., G.S. Baillie, T.A. Kohout, I. McPhee, M.M. Magiera, K.L. Ang, W.E. Miller, 
A.J. McLean, M. Conti, M.D. Houslay, and R.J. Lefkowitz. 2002. Targeting of 
cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science.
298:834-6.
Pincus, G., and E.V. Enzmann. 1935. The Comparative Behavior of Mammalian Eggs in 
Vivo and in Vitro : I. The Activation of Ovarian Eggs. J Exp Med. 62:665-75.
Pirino, G., M.P. Wescott, and P.J. Donovan. 2009. Protein kinase A regulates resumption 
of meiosis by phosphorylation of Cdc25B in mammalian oocytes. Cell Cycle.
8:665-70.
Ponsioen, B., J. Zhao, J. Riedl, F. Zwartkruis, G. van der Krogt, M. Zaccolo, W.H. 
Moolenaar, J.L. Bos, and K. Jalink. 2004. Detecting cAMP-induced Epac 
activation by fluorescence resonance energy transfer: Epac as a novel cAMP 
indicator. EMBO Rep. 5:1176-1180.
Prezeau, L., J.G. Richman, S.W. Edwards, and L.E. Limbird. 1999. The zeta isoform of 
14-3-3 proteins interacts with the third intracellular loop of different alpha2-
adrenergic receptor subtypes. J Biol Chem. 274:13462-13469.
Ravichandran, V., A. Chawla, and P.A. Roche. 1996. Identification of a novel syntaxin-
and synaptobrevin/VAMP-binding protein, SNAP-23, expressed in non-neuronal 
tissues. J Biol Chem. 271:13300-3.
Reiter, E., and R.J. Lefkowitz. 2006. GRKs and beta-arrestins: roles in receptor silencing, 
trafficking and signaling. Trends Endocrinol Metab. 17:159-65.
Reiter, E., S. Marion, F. Robert, C. Troispoux, F. Boulay, F. Guillou, and P. Crepieux. 
2001. Kinase-inactive G-protein-coupled receptor kinases are able to attenuate 
follicle-stimulating hormone-induced signaling. Biochem Biophys Res Commun.
282:71-8.
Richman, J.G., A.E. Brady, Q. Wang, J.L. Hensel, R.J. Colbran, and L.E. Limbird. 2001. 
Agonist-regulated Interaction between alpha2-adrenergic receptors and 
spinophilin. J Biol Chem. 276:15003-15008.
Rienzi, L., F. Martinez, F. Ubaldi, M.G. Minasi, M. Iacobelli, J. Tesarik, and E. Greco. 
2004. Polscope analysis of meiotic spindle changes in living metaphase II human 
oocytes during the freezing and thawing procedures. Hum Reprod. 19:655-9.
Rios-Cardona, D., R.R. Ricardo-Gonzalez, A. Chawla, and J.E. Ferrell, Jr. 2008. A role 
for GPRx, a novel GPR3/6/12-related G-protein coupled receptor, in the 
maintenance of meiotic arrest in Xenopus laevis oocytes. Dev Biol. 317:380-8.
157 
 
 Roberts, S.J., D.S. Leaf, H.P. Moore, and J.C. Gerhart. 1992. The establishment of 
polarized membrane traffic in Xenopus laevis embryos. J Cell Biol. 118:1359-69.
Robinson, J.W., M. Zhang, L.C. Shuhaibar, R.P. Norris, A. Geerts, F. Wunder, J.J. Eppig, 
L.R. Potter, and L.A. Jaffe. 2012. Luteinizing hormone reduces the activity of the 
NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP 
decrease that promotes resumption of meiosis in oocytes. Dev Biol. 366:308-16.
Rodal, S.K., G. Skretting, O. Garred, F. Vilhardt, B. van Deurs, and K. Sandvig. 1999. 
Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of 
clathrin-coated endocytic vesicles. Mol Biol Cell. 10:961-974.
Rojas, C., M.J. Palomo, J.L. Albarracin, and T. Mogas. 2004. Vitrification of immature 
and in vitro matured pig oocytes: study of distribution of chromosomes, 
microtubules, and actin microfilaments. Cryobiology. 49:211-20.
Ruiz-Medina, J., C. Ledent, and O. Valverde. 2011. GPR3 orphan receptor is involved in 
neuropathic pain after peripheral nerve injury and regulates morphine-induced 
antinociception. Neuropharmacology. 61:43-50.
Runft, L.L., L.A. Jaffe, and L.M. Mehlmann. 2002. Egg activation at fertilization: where 
it all begins. Dev Biol. 245:237-54.
Saeki, Y., S. Ueno, R. Mizuno, T. Nishimura, H. Fujimura, Y. Nagai, and T. Yanagihara. 
1993. Molecular cloning of a novel putative G protein-coupled receptor 
(GPCR21) which is expressed predominantly in mouse central nervous system. 
FEBS Lett. 336:317-22.
Sathananthan, A.H., S.C. Ng, A.O. Trounson, A. Bongso, S.S. Ratnam, J. Ho, H. Mok, 
and M.N. Lee. 1988. The effects of ultrarapid freezing on meiotic and mitotic 
spindles of mouse oocytes and embryos. Gamete Res. 21:385-401.
Scheer, A., F. Fanelli, T. Costa, P.G. De Benedetti, and S. Cotecchia. 1997. The 
activation process of the alpha1B-adrenergic receptor: potential role of 
protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad 
Sci U S A. 94:808-13.
Schlegel, R., R.B. Dickson, M.C. Willingham, and I.H. Pastan. 1982. Amantadine and 
dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated 
endocytosis of alpha 2-macroglobulin. Proc Natl Acad Sci U S A. 79:2291-5.
Seifert, R., and K. Wenzel-Seifert. 2002. Constitutive activity of G-protein-coupled 
receptors: cause of disease and common property of wild-type receptors. Naunyn 
Schmiedebergs Arch Pharmacol. 366:381-416.
Shenoy, S.K., and R.J. Lefkowitz. 2003. Multifaceted roles of beta-arrestins in the 
regulation of seven-membrane-spanning receptor trafficking and signalling. 
Biochem J. 375:503-15.
Sherrill, J.D., and W.E. Miller. 2008. Desensitization of herpesvirus-encoded G protein-
coupled receptors. Life Sci. 82:125-34.
Shiina, T., K. Arai, S. Tanabe, N. Yoshida, T. Haga, T. Nagao, and H. Kurose. 2001. 
Clathrin box in G protein-coupled receptor kinase 2. J Biol Chem. 276:33019-26.
Shiraishi, K., A. Okada, H. Shirakawa, S. Nakanishi, K. Mikoshiba, and S. Miyazaki. 
1995. Developmental changes in the distribution of the endoplasmic reticulum 
and inositol 1,4,5-trisphosphate receptors and the spatial pattern of Ca2+ release 
during maturation of hamster oocytes. Dev Biol. 170:594-606.
158 
 
 Shitsukawa, K., C.B. Andersen, F.J. Richard, A.K. Horner, A. Wiersma, M. van Duin, 
and M. Conti. 2001. Cloning and characterization of the cyclic guanosine 
monophosphate-inhibited phosphodiesterase PDE3A expressed in mouse oocyte. 
Biol Reprod. 65:188-96.
Singal, P.K., and E.J. Sanders. 1974. An ultrastructural study of the first cleavage of 
Xenopus embryos. J Ultrastruct Res. 47:433-51.
Soderstrom-Anttila, V., S. Makinen, T. Tuuri, and A.M. Suikkari. 2005. Favourable 
pregnancy results with insemination of in vitro matured oocytes from 
unstimulated patients. Hum Reprod. 20:1534-40.
Song, Z.H., W. Modi, and T.I. Bonner. 1995. Molecular cloning and chromosomal 
localization of human genes encoding three closely related G protein-coupled 
receptors. Genomics. 28:347-9.
Song, Z.H., W.S. Young, 3rd, M.J. Brownstein, and T.I. Bonner. 1994. Molecular 
cloning of a novel candidate G protein-coupled receptor from rat brain. FEBS 
Lett. 351:375-9.
Stanford, J.S., and J.V. Ruderman. 2005. Changes in regulatory phosphorylation of 
Cdc25C Ser287 and Wee1 Ser549 during normal cell cycle progression and 
checkpoint arrests. Mol Biol Cell. 16:5749-60.
Su, Y.Q., K. Sugiura, and J.J. Eppig. 2009. Mouse oocyte control of granulosa cell 
development and function: paracrine regulation of cumulus cell metabolism. 
Semin Reprod Med. 27:32-42.
Sugiura, K., Y.Q. Su, F.J. Diaz, S.A. Pangas, S. Sharma, K. Wigglesworth, M.J. O'Brien, 
M.M. Matzuk, S. Shimasaki, and J.J. Eppig. 2007. Oocyte-derived BMP15 and 
FGFs cooperate to promote glycolysis in cumulus cells. Development. 134:2593-
603.
Suh, Y.H., A. Terashima, R.S. Petralia, R.J. Wenthold, J.T. Isaac, K.W. Roche, and P.A. 
Roche. 2010. A neuronal role for SNAP-23 in postsynaptic glutamate receptor 
trafficking. Nat Neurosci. 13:338-43.
Suh, Y.H., A. Yoshimoto-Furusawa, K.A. Weih, L. Tessarollo, K.W. Roche, S. Mackem, 
and P.A. Roche. 2011. Deletion of SNAP-23 results in pre-implantation 
embryonic lethality in mice. PLoS One. 6:e18444.
Suikkari, A.M., and V. Soderstrom-Anttila. 2007. In-vitro maturation of eggs: is it really 
useful? Best Pract Res Clin Obstet Gynaecol. 21:145-55.
Suzuki, T., A. Boediono, M. Takagi, S. Saha, and C. Sumantri. 1996. Fertilization and 
development of frozen-thawed germinal vesicle bovine oocytes by a one-step 
dilution method in vitro. Cryobiology. 33:515-24.
Tanaka, S., K. Ishii, K. Kasai, S.O. Yoon, and Y. Saeki. 2007. Neural expression of G 
protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP 
levels and promotes neurite outgrowth. J Biol Chem. 282:10506-15.
Tanaka, S., I.M. Shaikh, E.A. Chiocca, and Y. Saeki. 2009. The Gs-linked receptor GPR3 
inhibits the proliferation of cerebellar granule cells during postnatal development. 
PLoS One. 4:e5922.
Terasaki, M., L.B. Chen, and K. Fujiwara. 1986. Microtubules and the endoplasmic 
reticulum are highly interdependent structures. J Cell Biol. 103:1557-68.
Terasaki, M., and L.A. Jaffe. 1993. Imaging endoplasmic reticulum in living sea urchin 
eggs. Methods Cell Biol. 38:211-20.
159 
 
 Terasaki, M., and L.A. Jaffe. 2004. Labeling of cell membranes and compartments for 
live cell fluorescence microscopy. Methods Cell Biol. 74:469-89.
Terasaki, M., and C. Sardet. 1991. Demonstration of calcium uptake and release by sea 
urchin egg cortical endoplasmic reticulum. J Cell Biol. 115:1031-7.
Tetsuka, M., Y. Saito, K. Imai, H. Doi, and K. Maruyama. 2004. The basic residues in the 
membrane-proximal C-terminal tail of the rat melanin-concentrating hormone 
receptor 1 are required for receptor function. Endocrinology. 145:3712-23.
Thathiah, A., K. Spittaels, M. Hoffmann, M. Staes, A. Cohen, K. Horre, M. Vanbrabant, 
F. Coun, V. Baekelandt, A. Delacourte, D.F. Fischer, D. Pollet, B. De Strooper, 
and P. Merchiers. 2009. The orphan G protein-coupled receptor 3 modulates 
amyloid-beta peptide generation in neurons. Science. 323:946-51.
Tobin, A.B. 2008. G-protein-coupled receptor phosphorylation: where, when and by 
whom. Br J Pharmacol. 153 Suppl 1:S167-76.
Tourino, C., E. Valjent, J. Ruiz-Medina, D. Herve, C. Ledent, and O. Valverde. 2012. 
The orphan receptor GPR3 modulates early phases of cocaine reinforcement. Br J 
Pharmacol.
Tsafriri, A., S.Y. Chun, R. Zhang, A.J. Hsueh, and M. Conti. 1996. Oocyte maturation 
involves compartmentalization and opposing changes of cAMP levels in follicular 
somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev 
Biol:393-402.
Tsai, P.S., T. van Haeften, and B.M. Gadella. 2010. Preparation of the cortical reaction: 
maturation-dependent migration of SNARE proteins, clathrin, and complexin to 
the porcine oocyte's surface blocks membrane traffic until fertilization. Biol 
Reprod. 84:327-35.
Uhlenbrock, K., H. Gassenhuber, and E. Kostenis. 2002. Sphingosine 1-phosphate is a 
ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G 
protein-coupled receptors. Cell Signal. 14:941-53.
Vaccari, S., K. Horner, L.M. Mehlmann, and M. Conti. 2008. Generation of mouse 
oocytes defective in cAMP synthesis and degradation: endogenous cyclic AMP is 
essential for meiotic arrest. Dev Biol. 316:124-34.
Vaccari, S., J.L. Weeks, 2nd, M. Hsieh, F.S. Menniti, and M. Conti. 2009. Cyclic GMP 
signaling is involved in the luteinizing hormone-dependent meiotic maturation of 
mouse oocytes. Biol Reprod. 81:595-604.
Valverde, O., E. Celerier, M. Baranyi, P. Vanderhaeghen, R. Maldonado, B. Sperlagh, G. 
Vassart, and C. Ledent. 2009. GPR3 receptor, a novel actor in the emotional-like 
responses. PLoS One. 4:e4704.
van der Bliek, A.M., T.E. Redelmeier, H. Damke, E.J. Tisdale, E.M. Meyerowitz, and 
S.L. Schmid. 1993. Mutations in human dynamin block an intermediate stage in 
coated vesicle formation. J Cell Biol. 122:553-563.
Varma, D.R. 1999. Ligand-independent negative chronotropic responses of rat and mouse 
right atria to beta-adrenoceptor antagonists. Can J Physiol Pharmacol. 77:943-9.
Venkatesan, S., A. Petrovic, M. Locati, Y.O. Kim, D. Weissman, and P.M. Murphy. 
2001. A membrane-proximal basic domain and cysteine cluster in the C-terminal 
tail of CCR5 constitute a bipartite motif critical for cell surface expression. J Biol 
Chem. 276:40133-45.
160 
 
 Vieira, A.D., F. Forell, C. Feltrin, and J.L. Rodrigues. 2008. Calves born after direct 
transfer of vitrified bovine in vitro-produced blastocysts derived from vitrified 
immature oocytes. Reprod Domest Anim. 43:314-8.
Vieira, A.D., A. Mezzalira, D.P. Barbieri, R.C. Lehmkuhl, M.I. Rubin, and G. Vajta. 
2002. Calves born after open pulled straw vitrification of immature bovine 
oocytes. Cryobiology. 45:91-4.
Vivarelli, E., M. Conti, M. De Felici, and G. Siracusa. 1983. Meiotic resumption and
intracellular cAMP levels in mouse oocytes treated with compounds which act on 
cAMP metabolism. Cell Differ. 12:271-6.
Wade, S.M., W.K. Lim, K.L. Lan, D.A. Chung, M. Nanamori, and R.R. Neubig. 1999. 
G(i) activator region of alpha(2A)-adrenergic receptors: distinct basic residues 
mediate G(i) versus G(s) activation. Mol Pharmacol. 56:1005-1013.
Waldhoer, M., P. Casarosa, M.M. Rosenkilde, M.J. Smit, R. Leurs, J.L. Whistler, and 
T.W. Schwartz. 2003. The carboxyl terminus of human cytomegalovirus-encoded 
7 transmembrane receptor US28 camouflages agonism by mediating constitutive 
endocytosis. J Biol Chem. 278:19473-19482.
Wang, J., and X.J. Liu. 2003. A G protein-coupled receptor kinase induces Xenopus 
oocyte maturation. J Biol Chem. 278:15809-14.
Webb, B.L., S.J. Hirst, and M.A. Giembycz. 2000. Protein kinase C isoenzymes: a review 
of their structure, regulation and role in regulating airways smooth muscle tone 
and mitogenesis. Br J Pharmacol. 130:1433-52.
Webb, R.J., L. Tinworth, G.M. Thomas, M. Zaccolo, and J. Carroll. 2008. 
Developmentally acquired PKA localisation in mouse oocytes and embryos. Dev 
Biol. 317:36-45.
Wessel, G.M., J.M. Brooks, E. Green, S. Haley, E. Voronina, J. Wong, V. Zaydfudim, 
and S. Conner. 2001. The biology of cortical granules. Int Rev Cytol. 209:117-
206.
Wolfe, B.L., and J. Trejo. 2007. Clathrin-dependent mechanisms of G protein-coupled 
receptor endocytosis. Traffic. 8:462-70.
Wu, C., R. Rui, J. Dai, C. Zhang, S. Ju, B. Xie, X. Lu, and X. Zheng. 2006. Effects of 
cryopreservation on the developmental competence, ultrastructure and 
cytoskeletal structure of porcine oocytes. Mol Reprod Dev. 73:1454-62.
Wu, G., J.G. Krupnick, J.L. Benovic, and S.M. Lanier. 1997. Interaction of arrestins with 
intracellular domains of muscarinic and alpha2-adrenergic receptors. J Biol Chem.
272:17836-17842.
Yan, C., P. Wang, J. DeMayo, F.J. DeMayo, J.A. Elvin, C. Carino, S.V. Prasad, S.S. 
Skinner, B.S. Dunbar, J.L. Dube, A.J. Celeste, and M.M. Matzuk. 2001. 
Synergistic roles of bone morphogenetic protein 15 and growth differentiation 
factor 9 in ovarian function. Mol Endocrinol. 15:854-66.
Yang, C., Y. Wei, S. Qi, L. Chen, Q. Zhang, J. Ma, Y. Lou, Y. Wang, Y. Hou, H. 
Schatten, Z. Liu, and Q. Sun. 2012. The G Protein Coupled Receptor 3 is involved 
in cAMP and cGMP Signaling and Maitenance of Meiotic Arrest in Porcine 
Oocytes. PLoS One. 7:e38807.
Yin, H., A. Chu, W. Li, B. Wang, F. Shelton, F. Otero, D.G. Nguyen, J.S. Caldwell, and 
Y.A. Chen. 2009. Lipid G protein-coupled receptor ligand identification using 
beta-arrestin PathHunter assay. J Biol Chem. 284:12328-38.
161 
 
 Zaccolo, M., and T. Pozzan. 2002. Discrete microdomains with high concentration of 
cAMP in stimulated rat neonatal cardiac myocytes. Science. 295:1711-5.
Zenzes, M.T., R. Bielecki, R.F. Casper, and S.P. Leibo. 2001. Effects of chilling to 0 
degrees C on the morphology of meiotic spindles in human metaphase II oocytes. 
Fertil Steril. 75:769-77.
Zhang, B.L., Y. Li, J.H. Ding, F.L. Dong, Y.J. Hou, B.C. Jiang, F.X. Shi, and Y.X. Xu. 
2012. Sphingosine 1-phosphate acts as an activator for the porcine Gpr3 of 
constitutively active G protein-coupled receptors. J Zhejiang Univ Sci B. 13:555-
566.
Zhang, J., L.S. Barak, P.H. Anborgh, S.A. Laporte, M.G. Caron, and S.S. Ferguson. 
1999. Cellular trafficking of G protein-coupled receptor/beta-arrestin endocytic 
complexes. J Biol Chem. 274:10999-1006.
Zhang, M., Y.Q. Su, K. Sugiura, G. Xia, and J.J. Eppig. 2010. Granulosa cell ligand 
NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes. Science.
330:366-9.
Zhou, S., B. Wang, F. Ni, J. Wang, Y. Cao, and X. Ma. 2009. GPR3 may not be a 
potential candidate gene for premature ovarian failure. Reprod Biomed Online.
20:53-5.
Zucker, R.S., and R.A. Steinhardt. 1978. Prevention of the cortical reaction in fertilized 
sea urchin eggs by injection of calcium-chelating ligands. Biochim Biophys Acta.
541:459-66.
162 
 
